<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP2015534950A - 
  Streptomyces microflavus strain and methods for its use for controlling plant diseases and pests
 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP2015534950A/en">
    <meta name="description" content="
   
    The present invention relates to a novel strain of Streptomyces microflavus and its use for controlling plant diseases or pests. The present invention also relates to a fermentation broth obtained by culturing a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin. The invention also relates to a method of producing a fermentation broth of a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin, which is digestible. Including culturing a Streptomyces strain under aerobic conditions in a medium containing a carbon source and a digestible nitrogen source, said medium being effective to achieve a gougerotin concentration of at least 1 g / L Contains amino acids in various concentrations. The present disclosure also relates to the molecular cloning of the gougerotin biosynthetic gene cluster from Streptomyces microflavus and the identification of individual genes within the gene cluster and the proteins encoded thereby. . A gougerotin gene cluster containing 13 open reading frames (ORFs) is located within a locus of Streptomyces microflavus.
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Streptomyces microflavus strain and methods for its use for controlling plant diseases and pests
 
     ">
    <meta name="DC.date" content="2013-10-11" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    The present invention relates to a novel strain of Streptomyces microflavus and its use for controlling plant diseases or pests. The present invention also relates to a fermentation broth obtained by culturing a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin. The invention also relates to a method of producing a fermentation broth of a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin, which is digestible. Including culturing a Streptomyces strain under aerobic conditions in a medium containing a carbon source and a digestible nitrogen source, said medium being effective to achieve a gougerotin concentration of at least 1 g / L Contains amino acids in various concentrations. The present disclosure also relates to the molecular cloning of the gougerotin biosynthetic gene cluster from Streptomyces microflavus and the identification of individual genes within the gene cluster and the proteins encoded thereby. . A gougerotin gene cluster containing 13 open reading frames (ORFs) is located within a locus of Streptomyces microflavus.
   
 
   ">
    <meta name="citation_patent_application_number" content="JP:2015536935A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/ee/ad/dd/8cf510021534ea/JP2015534950A.pdf">
    <meta name="citation_patent_publication_number" content="JP:2015534950:A">
    <meta name="DC.date" content="2015-12-07">
    <meta name="DC.contributor" content="キャンベル，ブライアン" scheme="inventor">
    <meta name="DC.contributor" content="カーティス，ダミアン" scheme="inventor">
    <meta name="DC.contributor" content="グアン，シャオフア" scheme="inventor">
    <meta name="DC.contributor" content="ギラバート−ゴヤ，マガリー" scheme="inventor">
    <meta name="DC.contributor" content="ジョー，ダニエル，エム" scheme="inventor">
    <meta name="DC.contributor" content="ルー，タラ" scheme="inventor">
    <meta name="DC.contributor" content="マルゴリス，ジョナサン，エス" scheme="inventor">
    <meta name="DC.contributor" content="ロイヤルティー，リード，ネイサン" scheme="inventor">
    <meta name="DC.contributor" content="サラザー，ジェラルド，ブーノ" scheme="inventor">
    <meta name="DC.contributor" content="セシン，デイビッド" scheme="inventor">
    <meta name="DC.contributor" content="スミス，フリスビー，デービス" scheme="inventor">
    <meta name="DC.contributor" content="テイラー，コリーン" scheme="inventor">
    <meta name="DC.contributor" content="ジュウ，ホーン" scheme="inventor">
    <meta name="DC.contributor" content="Bayer CropScience LP" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Streptomyces microflavus strain and methods for its use for controlling plant diseases and pests
 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA166302681" lang="EN" source="national office" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">本発明は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ ｍｉｃｒｏｆｌａｖｕｓ）の新規な菌株及び植物の病害又は害虫を防除するためのその使用方法に関する。本発明はまた、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することにより得られる発酵ブロスにも関し、ここで発酵ブロスは少なくとも約１ｇ／Ｌのグーゲロチンを含有している。また、本発明は、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスを製造する方法にも関し、ここで発酵ブロスは少なくとも約１ｇ／Ｌのグーゲロチンを含有し、この方法は消化可能な炭素源及び消化可能な窒素源を含有する培地中好気性条件下でストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することを含んでおり、前記培地は少なくとも１ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度のアミノ酸を含有している。本開示は、また、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ ｍｉｃｒｏｆｌａｖｕｓ）に由来のグーゲロチン生合成遺伝子クラスターの分子クローニング、及び、遺伝子クラスター内の個々の遺伝子の同定、並びに、それによりコードされるタンパク質にも関する。１３のオープンリーディングフレーム（ＯＲＦ）を含んでいるグーゲロチン遺伝子クラスターは、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ ｍｉｃｒｏｆｌａｖｕｓ）のある遺伝子座内に位置する。</span>The present invention relates to a novel strain of Streptomyces microflavus and its use for controlling plant diseases or pests. The present invention also relates to a fermentation broth obtained by culturing a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin. The invention also relates to a method of producing a fermentation broth of a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin, which is digestible. Including culturing a Streptomyces strain under aerobic conditions in a medium containing a carbon source and a digestible nitrogen source, said medium being effective to achieve a gougerotin concentration of at least 1 g / L Contains amino acids in various concentrations. The present disclosure also relates to the molecular cloning of the gougerotin biosynthetic gene cluster from Streptomyces microflavus and the identification of individual genes within the gene cluster and the proteins encoded thereby. . A gougerotin gene cluster containing 13 open reading frames (ORFs) is located within a locus of Streptomyces microflavus.</span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">12</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ff/7e/26/9f7223ebe95de9/2015534950-31.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/77/05/38/9c68afd13ca8df/2015534950-32.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/6c/c6/94/ce737a113aeb78/2015534950-33.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/52/f1/70/b5ae62efb8d9db/2015534950-34.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/af/65/91/56594147544eb1/2015534950-35.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c1/b8/d3/248b32dceb2bf4/2015534950-36.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/1c/7d/8c/26182d76d1aee3/2015534950-37.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/57/09/c8/539c7b1e78c834/2015534950-38.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/cb/df/08/e29ef5cf9664a4/2015534950-39.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/2f/2f/eb/075ea41605027b/2015534950-40.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ef/b7/59/c7327d53ed0b5c/2015534950-41.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a4/66/f1/193ef73ef072db/2015534950-42.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01"><a id="link" href="#" class="style-scope state-modifier">A01</a></state-modifier>
                  <span class="description style-scope classification-tree">AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N"><a id="link" href="#" class="style-scope state-modifier">A01N</a></state-modifier>
                  <span class="description style-scope classification-tree">PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N63/00"><a id="link" href="#" class="style-scope state-modifier">A01N63/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N63/20"><a id="link" href="#" class="style-scope state-modifier">A01N63/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Bacteria; Substances produced thereby or obtained therefrom</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="A01N63/28"><a id="link" href="#" class="style-scope state-modifier">A01N63/28</a></state-modifier>
                  <span class="description style-scope classification-tree">Streptomyces</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01"><a id="link" href="#" class="style-scope state-modifier">A01</a></state-modifier>
                  <span class="description style-scope classification-tree">AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N"><a id="link" href="#" class="style-scope state-modifier">A01N</a></state-modifier>
                  <span class="description style-scope classification-tree">PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/00"><a id="link" href="#" class="style-scope state-modifier">A01N43/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/48"><a id="link" href="#" class="style-scope state-modifier">A01N43/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A01N43/54"><a id="link" href="#" class="style-scope state-modifier">A01N43/54</a></state-modifier>
                  <span class="description style-scope classification-tree">1,3-Diazines; Hydrogenated 1,3-diazines</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/00"><a id="link" href="#" class="style-scope state-modifier">C12P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of compounds containing saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/26"><a id="link" href="#" class="style-scope state-modifier">C12P19/26</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of nitrogen-containing carbohydrates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/28"><a id="link" href="#" class="style-scope state-modifier">C12P19/28</a></state-modifier>
                  <span class="description style-scope classification-tree">N-glycosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/00"><a id="link" href="#" class="style-scope state-modifier">C12P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of compounds containing saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/26"><a id="link" href="#" class="style-scope state-modifier">C12P19/26</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of nitrogen-containing carbohydrates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/28"><a id="link" href="#" class="style-scope state-modifier">C12P19/28</a></state-modifier>
                  <span class="description style-scope classification-tree">N-glycosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/38"><a id="link" href="#" class="style-scope state-modifier">C12P19/38</a></state-modifier>
                  <span class="description style-scope classification-tree">Nucleosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C12P19/385"><a id="link" href="#" class="style-scope state-modifier">C12P19/385</a></state-modifier>
                  <span class="description style-scope classification-tree">Pyrimidine nucleosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 3 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP2015534950A</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published unexamined patent application (based on international application)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/ee/ad/dd/8cf510021534ea/JP2015534950A.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;seq&quot;,&quot;mite&quot;,&quot;gougerotin&quot;,&quot;strain&quot;,&quot;streptomyces&quot;]" data-before="20121011"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP2015534950A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2015534950A/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="キャンベル，ブライアン"><a id="link" href="#" class="style-scope state-modifier">キャンベル，ブライアン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="カーティス，ダミアン"><a id="link" href="#" class="style-scope state-modifier">カーティス，ダミアン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="グアン，シャオフア"><a id="link" href="#" class="style-scope state-modifier">グアン，シャオフア</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ギラバート−ゴヤ，マガリー"><a id="link" href="#" class="style-scope state-modifier">ギラバート−ゴヤ，マガリー</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ジョー，ダニエル，エム"><a id="link" href="#" class="style-scope state-modifier">ジョー，ダニエル，エム</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ルー，タラ"><a id="link" href="#" class="style-scope state-modifier">ルー，タラ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="マルゴリス，ジョナサン，エス"><a id="link" href="#" class="style-scope state-modifier">マルゴリス，ジョナサン，エス</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ロイヤルティー，リード，ネイサン"><a id="link" href="#" class="style-scope state-modifier">ロイヤルティー，リード，ネイサン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="サラザー，ジェラルド，ブーノ"><a id="link" href="#" class="style-scope state-modifier">サラザー，ジェラルド，ブーノ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="セシン，デイビッド"><a id="link" href="#" class="style-scope state-modifier">セシン，デイビッド</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="スミス，フリスビー，デービス"><a id="link" href="#" class="style-scope state-modifier">スミス，フリスビー，デービス</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="テイラー，コリーン"><a id="link" href="#" class="style-scope state-modifier">テイラー，コリーン</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ジュウ，ホーン"><a id="link" href="#" class="style-scope state-modifier">ジュウ，ホーン</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Bayer CropScience LP
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2013</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2765200A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP13154355.5A</div>
                <div class="style-scope application-timeline">Filing date: 2013-02-07</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2014059275A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/US2013/064537</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR20150071011A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1020157009064A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2015534950A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2015536935A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR112015008045A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR112015008045A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2906710A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP13785692.8A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW201438582A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">TW</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: TW102136778A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20140105862A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/052,094</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MX2015004401A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MX2015004401A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN104968794A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201380053082.XA</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2013329026A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2013329026A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PE20151080A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">PE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PE2015000480A</div>
                <div class="style-scope application-timeline">Filing date: 2013-10-11</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2015536935A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2013-10-11</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Bayer CropScience LP"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Bayer CropScience LP</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2015-12-07</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2015534950A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2015534950A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Pending</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (7)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (8)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=2015534950A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/2015534950/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP2015534950A">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES98260812" lang="EN" load-source="google" class="style-scope patent-text">
  <technical-field class="style-scope patent-text">
    <p num="0001" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、細菌菌株並びにその植物病害及び害虫を防除する能力の分野に係る。
</span>
&nbsp;&nbsp;The present invention relates to the field of bacterial strains and their ability to control plant diseases and pests.
</span>
    </p>
    <p num="0002" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">電子データとして提出された配列表への言及</u> <br class="style-scope patent-text">
  配列表の公式コピーは、２０１３年１０月１０日に作成された１７５キロバイトのサイズを有するファイル名「２５０−ＵＳ＿ＳＴ２５．ｔｘｔ」というＡＳＣＩＩ−形式の配列表として、本明細書と共に、ＥＦＳ−Ｗｅｂにより電子データとして提出されている。このＡＳＣＩＩ−形式の文書内に収容されている配列表は本明細書の一部であり、参照によりその全体を本明細書に組み入れる。
</span>The official copy of <u class="style-scope patent-text">the sequence listing which is referred to the sequence listing submitted as electronic data is</u> an ASCII-format sequence listing created on October 10, 2013 and having a file name “250-US_ST25.txt” having a size of 175 kilobytes. As well as this specification, it is submitted as electronic data by EFS-Web. The sequence listing contained within this ASCII-format document is part of this specification and is hereby incorporated by reference in its entirety.</span>
    </p>
  </technical-field>
  <background-art class="style-scope patent-text">
    <p num="0003" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  植物食性のダニ類、殊にハダニ類は、果樹園、温室並びに多くの野菜及び果実作物、例えばコショウ、トマト、ジャガイモ、トウナス、ナス、キュウリ及びイチゴの主要な農業害虫である。ダニはその鋭い口器を用いて葉及び／又は果実表面に損害を与える。植物の部分に対する直接損傷（斑点を生じるスティップリングといわれる）の他に、ダニによる摂食はまた、植物病害へのかかりやすさを増大させる。
</span>
&nbsp;&nbsp;Herbivorous mites, in particular spider mites, are the main agricultural pests of orchards, greenhouses and many vegetable and fruit crops such as pepper, tomatoes, potatoes, corns, eggplants, cucumbers and strawberries. Tick uses its sharp mouth to damage leaves and / or fruit surfaces. In addition to direct damage to plant parts (referred to as spotting stippling), tick feeding also increases susceptibility to plant diseases.
</span>
    </p>
  </background-art>
  
  <summary-of-invention class="style-scope patent-text">
    <tech-problem class="style-scope patent-text">
      <p num="0004" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ダニ類は昆虫というよりはダニ目であり、またダニに対して有効な広いスペクトルの殺虫剤は殆どない。ダニの特性及び利用可能な殺ダニ剤の特性のため、ダニの防除は難問となっている。例えば、ダニの中で経済的に最も重要な一群であるハダニは、通常植物の葉の裏面にいるので、処理するのが難しい。さらに、ダニは、多くが単一モードの作用様式を有する現在利用可能な殺ダニ剤に対して２〜４年以内に抵抗性を示すようになることが知られている。ダニの卵に対して活性を有する利用可能な殺ダニ剤は殆どなく、繰り返して施用する必要がある。従って、良好なノックダウン活性に加えて層透過性（ｔｒａｎｓｌａｍｉｎａｒ）で殺卵性の強力な残留活性を有する新しい殺ダニ剤が必要とされている。
</span>
&nbsp;&nbsp;Mites are mites rather than insects, and few broad-spectrum insecticides are effective against mites. Due to the characteristics of ticks and the characteristics of available acaricides, the control of ticks is a challenge. For example, spider mites, the most economically important group of mites, are usually difficult to treat because they are usually on the backside of the leaves of plants. Furthermore, mites are known to become resistant within 2-4 years to currently available acaricides, many of which have a unimodal mode of action. There are few available acaricides that are active on mite eggs and need to be applied repeatedly. Therefore, there is a need for new acaricides that have strong residual activity that is translaminar and ovicidal in addition to good knockdown activity.
</span>
      </p>
    </tech-problem>
    <tech-solution class="style-scope patent-text">
      <p num="0005" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異体（株）を提供する。１つの実施形態において、植物食性−殺ダニ性及び／又は殺真菌性の突然変異株はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｍ株である。本発明はまた、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異体（株）も提供する。
</span>
&nbsp;&nbsp;The present invention provides Streptomyces microflavus NRRL B-50550 strain or a phytophagous-acaricidal mutant strain derived therefrom. In one embodiment, the phytophagous-acaricidal and / or fungicidal mutant is a Streptomyces microflavus M strain. The present invention also provides a Streptomyces puniceus A strain or a phytophagous-acaricidal and / or fungicidal mutant (strain) derived therefrom.
</span>
      </p>
      <p num="0006" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、本発明は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異体（株）を含有する組成物を提供する。１つの態様において、組成物は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株の発酵産物である。また本発明は、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異体（株）を含有する組成物も提供する。１つの態様において、組成物は、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株の発酵産物である。
</span>
&nbsp;&nbsp;The present invention also provides a composition comprising a Streptomyces microflavus NRRL B-50550 strain or a phytophagous-acaricidal and / or fungicidal mutant (strain) derived therefrom. provide. In one embodiment, the composition is a fermentation product of a Streptomyces microflavus NRRL B-50550 strain or a phytophagous-acaricidal and / or fungicidal mutant strain derived therefrom. The present invention also provides a composition comprising a Streptomyces puniceus strain A or a phytophagous-acaricidal and / or fungicidal mutant strain derived therefrom. In one embodiment, the composition is a fermentation product of a Streptomyces puniceus A strain or a phytophagous-acaricidal and / or fungicidal mutant strain derived therefrom.
</span>
      </p>
      <p num="0007" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することによって得られる発酵産物も提供し、ここで発酵産物は少なくとも約１ｇ／Ｌのグーゲロチンを含有する。
</span>
&nbsp;&nbsp;The present invention also provides a fermentation product obtained by culturing a Streptomyces strain that produces gougerotin, wherein the fermentation product contains at least about 1 g / L of gougerotin.
</span>
      </p>
      <p num="0008" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、少なくとも約１ｇ／Ｌのグーゲロチンを含有する発酵ブロスも提供される。１つの実施形態において、この発酵ブロスは後処理に全くかけられていない。特定の実施形態において、発酵ブロスはストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株由来である。本発明に適したストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の種類は本明細書中で詳細に説明する。
</span>
&nbsp;&nbsp;Also provided is a fermentation broth containing at least about 1 g / L gougerotin. In one embodiment, the fermentation broth has not been subjected to any post-treatment. In certain embodiments, the fermentation broth is from a Streptomyces strain. The types of Streptomyces strains suitable for the present invention are described in detail herein.
</span>
      </p>
      <p num="0009" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵産物も提供され、ここで発酵産物は少なくとも約１ｇ／Ｌのグーゲロチンを含む。１つの実施形態において、発酵産物は発酵ブロスである。また、少なくとも約１ｇ／Ｌ、少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、少なくとも約７ｇ／Ｌ又は少なくとも約８ｇ／Ｌのグーゲロチンを含有する発酵ブロスも提供される。１つの実施形態において、発酵ブロスは約１ｇ／Ｌ〜約１５ｇ／Ｌの濃度でグーゲロチンを含有する。１つの実施形態において、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株はＳ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）、Ｓ．グリセウス（Ｓ．ｇｒｉｓｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）、又はＳ．グラミネアルス（Ｓ．ｇｒａｍｉｎｅａｒｕｓ）である。他に、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約８０％の配列同一性、少なくとも約８５％の配列同一性、少なくとも約９０％の配列同一性、又は少なくとも約９５％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む。１つの例において、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、配列番号：２、配列番号：４、配列番号：６，配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される全てのアミノ酸配列に対して少なくとも約８０％の配列同一性、少なくとも約８５％の配列同一性、少なくとも約９０％の配列同一性、又は少なくとも約９５％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む。別の例において、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、及び配列番号：３０からなる群から選択される全てのアミノ酸配列に対して少なくとも約８０％の配列同一性、少なくとも約８５％の配列同一性、少なくとも約９０％の配列同一性、又は少なくとも約９５％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む。他に、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、及び配列番号：３０からなる群から選択される全てのアミノ酸配列に対して少なくとも約８０％の配列同一性、少なくとも約８５％の配列同一性、少なくとも約９０％の配列同一性、又は少なくとも約９５％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む。別の実施形態において、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、配列番号：７７、配列番号：７８、配列番号：７９、配列番号：８０、配列番号：８１、配列番号：８２、配列番号：８３、配列番号：８４、配列番号：８５、配列番号：８６、配列番号：８７、及び配列番号：８８からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約８０％の配列同一性、少なくとも約８５％の配列同一性、少なくとも約９０％の配列同一性、又は少なくとも約９５％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む。１つの例において、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、配列番号：７７、配列番号：７８、配列番号：７９、配列番号：８０、配列番号：８１、配列番号：８２、配列番号：８３、配列番号：８４、配列番号：８５、配列番号：８６、配列番号：８７、及び配列番号：８８からなる群から選択される全てのアミノ酸配列に対して少なくとも約８０％の配列同一性、少なくとも約８５％の配列同一性、少なくとも約９０％の配列同一性、又は少なくとも約９５％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む。さらにもう１つ別の実施形態において、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株である。他には、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性の突然変異株である。さらに他には、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｍ株である。
</span>
&nbsp;&nbsp;Also provided is a fermentation product of a Streptomyces strain that produces gougerotin, wherein the fermentation product contains at least about 1 g / L of gougerotin. In one embodiment, the fermentation product is a fermentation broth. Also, at least about 1 g / L, at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, at least about 6 g / L, at least about 7 g / L, or at least about 8 g / L. Also provided is a fermentation broth containing gougerotin. In one embodiment, the fermentation broth contains gougerotin at a concentration of about 1 g / L to about 15 g / L. In one embodiment, the Streptomyces strain that produces gougerotin is S. cerevisiae. S. microflavus, S. S. griseus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. S. alboviridis, S. alboviridis S. puniceus, or S. Gramineales. In addition, Streptomyces strains that produce gougerotin are SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16. SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and at least one amino acid sequence selected from the group consisting of SEQ ID NO: 42 A nucleic acid sequence encoding an amino acid sequence having at least about 80% sequence identity, at least about 85% sequence identity, at least about 90% sequence identity, or at least about 95% sequence identity. In one example, the Streptomyces strain that produces gougerotin is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: : 16, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and all amino acid sequences selected from the group consisting of SEQ ID NO: 42 Nucleic acid sequences encoding amino acid sequences having at least about 80% sequence identity, at least about 85% sequence identity, at least about 90% sequence identity, or at least about 95% sequence identity. In another example, the Streptomyces strain that produces gougerotin is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: : 16, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, and at least about 80 for all amino acid sequences selected from the group consisting of SEQ ID NO: 30 A nucleic acid sequence encoding an amino acid sequence having% sequence identity, at least about 85% sequence identity, at least about 90% sequence identity, or at least about 95% sequence identity. In addition, the strains of Streptomyces producing gougerotin are SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18. At least about 80% sequence identity to all amino acid sequences selected from the group consisting of: SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, and SEQ ID NO: 30, Nucleic acid sequences encoding amino acid sequences having about 85% sequence identity, at least about 90% sequence identity, or at least about 95% sequence identity. In another embodiment, the Streptomyces strain that produces gougerotin is SEQ ID NO: 77, SEQ ID NO: 78, SEQ ID NO: 79, SEQ ID NO: 80, SEQ ID NO: 81, SEQ ID NO: 82, sequence. SEQ ID NO: 83, SEQ ID NO: 84, SEQ ID NO: 85, SEQ ID NO: 86, SEQ ID NO: 87, and at least about 80% of the sequence with respect to at least one amino acid sequence selected from the group consisting of SEQ ID NO: 88 Nucleic acid sequences encoding amino acid sequences having identity, at least about 85% sequence identity, at least about 90% sequence identity, or at least about 95% sequence identity. In one example, the Streptomyces strain that produces gougerotin is SEQ ID NO: 77, SEQ ID NO: 78, SEQ ID NO: 79, SEQ ID NO: 80, SEQ ID NO: 81, SEQ ID NO: 82, SEQ ID NO: 82. : 83, SEQ ID NO: 84, SEQ ID NO: 85, SEQ ID NO: 86, SEQ ID NO: 87, and SEQ ID NO: 88, at least about 80% sequence identity to all amino acid sequences selected from the group consisting of A nucleic acid sequence encoding an amino acid sequence having at least about 85% sequence identity, at least about 90% sequence identity, or at least about 95% sequence identity. In yet another embodiment, the Streptomyces strain that produces gougerotin is a Streptomyces microflavus NRRL B-50550 strain or a phytophagocytic-acaricidal and / or derived therefrom. It is a fungicidal mutant. Others are Streptomyces puniceus strain A or a phytophagous-acaricidal mutant derived therefrom. Still another is the Streptomyces microflavus M strain.
</span>
      </p>
      <p num="0010" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスを製造する方法も提供し、ここで発酵ブロスは少なくとも約０．５ｇ／Ｌのグーゲロチンを含有し、この方法は消化可能な炭素源及び消化可能な窒素源を含有する培地中において前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を好気性条件下で培養することを含み、ここで培地は少なくとも０．５ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度でアミノ酸を含有する。また、本発明は、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスを製造する方法も提供し、ここで発酵ブロスは少なくとも約１ｇ／Ｌのグーゲロチンを含有し、この方法は消化可能な炭素源及び消化可能な窒素源を含有する培地中において前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を好気性条件下で培養することを含み、ここで培地は少なくとも１ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度でアミノ酸を含有する。本発明はまた、植物を処理して植物病害又は害虫を防除する方法も提供し、この方法はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株を植物、植物の部分及び／又は植物の生育場所に施用することを含む。１つの実施形態においては、菌株の発酵産物又はそれから誘導される突然変異体の発酵産物を植物及び／又は植物の生育場所に施用する。
</span>
&nbsp;&nbsp;The present invention also provides a method for producing a fermentation broth of a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 0.5 g / L of gougerotin, which is digestible. Culturing the Streptomyces strain under aerobic conditions in a medium containing a fresh carbon source and a digestible nitrogen source, wherein the medium achieves a gougerotin concentration of at least 0.5 g / L Contains amino acids in a concentration effective to do so. The present invention also provides a method for producing a fermentation broth of a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin, which is digestible. Culturing the Streptomyces strain in an aerobic condition in a medium containing a carbon source and a digestible nitrogen source, wherein the medium achieves a gougerotin concentration of at least 1 g / L. Contains amino acids in effective concentrations. The present invention also provides a method of treating a plant to control a plant disease or pest, the method comprising a Streptomyces microflavus NRRL B-50550 strain or a phytophagocytic-acaricidal property derived therefrom. Application to the plant, plant part and / or plant growth location. In one embodiment, the fermentation product of the strain or the mutant fermentation product derived therefrom is applied to the plant and / or plant growth site.
</span>
      </p>
      <p num="0011" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、植物を処理して植物病害又は害虫を防除する方法を提供し、この方法はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）株、例えばストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株を植物、植物の部分及び／又は植物の生育場所に施用することを含む。１つの実施形態においては、菌株の発酵産物又はそれから誘導される突然変異体の発酵産物を植物及び／又は植物の生育場所に施用する。
</span>
&nbsp;&nbsp;The present invention also provides a method of treating a plant to control a plant disease or pest, which method comprises a Streptomyces microflavus strain, such as the Streptomyces microflavus strain NRRL-50550. Or applying a phytophagous-acaricidal mutant derived therefrom to plants, plant parts and / or plant habitats. In one embodiment, the fermentation product of the strain or the mutant fermentation product derived therefrom is applied to the plant and / or plant growth site.
</span>
      </p>
      <p num="0012" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）株、例えばストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の株を植物又は植物を取り巻く土壌に施用することを含む、植物食性のダニ又は昆虫を防除する方法も提供する。１つの実施形態においては、菌株の発酵産物又はそれから誘導される突然変異体の発酵産物を植物及び／又は植物の生育場所に施用する。
</span>
&nbsp;&nbsp;The present invention also encompasses a Streptomyces microflavus strain, such as a Streptomyces microflavus NRRL B-50550 strain or a phytophagocytic-acaricidal strain derived therefrom. Also provided is a method for controlling phytophagous mites or insects, comprising applying to soil. In one embodiment, the fermentation product of the strain or the mutant fermentation product derived therefrom is applied to the plant and / or plant growth site.
</span>
      </p>
      <p num="0013" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、グーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスを製造する方法も提供され、ここで発酵ブロスは少なくとも約１ｇ／Ｌのグーゲロチンを含有し、この方法は消化可能な炭素源及び消化可能な窒素源を含有する培地中において好気性条件下でストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することを含み、ここで培地は少なくとも１ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度でアミノ酸を含有する。１つの実施形態において、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、培地が少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、少なくとも約７ｇ／Ｌ又は少なくとも約８ｇ／Ｌのグーゲロチンの濃度でグーゲロチンを含有するようになるまで培地で培養される。他に、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、培地が約１ｇ／Ｌ〜約１５ｇ／Ｌのグーゲロチンの範囲の濃度でグーゲロチンを含有するようになるまで培地で培養される。
</span>
&nbsp;&nbsp;Also provided is a method of producing a fermentation broth of a Streptomyces strain that produces gougerotin, wherein the fermentation broth contains at least about 1 g / L of gougerotin, the method comprising a digestible carbon source and digestion Culturing the Streptomyces strain in an aerobic condition in a medium containing a possible nitrogen source, wherein the medium is an amino acid at a concentration effective to achieve a gougerotin concentration of at least 1 g / L. Containing. In one embodiment, the Streptomyces strain has a medium of at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, at least about 6 g / L, at least about 7 g. Incubate in medium until it contains gougerotin at a concentration of / L or at least about 8 g / L of gougerotin. Alternatively, the Streptomyces strain is cultured in the medium until the medium contains gougerotin at a concentration in the range of about 1 g / L to about 15 g / L of gougerotin.
</span>
      </p>
      <p num="0014" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵ブロスを製造する方法の１つの実施形態において、アミノ酸はグリシン、グルタミン酸、グルタミン、セリン及びこれらの混合物からなる群から選択される。１つの例において、培地は、少なくとも約２ｇ／Ｌの初期濃度でアミノ酸を含有する。特定の例において、培地は、グリシンをある初期濃度で、及び／又はグルタミン酸を約５ｇ／Ｌ〜約１５ｇ／Ｌの初期濃度で含有する。
</span>
&nbsp;&nbsp;In one embodiment of the method for producing the fermentation broth, the amino acid is selected from the group consisting of glycine, glutamic acid, glutamine, serine and mixtures thereof. In one example, the medium contains amino acids at an initial concentration of at least about 2 g / L. In particular examples, the medium contains glycine at an initial concentration and / or glutamic acid at an initial concentration of about 5 g / L to about 15 g / L.
</span>
      </p>
      <p num="0015" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  培地は、上記のように、１つの実施形態において、炭素源としてグルコース及びオリゴ糖の混合物を含有する。１つの例において、オリゴ糖はマルトデキストリン又はデキストリンである。特定の例において、培地中の初期のマルトデキストリン濃度は約５０ｇ／Ｌ〜約１００ｇ／Ｌである。他に、初期のマルトデキストリン濃度は約６０ｇ／Ｌ〜約８０ｇ／Ｌである。
</span>
&nbsp;&nbsp;As described above, the medium contains, in one embodiment, a mixture of glucose and oligosaccharides as a carbon source. In one example, the oligosaccharide is maltodextrin or dextrin. In particular examples, the initial maltodextrin concentration in the medium is from about 50 g / L to about 100 g / L. Alternatively, the initial maltodextrin concentration is from about 60 g / L to about 80 g / L.
</span>
      </p>
      <p num="0016" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、培地中の初期のグルコース濃度は約２０ｇ／Ｌ〜６０ｇ／Ｌ又は約３０ｇ／Ｌ〜約５０ｇ／Ｌである。
</span>
&nbsp;&nbsp;In one embodiment, the initial glucose concentration in the medium is about 20 g / L to 60 g / L or about 30 g / L to about 50 g / L.
</span>
      </p>
      <p num="0017" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、培地は、約１ｇ／Ｌ〜３ｇ／Ｌの初期濃度で炭酸カルシウムを含有する。
</span>
&nbsp;&nbsp;In one embodiment, the medium contains calcium carbonate at an initial concentration of about 1 g / L to 3 g / L.
</span>
      </p>
      <p num="0018" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、窒素源は少なくとも部分的に、大豆ペプトン、大豆酸加水分解物、大豆粉加水分解物、カゼイン加水分解物、酵母エキス、及びこれらの混合物からなる群から選択される。
</span>
&nbsp;&nbsp;In one embodiment, the nitrogen source is at least partially selected from the group consisting of soy peptone, soy acid hydrolyzate, soy flour hydrolysate, casein hydrolysate, yeast extract, and mixtures thereof.
</span>
      </p>
      <p num="0019" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上記したグーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）株のいずれもこの方法を実施するのに使用することができる。
</span>
&nbsp;&nbsp;Any of the Streptomyces strains that produce gougerotin described above can be used to carry out this method.
</span>
      </p>
      <p num="0020" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、消化可能な炭素源及び消化可能な窒素源を含有する培地中において好気性条件下でグーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することを含む、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロス中のグーゲロチンレベルを高める方法も提供され、ここで培地は約１ｇ／Ｌ、約２ｇ／Ｌ、約３ｇ／Ｌ、約４ｇ／Ｌ、約５ｇ／Ｌ、約６ｇ／Ｌ、約７ｇ／Ｌ、約８ｇ／Ｌ、約９ｇ／Ｌ、又は約１０ｇ／Ｌ未満の１種以上のアミノ酸を含有する培地で達成されるグーゲロチン濃度より少なくとも２倍高いグーゲロチン濃度を達成するのに有効な濃度でアミノ酸を含有する。１つの実施形態において、培地中に使用されるアミノ酸はグルタミン酸、セリン及び／又はグリシンである。１つの実施形態において、グーゲロチンの高まったレベルを得るのに使用される培地（すなわち、増強培地）中のアミノ酸濃度は約２ｇ／Ｌ〜約１５ｇ／Ｌであり、達成されるグーゲロチン濃度は出発培地で達成されるものの少なくとも２倍であり、この出発培地は１つの実施形態において増強培地に含有されるアミノ酸の濃度の約１／２以下を含有する。
</span>
&nbsp;&nbsp;A Streptomyces strain comprising culturing a Streptomyces strain that produces gougerotin under aerobic conditions in a medium containing a digestible carbon source and a digestible nitrogen source. Also provided is a method of increasing gougerotin levels in a fermentation broth, wherein the medium is about 1 g / L, about 2 g / L, about 3 g / L, about 4 g / L, about 5 g / L, about 6 g / L, about Effective to achieve a gougerotin concentration that is at least twice as high as that achieved with media containing one or more amino acids less than 7 g / L, about 8 g / L, about 9 g / L, or about 10 g / L Contains amino acids in concentration. In one embodiment, the amino acid used in the medium is glutamic acid, serine and / or glycine. In one embodiment, the amino acid concentration in the medium used to obtain elevated levels of gougerotin (ie, enhanced medium) is from about 2 g / L to about 15 g / L, and the achieved gougerotin concentration is the starting medium. This starting medium contains in one embodiment about half or less of the concentration of amino acids contained in the enhancement medium.
</span>
      </p>
      <p num="0021" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  上記したグーゲロチンを産生するストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株のいずれもこの方法を実施するのに使用することができる。
</span>
&nbsp;&nbsp;Any of the Streptomyces strains producing Gougerotin described above can be used to carry out this method.
</span>
      </p>
      <p num="0022" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）由来（特にストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０由来）のグーゲロチン生合成遺伝子クラスター、遺伝子クラスター内の個々の遺伝子の特性決定、及びそれによりコードされるタンパク質も提供する。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）由来のグーゲロチン遺伝子クラスターが開示されており、この遺伝子クラスターはそれぞれＯＲＦ４２５１〜４２５３、４２５５〜４２５９、４２６１〜４２６５、及び４２７１（それぞれ配列番号：１、３、５、９、１１、１３、１５、１７、２１、２３、２５、２７、２９、及び４１）といわれ、本明細書中でそれぞれＧｏｕＡ、ＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、ＧｏｕＭ、及びＧｏｕＮとされている１４のオープンリーディングフレーム（ＯＲＦ）を含む。対応するタンパク質はそれぞれ配列番号：２、４、６、１０、１２、１４、１６、１８、２２、２４、２６、２８、３０、及び４２として示されている。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）由来のグーゲロチン生合成遺伝子クラスター及びフランキング領域の幾つかを含むゲノムＤＮＡ配列は配列番号：４３に示されており、遺伝子ＧｏｕＡ〜ＧｏｕＮの位置が示されている。
</span>
&nbsp;&nbsp;The present invention also relates to the determination of individual genes within a gougerotin biosynthetic gene cluster from Streptomyces microflavus (especially from Streptomyces microflavus NRRL B-50550), gene clusters, And the proteins encoded thereby. A gougerotin gene cluster from Streptomyces microflavus has been disclosed, which is ORF 4251-4253, 4255-4259, 4261-4265, and 4271 (SEQ ID NO: 1, 3, 5, respectively). 9, 11, 13, 15, 17, 21, 23, 25, 27, 29, and 41). In this specification, GouA, GouB, GouC, GouD, GouE, GouF, GouG, GouH, GouI, It includes 14 open reading frames (ORFs) designated GouJ, GouK, GouL, GouM, and GouN. The corresponding proteins are shown as SEQ ID NOs: 2, 4, 6, 10, 12, 14, 16, 18, 22, 24, 26, 28, 30, and 42, respectively. A genomic DNA sequence containing the Guguerotin biosynthetic gene cluster from Streptomyces microflavus and some of the flanking regions is shown in SEQ ID NO: 43, and the positions of the genes GouA to GOUN are shown. .
</span>
      </p>
      <p num="0023" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）由来（特にストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株由来）の部分的なグーゲロチン生合成遺伝子クラスター、遺伝子クラスター内の個々の遺伝子の特性決定、及びそれによりコードされるタンパク質を提供する。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）由来の部分的なグーゲロチン遺伝子クラスターが開示され、この開示された遺伝子クラスターは１２のオープンリーディングフレーム（ＯＲＦ）を含み、それぞれＯＲＦ（それぞれ配列番号：８９−１００）といわれ、本明細書中ではそれぞれＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、ＧｏｕＭとされている。これらは、それぞれ配列番号：３、５、９、１１、１３、１５、１７、２１、２３、２５、２７、及び２９に提供され、本明細書でそれぞれＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、及びＧｏｕＭとされている遺伝子に対してオルソロガスである。対応するタンパク質はそれぞれ配列番号：７７−８８に示されている。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）由来のグーゲロチン生合成遺伝子クラスターを含むゲノムＤＮＡ配列は配列番号：７６に提供されている。
</span>
&nbsp;&nbsp;The present invention also provides a partial gougerotin biosynthetic gene cluster from Streptomyces puniceus (particularly from Streptomyces puniceus strain A), characterization of individual genes within the gene cluster And the protein encoded thereby. Disclosed are partial gougerotin gene clusters from Streptomyces puniceus, the disclosed gene clusters comprising 12 open reading frames (ORFs), each ORF (SEQ ID NOs: 89-100, respectively) In this specification, it is referred to as GouB, GouC, GouD, GouE, GouF, GouG, GouH, GouI, GouJ, GouK, GouL, GouM, respectively. These are provided in SEQ ID NOs: 3, 5, 9, 11, 13, 15, 17, 21, 23, 25, 27, and 29, respectively, where GouB, GouC, GouD, GouE, GouF, It is orthologous to the genes designated as GouG, GouH, GouI, GouJ, GouK, GouL and GouM. The corresponding proteins are shown in SEQ ID NOs: 77-88, respectively. A genomic DNA sequence comprising a gougerotin biosynthetic gene cluster from Streptomyces puniceus is provided in SEQ ID NO: 76.
</span>
      </p>
      <p num="0024" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、核酸配列の発現を指令する少なくとも１の外因性及び／又は異種調節要素に機能可能なように結合された、配列番号：４３のヌクレオチド配列に対して少なくとも７０％の配列同一性を有する核酸配列が提供される。この核酸配列はさらに、配列番号：４３の位置１０８２０〜位置１２０１３のヌクレオチド配列を含んでいてもよく、及び／又はさらに配列番号：４３の位置１３２１９〜位置１４３３４のヌクレオチド配列を含んでいてもよい。前記核酸配列はＳ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）、Ｓ．グリセウス（Ｓ．ｇｒｉｃｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）、又はＳ．グラミネアルス（Ｓ．ｇｒａｍｉｎｅａｒｕｓ）から単離することができる。
</span>
&nbsp;&nbsp;A nucleic acid having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 43 operably linked to at least one exogenous and / or heterologous regulatory element that directs expression of the nucleic acid sequence An array is provided. This nucleic acid sequence may further comprise the nucleotide sequence of positions 10820 to 12013 of SEQ ID NO: 43 and / or may further comprise the nucleotide sequence of positions 13219 to 14334 of SEQ ID NO: 43. The nucleic acid sequence is S. cerevisiae. S. microflavus, S. S. griiceus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. S. alboviridis, S. alboviridis S. puniceus, or S. It can be isolated from S. graminearus.
</span>
      </p>
      <p num="0025" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、本明細書、特に直前の段落に記載されている核酸配列のいずれか１つを含む宿主細胞が提供される。さらにまた、前記核酸配列のいずれか１つを含む発現ベクター、並びに前記ベクターを含む宿主細胞が提供される。
</span>
&nbsp;&nbsp;Also provided is a host cell comprising any one of the nucleic acid sequences described herein, particularly in the immediately preceding paragraph. Furthermore, an expression vector comprising any one of the nucleic acid sequences, and a host cell comprising the vector are provided.
</span>
      </p>
      <p num="0026" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属のグーゲロチン又はグーゲロチン産生性細菌を培地中で培養して前記グーゲロチン又はグーゲロチンアナログを産生させ培地中に排泄させ、前記グーゲロチン又はグーゲロチンアナログを培地から収集することを含む、グーゲロチン又はグーゲロチンアナログを製造する方法が提供され、ここで前記細菌は配列番号：４３のヌクレオチド配列に対して少なくとも７０％の配列同一性を有する核酸配列の発現を高めるように改変されている。細菌はＳ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）、Ｓ．グリセウス（Ｓ．ｇｒｉｃｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）、及びＳ．グラミネアルス（Ｓ．ｇｒａｍｉｎｅａｒｕｓ）からなる群から選択され得る。
</span>
&nbsp;&nbsp;Culturing a gougerotin or gougerotin-producing bacterium belonging to the genus Streptomyces in a medium to produce the gougerotin or the gougerotin analog, excreting it in the medium, and collecting the gougerotin or the gougerotin analog from the medium. Wherein the bacterium is modified to enhance the expression of a nucleic acid sequence having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 43. Has been. The bacteria are S. cerevisiae. S. microflavus, S. S. griiceus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. S. alboviridis, S. alboviridis S. puniceus, and S. It can be selected from the group consisting of S. graminearus.
</span>
      </p>
      <p num="0027" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン又はグーゲロチンアナログを製造する方法が提供され、ここで、該方法は、以下のステップを含んでいる：（ａ）配列番号：４３の核酸配列を含有し、さらに、配列番号：４３の位置１０８２０〜位置１２０１３のヌクレオチド配列を含有し、及び／又は、さらに、配列番号：４３の位置１３２１９〜位置１４３３４のヌクレオチド配列を含有している組換え発現ベクターを構築するステップ；（ｂ）ステップ（ａ）の核酸配列を含有する発現ベクターで宿主細胞を形質転換して形質転換体を生成させるステップ；（ｃ）ステップ（ｂ）の形質転換体を培養するステップ；及び（ｄ）ステップ（ｃ）の形質転換体の培養産物から前記グーゲロチン又はグーゲロチンアナログを単離し精製するステップ。
</span>
&nbsp;&nbsp;A method for producing gougerotin or a gougerotin analog is provided, wherein the method comprises the following steps: (a) containing the nucleic acid sequence of SEQ ID NO: 43, and further comprising of SEQ ID NO: 43 Constructing a recombinant expression vector containing the nucleotide sequence of position 10820 to position 12013 and / or further containing the nucleotide sequence of position 13219 to position 14334 of SEQ ID NO: 43; (b) step ( a) transforming a host cell with an expression vector containing the nucleic acid sequence of a) to produce a transformant; (c) culturing the transformant of step (b); and (d) step (c). Isolating and purifying the gougerotin or the gougerotin analog from the culture product of the transformant.
</span>
      </p>
      <p num="0028" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも７０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含むトランスジェニック原核生物細胞が提供される。別の実施形態において、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも７５％の配列同一性、少なくとも８０％の配列同一性、少なくとも８５％の配列同一性、少なくとも９０％の配列同一性、少なくとも９５％の配列同一性、又は少なくとも９９％の配列同一性を有するアミノ酸配列をコードする核酸配列を含むトランスジェニック原核生物細胞が提供される。
</span>
&nbsp;&nbsp;SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, Nucleic acid encoding an amino acid sequence having at least 70% sequence identity to at least one amino acid sequence selected from the group consisting of SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42 A transgenic prokaryotic cell comprising the sequence is provided. In another embodiment, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 22 At least 75% sequence identity to at least one amino acid sequence selected from the group consisting of: SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42, Comprising a nucleic acid sequence encoding an amino acid sequence having 80% sequence identity, at least 85% sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity Transgenic prokaryotic cells are provided.
</span>
      </p>
      <p num="0029" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：７７、配列番号：７８、配列番号：７９、配列番号：８０、配列番号：８１、配列番号：８２、配列番号：８３、配列番号：８４、配列番号：８５、配列番号：８６、配列番号：８７、配列番号：８８からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも７０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含むトランスジェニック原核生物細胞も提供される。別の実施形態において、配列番号：７７、配列番号：７８、配列番号：７９、配列番号：８０、配列番号：８１、配列番号：８２、配列番号：８３、配列番号：８４、配列番号：８５、配列番号：８６、配列番号：８７、配列番号：８８からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも７０％の配列同一性、少なくとも８０％の配列同一性、少なくとも８５％の配列同一性、少なくとも９０％の配列同一性、少なくとも９５％の配列同一性、又は少なくとも９９％の配列同一性を有するアミノ酸配列をコードする核酸配列を含むトランスジェニック原核生物細胞が提供される。
</span>
&nbsp;&nbsp;SEQ ID NO: 77, SEQ ID NO: 78, SEQ ID NO: 79, SEQ ID NO: 80, SEQ ID NO: 81, SEQ ID NO: 82, SEQ ID NO: 83, SEQ ID NO: 84, SEQ ID NO: 85, SEQ ID NO: 86, Also provided is a transgenic prokaryotic cell comprising a nucleic acid sequence encoding an amino acid sequence having at least 70% sequence identity to at least one amino acid sequence selected from the group consisting of SEQ ID NO: 87, SEQ ID NO: 88. The In another embodiment, SEQ ID NO: 77, SEQ ID NO: 78, SEQ ID NO: 79, SEQ ID NO: 80, SEQ ID NO: 81, SEQ ID NO: 82, SEQ ID NO: 83, SEQ ID NO: 84, SEQ ID NO: 85 , At least 70% sequence identity, at least 80% sequence identity, at least 85% to at least one amino acid sequence selected from the group consisting of: SEQ ID NO: 86, SEQ ID NO: 87, SEQ ID NO: 88 Transgenic prokaryotic cells comprising a nucleic acid sequence encoding an amino acid sequence having sequence identity, at least 90% sequence identity, at least 95% sequence identity, or at least 99% sequence identity are provided.
</span>
      </p>
      <p num="0030" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、配列番号：１、配列番号：３、配列番号：５、配列番号：９、配列番号：１１、配列番号：１３、配列番号：１５、配列番号：１７、配列番号：２１、配列番号：２３、配列番号：２５、配列番号：２７、配列番号：２９、及び配列番号：４１からなる群から選択される核酸配列に対して少なくとも７０％の配列同一性を有し、さらに外因性の制限酵素開裂部位を含む核酸配列を含む核酸配列も提供される。
</span>
&nbsp;&nbsp;Also, SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 23, having at least 70% sequence identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29, and SEQ ID NO: 41, and exogenous restriction Nucleic acid sequences are also provided that include a nucleic acid sequence that includes an enzyme cleavage site.
</span>
      </p>
    </tech-solution>
  </summary-of-invention>
  
  <description-of-drawings class="style-scope patent-text">
    <p num="0031" class="style-scope patent-text">
      <figref num="1" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１は、細菌候補株を用い、ナミハダニを寄生させたライマメ植物の葉に菌株の希釈した発酵産物を噴霧したときのＵＶ安定性試験の結果を示す。薄い灰色の横棒（各菌株について下の棒）はＵＶ光照射がないときの抗殺ダニ活性を表し、濃い灰色の横棒（各菌株について上の棒）はＵＶ光を２４時間照射した後の抗殺ダニ活性を表す。５日目、植物のダニ及び卵の存在を１〜４の目盛で評価した。</span>FIG. 1 shows the results of a UV stability test using a bacterial candidate strain and spraying a fermented product obtained by diluting the strain on the leaves of a lentil plant infested with spider mites. The light gray horizontal bar (bottom bar for each strain) represents anti-miticidal activity in the absence of UV light irradiation, and the dark gray horizontal bar (top bar for each strain) after UV light irradiation for 24 hours. Represents anti-miticidal activity of. On day 5, the presence of plant ticks and eggs was evaluated on a scale of 1-4.</span>
      </figref>
      <figref num="2" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図２は、試験した細菌候補株の層透過活性を、ナミハダニを寄生させたライマメ植物の葉に菌株の希釈した発酵産物を噴霧して試験したときの結果を示す。薄い灰色の横棒（各菌株について下の棒）は層透過性の（抗殺ダニ）活性を表し、濃い灰色の横棒（各菌株について上の棒）は全抗殺ダニ活性を表す。６日目、植物のダニ及び卵の存在を１〜４の目盛で評価した。</span>FIG. 2 shows the results when the bacterial permeation activity of the tested bacterial strains was tested by spraying the diluted fermentation products of the strains on the leaves of Lima spruce plants infested with spider mites. The light gray horizontal bar (bottom bar for each strain) represents laminar permeable (anti-miticide) activity, and the dark gray horizontal bar (top bar for each strain) represents total anti-miticidal activity. On day 6, the presence of plant mites and eggs was evaluated on a scale of 1-4.</span>
      </figref>
      <figref num="3" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図３は、１Ｌの振盪フラスコで増殖させたストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株の突然変異体における、親の菌株に対して増大したグーゲロチン産生を示す。</span>FIG. 3 shows increased gougerotin production relative to the parental strain in a mutant of Streptomyces microflavus NRRL B-50550 grown in a 1 L shake flask.</span>
      </figref>
      <figref num="4" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図４は、５Ｌのバイオリアクターで増殖させたストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株の突然変異体における、親の菌株に対して増大したグーゲロチン産生を示す。</span>FIG. 4 shows increased gougerotin production relative to the parental strain in a mutant of Streptomyces microflavus NRRL B-50550 grown in a 5 L bioreactor.</span>
      </figref>
      <figref num="5" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図５は、グーゲロチンの化学構造、並びにそのセリン、糖、シトシン及びサルコシンサブドメインを示す。</span>FIG. 5 shows the chemical structure of gougerotin and its serine, sugar, cytosine and sarcosine subdomains.</span>
      </figref>
      <figref num="6" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図６は、グーゲロチンに対する可能な生合成経路を示す。</span>FIG. 6 shows a possible biosynthetic pathway for gougerotin.</span>
      </figref>
      <figref num="7" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図７は、グーゲロチンの特定のサブドメイン構造に関与するか及び／又はそれを担う可能性があるオープンリーディングフレーム（ＯＲＦ）の番号を併記したグーゲロチンの化学構造を示す。</span>FIG. 7 shows the chemical structure of gougerotin, along with the number of open reading frames (ORFs) involved in and / or possibly responsible for a particular subdomain structure of gougerotin.</span>
      </figref>
      <figref num="8" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図８は、グーゲロチン生合成遺伝子クラスターの構成を示す。</span>FIG. 8 shows the structure of the gougerotin biosynthesis gene cluster.</span>
      </figref>
      <figref num="9" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図９は、アガロースゲル電気泳動によって分解した名前を付けたプライマー対（プライマー対の名称については配列表参照）のＰＣＲ産物を示す。ＭＷ＝１ｋＤａ分子量ラダー。Ｃ＝１６Ｓ陽性対照。ｇｏｕＣ１は配列番号：４４及び４５のプライマーに由来する。ｇｏｕＣ２は配列番号：４６及び４７のプライマーに由来する。ｇｏｕＤは配列番号：４８及び４９のプライマーに由来する。ｇｏｕＧ１は配列番号：５０及び５１のプライマーに由来する。ｇｏｕＧ２は配列番号：５２及び５３のプライマーに由来する。ｇｏｕＩ１は配列番号：５４及び５５のプライマーに由来する。ｇｏｕＦ２は配列番号：５６及び５７のプライマーに由来する。</span>FIG. 9 shows the PCR products of the named primer pairs resolved by agarose gel electrophoresis (see Sequence Listing for primer pair names). MW = 1 kDa molecular weight ladder. C = 16S positive control. gouCl is derived from the primers of SEQ ID NOs: 44 and 45. gouC2 is derived from the primers of SEQ ID NOs: 46 and 47. gouD is derived from the primers of SEQ ID NOs: 48 and 49. gouG1 is derived from the primers of SEQ ID NOs: 50 and 51. gouG2 is derived from the primers of SEQ ID NOs: 52 and 53. goI1 is derived from the primers of SEQ ID NOs: 54 and 55. gouF2 is derived from the primers of SEQ ID NOs: 56 and 57.</span>
      </figref>
      <figref num="10" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１０は、ｐＵＣ１１８ベクターの概略図である。</span>FIG. 10 is a schematic diagram of the pUC118 vector.</span>
      </figref>
      <figref num="11" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１１は、ｐＫＣ１１３９シャトルベクターの概略図である。</span>FIG. 11 is a schematic diagram of the pKC1139 shuttle vector.</span>
      </figref>
      <figref num="12" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">図１２は、いろいろなプライマーセットを用いたＰＣＲのＰＣＲ産物を示し、アガロースゲル電気泳動によって分解した。Ｉ＝ｇｏｕＩプライマー、Ｇ＝ｇｏｕＧプライマー、Ｉａ＝アプラマイシン抵抗性の単一クロスオーバー、ＩＫＩ（ＧｏｕＩｕｐ及びｇｏｕＩｄｏｗｎ）、ＣＫＷ（ｇｏｕＣｕｐ及びｇｏｕｗｈｏｌｅｃｕｓｔｅｒｄｏｗｎ）、及びＣＫＩ（ｇｏｕＣｕｐ及びｇｏｕＩｄｏｗｎ）は全てカナマイシン抵抗性二重クロスオーバーである。</span>FIG. 12 shows PCR products of PCR using various primer sets, which were resolved by agarose gel electrophoresis. I = gou I primer, G = gou G primer, Ia = apramycin resistant single crossover, IKI (GouIup and goudown), CKW (gouCup and gowholecasterdown), and CKI (gouCup and goIdown) are all kanamycin resistant A crossover.</span>
      </figref>
    </p>
  </description-of-drawings>
  <description-of-embodiments class="style-scope patent-text">
    <p num="0032" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <tables num="1" class="style-scope patent-text">
            </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000003" he="245" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="980" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div>
          
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000004" he="249" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="996" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div>
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000005" he="245" wi="162" file="2015534950.tif" img-format="tif" img-content="drawing" width="648" height="980" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div>
        
        <tables num="1" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000003" he="245" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="980" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div>
        </tables>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000004" he="249" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="996" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div>
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000005" he="245" wi="162" file="2015534950.tif" img-format="tif" img-content="drawing" width="648" height="980" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div>
      
    <p class="style-scope patent-text"></p>
    <p num="0033" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  全ての刊行物、特許及び特許出願は、あらゆる図面及び付属書類を含めて、あたかも個々の刊行物又は特許出願がそれぞれ具体的かつ個別に参照により本明細書に組み入れられると示されているように、参照により本明細書に組み入れられる。
</span>
&nbsp;&nbsp;All publications, patents and patent applications, including all drawings and attachments, are as if each individual publication or patent application was specifically and individually indicated to be incorporated herein by reference. , Incorporated herein by reference.
</span>
    </p>
    <p num="0034" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  以下の記載は本発明を理解する上で有用であり得る情報を含んでいる。しかし、本明細書に提供された情報のいずれかが現に特許請求の範囲に記載されている本発明に対して従来技術となるか若しくは関連があること、又は具体的若しくは暗黙に言及したいずれかの刊行物が従来技術であることを自認するものではない。
</span>
&nbsp;&nbsp;The following description includes information that may be useful in understanding the present invention. However, any of the information provided herein is either prior art or related to the present invention described in the claims, or has been specifically or implicitly mentioned. Is not admitted to be prior art.
</span>
    </p>
    <p num="0035" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株を提供する。ＮＲＲＬ  Ｂ−５０５５０株はいろいろな有利な性質を有することが見出された。ＮＲＲＬ  Ｂ−５０５５０株（又はその発酵産物）はそれ自体が殺ダニ活性を有するだけでなく、例えば、高いＵＶ安定性、良好な層透過活性、良好な殺卵活性、長い残効性、潅注活性並びに広範囲のダニに対する活性も示し（実施例の欄参照）、従って有効な殺ダニ剤としての要件を満たす。さらに、ＮＲＲＬ  Ｂ−５０５５０株（又はその発酵産物）は、殺虫活性と、赤さび病及びベと病のような様々な真菌の植物病原体に対する活性の両方を有する。この独特な活性の組合せのため、ＮＲＲＬ  Ｂ−５０５５０株は極めて多方面に使用できる候補とされ、またこの菌株は植物を処理して植物病害及び／又は植物害虫を防除する方法で広く使用するのに適切となる。かかる広範囲の活性及び農業における可能な応用は公知のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株に関して未だに報告されていない。可能な農業用途に関して、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は主として１９６０年代後期から１９７０年代早期にかけて刊行物に記載されている。例えば、微生物化合物Ｂ−９８８９１を産生するＡＴＣＣ  ３１１２０として寄託されたストレプトマイセス・リモファシエンス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｒｉｍｏｆａｃｉｅｎｓ）Ｂ−９８８９１株について記載している英国特許ＧＢ  １  ５０７  １９３を参照されたい。１９７５年３月に出願されたＧＢ  １  ５０７  １９３によると、微生物化合物Ｂ−９８８９１は、ストレプトマイセス・リモファシエンス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｒｉｍｏｆａｃｉｅｎｓ）Ｂ−９８８９１株の、うどんこ病に対する抗真菌活性を提供する活性成分である。１９７２年８月２日に出願された米国特許第３，８４９，３９８号は、菌株ストレプトマイセス・トヨカエンシス変種アスピクラマイセチクス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｔｏｙｏｃａｅｎｓｉｓ  ｖａｒ．  ａｓｐｉｃｕｌａｍｙｃｅｔｉｃｕｓ）が、グーゲロチンとしても知られている（Ｔｏｒｕ  Ｉｋｅｕｃｈｉ  ｅｔ  ａｌ．，２５  Ｊ．  Ａｎｔｉｂｉｏｔｉｃｓ  ５４８（１９７２年９月）参照）微生物化合物アスピクラマイシン（ａｓｐｉｃｕｌａｍｙｃｉｎ）を産生することを記載している。米国特許第３，８４９，３９８号によると、グーゲロチンは動物に寄生するギョウ虫などのような寄生生物に対して殺寄生生物作用を有しているが、グーゲロチンはグラム陽性、グラム陰性細菌及び結核菌に対する抗菌活性が弱いといわれている。同様に、１９７８年に発行された特開昭５３１０９９９８は、菌株ストレプトマイセス・トヨカエンシス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｔｏｙｏｃａｅｎｓｉｓ）（ＬＡ−６８１）及び殺ダニ剤として使用されるグーゲロチンを産生するその能力を報告している。しかし、かかるストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株に基づく殺ダニ性の発酵産物は市販されてないことに留意されたい。このように、ダニ目（グーゲロチン産生に基づく）、真菌及び昆虫に対するその広い効果並びに作用モード（例えば、層透過活性及び残効性）の点でのその有利な特性を有するストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株は、生物学上の重要で予想外の進歩であり、それ自体公知のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株では報告されてない有利な特性を表す。本出願人は、高濃度のグーゲロチンを含有する発酵ブロスを製造するという問題を解決し、商業的殺虫剤として、又は商業的殺虫剤として使用されるグーゲロチンの供給源として発酵ブロスを最終的に使用できるようにした。従って、本発明は、少なくとも約０．５ｇ／Ｌの濃度でグーゲロチンを含有する発酵ブロスを包含する。さらに、本発明は、少なくとも約１ｇ／Ｌ、少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、少なくとも約７ｇ／Ｌ若しくは少なくとも約８ｇ／Ｌ、又は少なくとも約１ｍｇ／ｇ、少なくとも約２ｍｇ／ｇ、少なくとも約３ｍｇ／ｇ、少なくとも約４ｍｇ／ｇ、少なくとも約５ｍｇ／ｇ、少なくとも約６ｍｇ／ｇ、少なくとも約７ｍｇ／ｇ若しくは少なくとも約８ｍｇ／ｇの濃度でグーゲロチンを含有する発酵ブロスを包含する。他の実施形態において、発酵ブロスは、約２ｇ／Ｌ〜約１５ｇ／Ｌの範囲の濃度で、例えば約３ｇ／Ｌ、約４ｇ／Ｌ、約５ｇ／Ｌ、約６ｇ／Ｌ、約７ｇ／Ｌ、約８ｇ／Ｌ、約９ｇ／Ｌ、約１０ｇ／Ｌ、約１１ｇ／Ｌ、約１２ｇ／Ｌ、約１３ｇ／Ｌ、及び約１４ｇ／Ｌの濃度で、又は約２ｍｇ／ｇ〜約１５ｍｇ／ｇの範囲の濃度でグーゲロチンを含有する。幾つかの実施形態において、発酵ブロスはストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）種に由来する。具体的な実施形態において、発酵ブロスはストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）に由来する。さらに他の具体的な実施形態において、発酵ブロスは、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ−５０５５０又はそれから誘導される植物食性−殺ダニ性の突然変異体に由来する。さらに、本出願人は、グーゲロチンの産生を担うストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）遺伝子クラスターを確認し操作した。下記及び図５のグーゲロチンの構造参照。<br class="style-scope patent-text">
<chemistry id="" num="1" class="style-scope patent-text"> </chemistry></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000006" he="45" wi="159" file="2015534950.tif" img-format="tif" img-content="drawing" width="636" height="180" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
The present invention provides a Streptomyces microflavus NRRL B-50550 strain or a phytophagous-acaricidal mutant derived therefrom. The NRRL B-50550 strain was found to have various advantageous properties. NRRL B-50550 strain (or its fermentation product) not only has acaricidal activity per se, but also, for example, high UV stability, good permeation activity, good ovicidal activity, long residual effect, irrigation activity It also shows activity against a wide range of mites (see the Examples section), thus satisfying the requirements as an effective acaricide. Furthermore, NRRL B-50550 strain (or its fermentation product) has both insecticidal activity and activity against various fungal plant pathogens such as leaf rust and downy mildew. Because of this unique combination of activities, the NRRL B-50550 strain is considered a very versatile candidate and is widely used in methods for treating plants to control plant diseases and / or plant pests. Appropriate to. Such a wide range of activities and possible applications in agriculture have not yet been reported for known Streptomyces strains. With regard to possible agricultural applications, Streptomyces strains are mainly described in publications from the late 1960s to the early 1970s. See, for example, British Patent GB 1 507 193, which describes the Streptomyces rimfaciens strain B-98891, deposited as ATCC 31120 producing the microbial compound B-98891. According to GB 1 507 193 filed in March 1975, the microbial compound B-98891 is an active ingredient that provides antifungal activity against powdery mildew in Streptomyces rimofaciens strain B-89891. is there. U.S. Pat. No. 3,849,398, filed Aug. 2, 1972, describes the strain Streptomyces toyocaensis var. Aspiculamyceticus, also known as gougerotin (Toru). Ikeuchi et al., 25 J. Antibiotics 548 (September 1972) describes the production of the microbial compound aspicuramycin. According to U.S. Pat. No. 3,849,398, gougerotin has a parasiticidal action against parasites such as leopards that parasitize animals, while gougerotin is a gram-positive, gram-negative bacterium and tuberculosis. Antibacterial activity against bacteria is said to be weak. Similarly, JP 53109998, published in 1978, reports the strain Streptomyces toyocaensis (LA-681) and its ability to produce gougerotin for use as an acaricide. However, it should be noted that acaricidal fermentation products based on such Streptomyces strains are not commercially available. Thus, Streptomyces microflavus (having its advantageous properties in terms of mite (based on gougerotin production), fungi and insects and its broad effect and mode of action (eg, permeation activity and aftereffect) ( The Streptomyces microflavus) NRRL B-50550 strain is an important and unexpected advance in biology, and exhibits advantageous properties not reported in Streptomyces strains known per se. The Applicant has solved the problem of producing a fermentation broth containing high concentrations of gougerotin and ultimately uses the fermentation broth as a commercial insecticide or as a source of gougerotin used as a commercial insecticide I was able to do it. Accordingly, the present invention includes a fermentation broth containing gougerotin at a concentration of at least about 0.5 g / L. Further, the present invention provides at least about 1 g / L, at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, at least about 6 g / L, at least about 7 g / L or at least about 8 g / L, or at least about 1 mg / g, at least about 2 mg / g, at least about 3 mg / g, at least about 4 mg / g, at least about 5 mg / g, at least about 6 mg / g, at least about 7 mg / g or at least about 8 mg Includes fermentation broth containing gougerotin at a concentration of / g. In other embodiments, the fermentation broth is at a concentration ranging from about 2 g / L to about 15 g / L, such as about 3 g / L, about 4 g / L, about 5 g / L, about 6 g / L, about 7 g / L. About 8 g / L, about 9 g / L, about 10 g / L, about 11 g / L, about 12 g / L, about 13 g / L, and about 14 g / L, or about 2 mg / g to about 15 mg / g. Contains gougerotin at concentrations in the range. In some embodiments, the fermentation broth is derived from a Streptomyces species. In a specific embodiment, the fermentation broth is derived from Streptomyces microflavus. In yet another specific embodiment, the fermentation broth is derived from Streptomyces microflavus NRRL-50550 or a phytophagic-acaricidal mutant derived therefrom. In addition, Applicants have identified and manipulated the Streptomyces microflavus gene cluster responsible for the production of gougerotin. See the structure of gougerotin below and in FIG. <br class="style-scope patent-text"> <chemistry id="" num="1" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000006" he="45" wi="159" file="2015534950.tif" img-format="tif" img-content="drawing" width="636" height="180" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </chemistry> 
    <p class="style-scope patent-text"></p>
    <p num="0036" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特に断らない限り、本明細書に記載した微生物及び特定の菌株は全て、本明細書に記載されているように、自然界から分離し（すなわち、単離し）、振盪フラスコ培養のような人工条件下で、又はバイオリアクターのようなスケールアップされた製造工程によって増殖させる。１つの実施形態において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株の植物食性−殺ダニ性の突然変異株が提供される。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）は土壌及び腐敗植物で共通して見られるストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属に属する中温性、腐生性の細菌である。ＮＲＲＬ  Ｂ−５０５５０は北米大陸のアメリカ合衆国の土壌から単離されたストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）の株である。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）は、十分に発達した糸状栄養菌糸（〜１．０μｍ幅、１０−１００μｍ長）を産生する好気性、グラム陽性の糸状細菌であり、分生子−無性胞子を産生することができる。菌糸は、渦巻（輪生）状に配列された多かれ少なかれ規則的な間隔でベージュ色の滑らかな胞子を生む長いまっすぐな糸状体からなる。輪生の各々の枝は、その頂点に、２〜幾つかの胞子の鎖を有する散形花序を生成する。
</span>
&nbsp;&nbsp;Unless otherwise noted, all microorganisms and specific strains described herein are isolated from nature (ie, isolated) and are subject to artificial conditions such as shake flask cultures as described herein. Or by a scaled-up manufacturing process such as a bioreactor. In one embodiment, a phytophagic-acaricidal mutant of the Streptomyces microflavus NRRL B-50550 strain is provided. Streptomyces microflavus is a mesophilic and humic bacterium belonging to the genus Streptomyces commonly found in soil and spoilage plants. NRRL B-50550 is a strain of Streptomyces microflavus isolated from United States soil on the North American continent. Streptomyces microflavus is an aerobic, gram-positive filamentous bacterium that produces fully developed filamentous vegetative mycelium (˜1.0 μm wide, 10-100 μm long), and conidia-asexual spores Can be produced. The hyphae consist of long straight filaments that produce beige smooth spores at more or less regular intervals arranged in a spiral. Each branch of the rotifer produces a diffuse inflorescence with two to several spore chains at its apex.
</span>
    </p>
    <p num="0037" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  用語「突然変異体」とは、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株から誘導された遺伝的変異体をいう。１つの実施形態において、突然変異体は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株を同定する（機能上の）特徴の１以上の又は全てを有する。特定の例において、突然変異体又はその発酵産物は（同定する機能上の特徴として）、親のストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株と同じように、少なくともダニを防除する。さらに、突然変異体又はその発酵産物は、殺ダニ活性に関する層透過活性、殺ダニ活性に関する残効性、殺卵活性、殺虫活性、特にジアブロチカ（ｄｉａｂｒｏｔｉｃａ）に対する活性、又は真菌の植物病原体、特にベと病及びさび病に対する活性という特性の１、２、３、４又は５つ全てを有し得る。かかる突然変異体は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株に対して約８５％より大きい、約９０％より大きい、約９５％より大きい、約９８％より大きい、又は約９９％より大きい配列同一性を有するゲノム配列を有する遺伝的変異体であり得る。突然変異体は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株細胞を化学物質若しくは照射で処理することにより、又はＮＲＲＬ  Ｂ−５０５５０細胞の集団から（ファージ抵抗性又は抗生物質抵抗性突然変異体のような）自然突然変異体を選択することにより、又は当業者に周知の他の手段により得ることができる。
</span>
&nbsp;&nbsp;The term “mutant” refers to a genetic variant derived from Streptomyces microflavus NRRL B-50550 strain. In one embodiment, the mutant has one or more or all of the (functional) features identifying the Streptomyces microflavus NRRL B-50550 strain. In certain instances, the mutant or its fermentation product (as a functional feature to identify) controls at least ticks, similar to the parental Streptomyces microflavus NRRL B-50550 strain. Furthermore, the mutant or its fermentation product may have a laminar permeation activity for acaricidal activity, a residual effect for acaricidal activity, an ovicidal activity, an insecticidal activity, in particular an activity against diabrotica, or a fungal plant pathogen, in particular a vector. Can have 1, 2, 3, 4 or all five of the properties of activity against illness and rust. Such mutants are greater than about 85%, greater than about 90%, greater than about 95%, greater than about 98%, or about 99% to the Streptomyces microflavus NRRL B-50550 strain. It may be a genetic variant having a genomic sequence with greater than% sequence identity. Mutants can be obtained by treating Streptomyces microflavus NRRL B-50550 cells with chemicals or irradiation, or from populations of NRRL B-50550 cells (phage resistant or antibiotic resistant suddenly). It can be obtained by selecting natural mutants (such as variants) or by other means well known to those skilled in the art.
</span>
    </p>
    <p num="0038" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）の突然変異誘発のための適切な化学物質としては、少しだけ挙げると、ヒドロキシルアミン塩酸塩、メタンスルホン酸メチル（ＭＭＳ）、メタンスルホン酸エチル（ＥＭＳ）、４−ニトロキノリン１−オキシド（ＮＱＯ）、マイトマイシンＣ又はＮ−メチル−Ｎ’−ニトロ−Ｎ−ニトロソグアニジン（ＮＴＧ）などがある（例えば、Ｓｔｏｎｅｓｉｆｅｒ  ＆  Ｂａｌｔｚ，Ｐｒｏｃ．  Ｎａｔｌ．  Ａｃａｄ．  Ｓｃｉ．  ＵＳＡ  Ｖｏｌ．  ８２、ｐｐ．  １１８０−１１８３、Ｆｅｂｒｕａｒｙ  １９８５参照）。それぞれのストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の胞子溶液を用いた、例えばＮＴＧによる、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の突然変異誘発は当業者に周知である。例えば、Ｄｅｌｉｃ  ｅｔ  ａｌ、Ｍｕｔａｔｉｏｎ  Ｒｅｓｅａｒｃｈ／Ｆｕｎｄａｍｅｎｔａｌ  ａｎｄ  Ｍｏｌｅｃｕｌａｒ  Ｍｅｃｈａｎｉｓｍｓ  ｏｆ  Ｍｕｔａｇｅｎｅｓｉｓ、Ｖｏｌｕｍｅ  ９、Ｉｓｓｕｅ  ２、Ｆｅｂｒｕａｒｙ  １９７０、ｐａｇｅｓ  １６７−１８２、又はＣｈｅｎ  ｅｔ  ａｌ．、Ｊ  Ａｎｔｉｂｉｏｔ  （Ｔｏｋｙｏ）、２００１  Ｎｏｖ；  ５４（１１）、ｐａｇｅｓ  ９６７−９７２．）を参照されたい。より詳細にいうと、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）は、Ｋｉｅｓｅｒ、Ｔ．、ｅｔ  ａｌ．、２０００、上掲  <u class="style-scope patent-text">Ｐｒａｃｔｉｃａｌ  Ｓｔｒｅｐｔｏｍｙｃｅｓ  Ｇｅｎｅｔｉｃｓ</u>、Ｃｈ．  ５  Ｊｏｈｎ  Ｉｎｎｅｓ  Ｃｅｎｔｒｅ、Ｎｏｒｗｉｃｈ  Ｒｅｓｅａｒｃｈ  Ｐａｒｋ、Ｅｎｇｌａｎｄ  （２０００）、ｐｐ．  ９９−１０７に記載されているプロトコルを用いてＮＴＧによる突然変異にかけることができる。紫外光（ＵＶ）によるストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）の胞子の突然変異誘発は標準的なプロトコルを用いて行うことができる。例えば、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の胞子懸濁液（２０％グリセロール中で新たに調製又は凍結）は２５４ｎｍの波長のＵＶ光を吸収しない媒質（例えば、水又は２０％グリセロールが適している）に懸濁することができる。その後、胞子懸濁液をガラスシャーレに入れ、絶えず撹拌しながら３０℃において適当な時間、エネルギーの殆どを２５４ｎｍで放出する低圧水銀ランプで照射する（照射の最も適当な時間は線量−生存曲線をプロットすることにより決定することができる）。次に、その照射した濃い胞子懸濁液を、例えば非選択培地のスラント又はプレートに植え付けることができ、そうして得られた突然変異株の特性を以下に説明するように評価することができる。Ｋｉｅｓｅｒ、Ｔ．、ｅｔ  ａｌ．、２０００、上掲参照。
</span>Suitable chemicals for mutagenesis of Streptomyces microflavus include hydroxylamine hydrochloride, methyl methanesulfonate (MMS), ethyl methanesulfonate (EMS), 4 to name a few. -Nitroquinoline 1-oxide (NQO), mitomycin C or N-methyl-N'-nitro-N-nitrosoguanidine (NTG) (see, for example, Stonesifer &amp; Baltz, Proc. Natl. Acad. Sci. USA Vol. 82, pp. 1180-1183, February 1985). Mutagenesis of Streptomyces strains using, for example, NTG, using a spore solution of the respective Streptomyces strain is well known to those skilled in the art. For example, Delic et al, Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis, Volume 9, Issue 2, February 1970, pages 167-182, or Chen et al. J Antibiot (Tokyo), 2001 Nov; 54 (11), pages 967-972. Refer to). More particularly, Streptomyces microflavus is described by Kieser, T .; Et al. 2000, supra, <u class="style-scope patent-text">Practical Streptomyces Genetics</u> , Ch. 5 John Innes Centre, Norwich Research Park, England (2000), pp. Mutations with NTG can be performed using the protocol described in 99-107. Mutagenesis of Streptomyces microflavus spores by ultraviolet light (UV) can be performed using standard protocols. For example, a spore suspension of a Streptomyces strain (freshly prepared or frozen in 20% glycerol) does not absorb UV light at a wavelength of 254 nm (eg water or 20% glycerol is suitable) Can be suspended. The spore suspension is then placed in a glass petri dish and irradiated with a low pressure mercury lamp that releases most of the energy at 254 nm for a suitable time at 30 ° C. with constant stirring (the most suitable time of irradiation is a dose-survival curve). Can be determined by plotting). The irradiated dense spore suspension can then be planted, for example, in a slant or plate of non-selective medium and the properties of the mutant strain so obtained can be evaluated as described below. . Kieser, T .; Et al. 2000, supra.</span>
    </p>
    <p num="0039" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  突然変異株は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株の同定特性の１以上又は全て、特にストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０に匹敵するか若しくはそれより良好な殺ダニ活性を有するあらゆる突然変異株であることができる。殺ダニ活性は、例えば本明細書の実施例２に説明されているようにナミハダニ（「ＴＳＳＭ」）に対して決定することができる。すなわち、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の突然変異株の培養ストックを１Ｌの振盪フラスコ内で２０−３０℃において３−５日実施例２の培地（Ｍｅｄｉａ）１又は培地２中で増殖させることができ、その後希釈した発酵産物を２つの植物のライマメの葉の上面と下面に施用することができ、その処理後、同じ日に植物に５０−１００のＴＳＳＭを寄生させ、温室内に５日間放置することができる。
</span>
&nbsp;&nbsp;The mutant strain is one or more or all of the identified characteristics of the Streptomyces microflavus NRRL B-50550 strain, in particular comparable or better than the Streptomyces microflavus NRRL B-50550. Any mutant strain having acaricidal activity can be used. Acaricidal activity can be determined, for example, against the spider mite (“TSSM”) as described in Example 2 herein. That is, the culture stock of the Streptomyces microflavus NRRL B-50550 mutant strain was cultured in a 1 L shake flask at 20-30 ° C. for 3-5 days. Can be grown in, and then the diluted fermentation product can be applied to the upper and lower surfaces of the two plant lima bean leaves, after that treatment the plants are infested with 50-100 TSSM on the same day, Can be left in the greenhouse for 5 days.
</span>
    </p>
    <p num="0040" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  実施例１６は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株の突然変異体を生じさせる方法の具体例を提供する。この方法で生じさせた１つの突然変異体は、実施例でより詳細に説明するストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｍ株である。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｍのグーゲロチン生合成遺伝子クラスターは、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株のグーゲロチン生合成遺伝子クラスター（すなわち、配列番号：４３）に対して約９９％の配列同一性を有する。
</span>
&nbsp;&nbsp;Example 16 provides a specific example of a method for generating a mutant of the Streptomyces microflavus NRRL B-50550 strain. One mutant generated by this method is the Streptomyces microflavus strain M, which is described in more detail in the examples. The gougerotin biosynthetic gene cluster of Streptomyces microflavus M is compared to the gougerotin biosynthetic gene cluster of Streptomyces microflavus NRRL B-50550 (ie, SEQ ID NO: 43). 99% sequence identity.
</span>
    </p>
    <p num="0041" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の１つの態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性の突然変異株は層透過活性を有する。本明細書において用語「層透過活性」は当業界におけるその普通の意味で用いられており、従って「層透過活性」とは化合物又は組成物（ここでは、例えばストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその突然変異株を含有する発酵産物のような組成物）が処理される植物の葉の組織を通って移動する能力を意味する。層透過性の化合物／組成物は葉の組織に浸透し、葉の内部に活性成分のリザーバーを形成する。従って、この層透過活性は葉を摂食する昆虫及びダニに対する残効性も提供する。組成物（又はその１以上の活性成分）は葉を通って移動することができるので、充分な噴霧被覆は通常葉の裏面を摂食するダニのようなダニ目を防除するのにあまり重要ではない。突然変異株単独又はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０と比較した層透過活性は、例えば本明細書中の実施例６で説明されているようにナミハダニ（「ＴＳＳＭ」）に対して決定することができる。層透過活性は実施例６の条件下で数日（例えば、約５日）後でも観察することができる。本発明の１つの態様において、層透過活性は処理後少なくとも約１、２、３、４、５、６、７、８、９、及び／又は１０日観察することができる（存在する）。
</span>
&nbsp;&nbsp;In one embodiment of the present invention, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant has layer-penetrating activity. As used herein, the term “layer permeability activity” is used in its ordinary sense in the art, and thus “layer permeability activity” refers to a compound or composition (for example, Streptomyces microflavus, for example). NRRL B-50550 or a composition such as a fermentation product containing a mutant thereof) means the ability to migrate through the leaf tissue of the plant being treated. The permeable compound / composition penetrates the leaf tissue and forms a reservoir of the active ingredient within the leaf. Thus, this permeation activity also provides a residual effect on insects and mites that feed on the leaves. Because the composition (or one or more of its active ingredients) can move through the leaves, sufficient spray coating is not very important to control ticks such as ticks that normally feed on the backside of the leaves. Absent. Layer permeability activity compared to mutant strain alone or Streptomyces microflavus NRRL B-50550 is, for example, against the spider mite ("TSSM") as described in Example 6 herein. Can be determined. Penetration activity can be observed even after several days (eg about 5 days) under the conditions of Example 6. In one embodiment of the present invention, layer permeability activity can be observed (present) for at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, and / or 10 days after treatment.
</span>
    </p>
    <p num="0042" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性の突然変異株は残効性を有する。本明細書で用語「残効性」は当業界におけるその普通の意味で用いられており、従って「残効性」とは、化合物又は組成物（ここではストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその突然変異株を含有する発酵産物のような組成物）が、施用されたあとで長期間に渡り有効なままである（すなわち、化合物又は組成物が施用されなかった場合と比べてダニのより大きな死亡率を生じるか又はダニの総数の低下を引き起こす）能力を意味する。時間の長さは、製剤（粉剤、液剤など）、植物又は位置の種類、及びストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその突然変異株を含有する組成物を施用する植物表面又は土壌表面（湿潤、乾燥など）の状態に依存し得る。突然変異株単独又はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０と比較した残効性は、例えば本明細書の実施例２又は７で説明されるようにナミハダニ（「ＴＳＳＭ」）に対して決定することができ、殺ダニ効果に関して、実施例５の条件下で数日（例えば、約１２日）後でも抗殺ダニ効果を観察することができるということを意味する。本発明の１つの態様において、残効性は、処理後少なくとも約１、２、３、４、５、６、７、８、９、１０、１１、１２、１３、１４、１５、１６、１７、１８、１９、２０、２１、２２、２３、２４、２５、２６、２７、２８、２９、３０、３１、３２、３３、３４、３５、３６、３７、３８、３９、及び／又は４０日観察することができる（存在する）。
</span>
&nbsp;&nbsp;In another embodiment of the present invention, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant has residual efficacy. As used herein, the term “residual” is used in its ordinary sense in the art, and thus “residual” refers to a compound or composition (here, Streptomyces microflavus NRRL). A composition such as a fermentation product containing the B-50550 strain or a mutant thereof) remains effective for a long time after being applied (i.e., the compound or composition has not been applied) Ability to cause greater mortality of ticks or cause a decrease in the total number of ticks). The length of time depends on the type of plant (powder, liquid, etc.), plant or location, and plant surface to which the composition containing Streptomyces microflavus NRRL B-50550 or a mutant thereof is applied. Or it may depend on the condition of the soil surface (wet, dry, etc.). The after-effect compared to the mutant strain alone or Streptomyces microflavus NRRL B-50550 is, for example, against the spider mite ("TSSM") as described in Examples 2 or 7 herein. With regard to the acaricidal effect, this means that the anti-acaricidal effect can be observed even after several days (for example, about 12 days) under the conditions of Example 5. In one aspect of the invention, the aftereffect is at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 after treatment. , 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, and / or 40 days Can be observed (exists).
</span>
    </p>
    <p num="0043" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は殺卵活性を有する。用語「殺卵活性」は、「卵の破壊又は死を生起させる能力」を意味するとして当業界でその普通の意味で使用されており、本明細書ではダニのようなダニ目の卵に関して使用されている。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の突然変異株単独又はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０と比較した殺卵活性は実施例７に記載されている方法を用いて決定することができる。殺卵活性は実施例７の条件下で数日（例えば、約５日）後でも観察することができる。本発明の１つの態様において、殺卵活性は処理後少なくとも約１、２、３、４、５、６、７、８、９、及び／又は１０日観察することができる（存在する）。
</span>
&nbsp;&nbsp;In another embodiment of the present invention, the Streptomyces microflavus NRRL B-50550 strain or a phytophagocytic-acaricidal mutant thereof has ovicidal activity. The term “ovicidal activity” is used in its ordinary sense in the art to mean “ability to cause egg destruction or death” and is used herein with respect to ticks such as ticks. Has been. The ovicidal activity of Streptomyces microflavus NRRL B-50550 alone or Streptomyces microflavus NRRL B-50550 compared to the method described in Example 7 Can be determined. Ovicidal activity can be observed even after several days (eg about 5 days) under the conditions of Example 7. In one embodiment of the invention, ovicidal activity can be observed (present) for at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, and / or 10 days after treatment.
</span>
    </p>
    <p num="0044" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は潅注活性を有し得る。用語「潅注活性」は、本明細書では当業界でその普通の意味で使用されており、土壌又は他の増殖培地から木質部を介して植物を通って上方へ移動する殺虫活性を意味する。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の突然変異株単独又はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５と比較した潅注活性は実施例８に記載する方法を用いて決定することができる。本発明の１つの態様において、潅注活性は実施例８の条件下で数日（例えば、約２、３、４、５、６、７、８、９、１０、又は１１日）後でも観察することができる（存在する）。
</span>
&nbsp;&nbsp;In another embodiment of the present invention, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant strain may have irrigation activity. The term “irrigation activity” is used herein in its ordinary sense in the art to mean insecticidal activity that migrates up through the plant from the soil or other growth medium through the wood. The irrigation activity compared to Streptomyces microflavus NRRL B-50550 mutant alone or Streptomyces microflavus NRRL B-5055 was determined using the method described in Example 8. be able to. In one embodiment of the invention, irrigation activity is also observed after several days (eg, about 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 days) under the conditions of Example 8. Can (exists).
</span>
    </p>
    <p num="0045" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は、実施例で例証されるように、限定されるものではないが、ナミハダニに対する活性、ミカンサビダニ（フィロコプツルタ・オレイボラ（Ｐｈｙｌｌｏｃｏｐｔｒｕｔａ  ｏｌｅｉｖｏｒａ））、フシダニ科（ｅｒｉｏｐｈｙｉｄ）（ｒｕｓｓｅｔ）ダニ及びチャノホコリダニ（ｂｒｏａｄ  ｍｉｔｅｓ）に対する活性をはじめとして、いろいろなダニ種に対する殺ダニ活性を有する。
</span>
&nbsp;&nbsp;In another aspect of the present invention, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant is not limited, as illustrated in the examples. Has activity against various mite species, including activity against urticid mites, activity against citrus mite (Phyllocoptruta oleivara), erophyid (russet) ticks and broad mites.
</span>
    </p>
    <p num="0046" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  かくして、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は、以下のものからなる群から選択されるダニに対する活性を有し得る：クローバーハダニ、ニセクローバーハダニ、ハシバミハダニ（ｈａｚｅｌｎｕｔ  ｓｐｉｄｅｒ  ｍｉｔｅ）、アスパラガスハダニ（ａｓｐａｒａｇｕｓ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ホモノハダニ、マメダニ（ｌｅｇｕｍｅ  ｍｉｔｅ）、カタバミダニ（ｏｘａｌｉｓ  ｍｉｔｅ）、ツゲダニ（ｂｏｘｗｏｏｄ  ｍｉｔｅ）、テキサスミカンハダニ（Ｔｅｘａｓ  ｃｉｔｒｕｓ  ｍｉｔｅ）、オリエンタルミカンハダニ（Ｏｒｉｅｎｔａｌ  ｒｅｄ  ｍｉｔｅ）、ミカンハダニ、リンゴハダニ、キイロハダニ（ｙｅｌｌｏｗ  ｓｐｉｄｅｒ  ｍｉｔｅ）、イチジクハダニ（ｆｉｇ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ルイスハダニ（Ｌｅｗｉｓ  ｓｐｉｄｅｒ  ｍｉｔｅ）、コウノシロハダニ（ｓｉｘ−ｓｐｏｔｔｅｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ウィラメットダニ（Ｗｉｌｌａｍｅｔｔｅ  ｍｉｔｅ）、ユマハダニ（Ｙｕｍａ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ウェブスピニングマイト（ｗｅｂ−ｓｐｉｎｎｉｎｇ  ｍｉｔｅ）、パイナップルダニ（ｐｉｎｅａｐｐｌｅ  ｍｉｔｅ）、シトラスグリーンマイト（ｃｉｔｒｕｓ  ｇｒｅｅｎ  ｍｉｔｅ）、アメリカサイカチハダニ（ｈｏｎｅｙ−ｌｏｃｕｓｔ  ｓｐｉｄｅｒ  ｍｉｔｅ）、チャアカハダニ（ｔｅａ  ｒｅｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、チビコブハダニ、アボカドブラウンマイト（ａｖｏｃａｄｏ  ｂｒｏｗｎ  ｍｉｔｅ）、トドマツノハダニ、アボカドレッドマイト（ａｖｏｃａｄｏ  ｒｅｄ  ｍｉｔｅ）、バンクスグラスマイト（Ｂａｎｋｓ  ｇｒａｓｓ  ｍｉｔｅ）、ニセナミハダニ、アシノワハダニ、ヤサイハダニ（ｖｅｇｅｔａｂｌｅ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ツミドスパイダーマイト（ｔｕｍｉｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、イチゴハダニ（ｓｔｒａｗｂｅｒｒｙ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ナミハダニ、マクダニエルマイト（ＭｃＤａｎｉｅｌ  ｍｉｔｅ）、パシフィックスパイダーマイト（Ｐａｃｉｆｉｃ  ｓｐｉｄｅｒ  ｍｉｔｅ）、オウトウハダニ、フォースポッテドスパイダーマイト（ｆｏｕｒ−ｓｐｏｔｔｅｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ショエネイスパイダーマイト（Ｓｃｈｏｅｎｅｉ  ｓｐｉｄｅｒ  ｍｉｔｅ）、チリヒメハダニ（Ｃｈｉｌｅａｎ  ｆａｌｓｅ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ブドウヒメハダニ、チャノヒメハダニ、フラットスカーレットマイト（ｆｌａｔ  ｓｃａｒｌｅｔ  ｍｉｔｅ）、ホワイトテイルドマイト（ｗｈｉｔｅ−ｔａｉｌｅｄ  ｍｉｔｅ）、パイナップルホコリダニ（ｐｉｎｅａｐｐｌｅ  ｔａｒｓｏｎｅｍｉｄ  ｍｉｔｅ）、ウェストインディアシュガーケーンマイト（Ｗｅｓｔ  Ｉｎｄｉａｎ  ｓｕｇａｒ  ｃａｎｅ  ｍｉｔｅ）、バルブスケールマイト（ｂｕｌｂ  ｓｃａｌｅ  ｍｉｔｅ）、シクラメンホコリダニ、チャノホコリダニ、ムギダニ、レッドレッグドアースマイト（ｒｅｄ−ｌｅｇｇｅｄ  ｅａｒｔｈ  ｍｉｔｅ）、フィルバートビッグ−ブッドマイト（ｆｉｌｂｅｒｔ  ｂｉｇ−ｂｕｄ  ｍｉｔｅ）、ブドウハモグリダニ、ピーアブリスターリーフマイト（ｐｅａｒ  ｂｌｉｓｔｅｒ  ｌｅａｆ  ｍｉｔｅ）、アップルリーフエッジローラーマイト（ａｐｐｌｅ  ｌｅａｆ  ｅｄｇｅｒｏｌｌｅｒ  ｍｉｔｅ）、ピーチモザイクベクターマイト（ｐｅａｃｈ  ｍｏｓａｉｃ  ｖｅｃｔｏｒ  ｍｉｔｅ）、アルダービーズゴールマイト（ａｌｄｅｒ  ｂｅａｄ  ｇａｌｌ  ｍｉｔｅ）、ペリアンウォルナットリーフゴールマイト（Ｐｅｒｉａｎ  ｗａｌｎｕｔ  ｌｅａｆ  ｇａｌｌ  ｍｉｔｅ）、ペカンリーフエッジロールマイト（ｐｅｃａｎ  ｌｅａｆ  ｅｄｇｅｒｏｌｌ  ｍｉｔｅ）、イチジクモンサビダニ（ｆｉｇ  ｂｕｄ  ｍｉｔｅ）、オリーブモンサビダニ（ｏｌｉｖｅ  ｂｕｄ  ｍｉｔｅ）、シトラスブッドマイト（ｃｉｔｒｕｓ  ｂｕｄ  ｍｉｔｅ）、ライチエリネウムマイト（ｌｉｔｃｈｉ  ｅｒｉｎｅｕｍ  ｍｉｔｅ）、チューリップサビダニ、ココナッツフラワーアンドナッツマイト（ｃｏｃｏｎｕｔ  ｆｌｏｗｅｒ  ａｎｄ  ｎｕｔ  ｍｉｔｅ）、シュガーケーンブリスターマイト（ｓｕｇａｒ  ｃａｎｅ  ｂｌｉｓｔｅｒ  ｍｉｔｅ）、バッファローグラスマイト（ｂｕｆｆａｌｏ  ｇｒａｓｓ  ｍｉｔｅ）、バミューダグラスマイト（ｂｅｒｍｕｄａ  ｇｒａｓｓ  ｍｉｔｅ）、ニンジンモンサビダニ（ｃａｒｒｏｔ  ｂｕｄ  ｍｉｔｅ）、スウィートポテトリーフゴールマイト（ｓｗｅｅｔ  ｐｏｔａｔｏ  ｌｅａｆ  ｇａｌｌ  ｍｉｔｅ）、ポメグラナテリーフカールマイト（ｐｏｍｅｇｒａｎａｔｅ  ｌｅａｆ  ｃｕｒｌ  ｍｉｔｅ）、アシュスプラングルゴールマイト（ａｓｈ  ｓｐｒａｎｇｌｅ  ｇａｌｌ  ｍｉｔｅ）、メイプルブラッダーゴールマイト（ｍａｐｌｅ  ｂｌａｄｄｅｒ  ｇａｌｌ  ｍｉｔｅ）、アルダーエリネウムマイト（ａｌｄｅｒ  ｅｒｉｎｅｕｍ  ｍｉｔｅ）、レッドベリーマイト（ｒｅｄｂｅｒｒｙ  ｍｉｔｅ）、コットンブリスターマイト（ｃｏｔｔｏｎ  ｂｌｉｓｔｅｒ  ｍｉｔｅ）、ブルーベリーブッドマイト（ｂｌｕｅｂｅｒｒｙ  ｂｕｄ  ｍｉｔｅ）、チャノナガサビダニ、チャノサビダニ、グレオシトラスマイト（ｇｒｅｙ  ｃｉｔｒｕｓ  ｍｉｔｅ）、サツマイモサビダニ（ｓｗｅｅｔ  ｐｏｔａｔｏ  ｒｕｓｔ  ｍｉｔｅ）、セイヨウトチノキサビダニ（ｈｏｒｓｅ  ｃｈｅｓｔｎｕｔ  ｒｕｓｔ  ｍｉｔｅ）、ミカンサビダニ（ｃｉｔｒｕｓ  ｒｕｓｔ  ｍｉｔｅ）、リンゴサビダニ、ブドウサビダニ、ナシサビダニ、フラットニードルシースパインマイト（ｆｌａｔ  ｎｅｅｄｌｅ  ｓｈｅａｔｈ  ｐｉｎｅ  ｍｉｔｅ）、ワイルドローズブッドアンドフルーツマイト（ｗｉｌｄ  ｒｏｓｅ  ｂｕｄ  ａｎｄ  ｆｒｕｉｔ  ｍｉｔｅ）、ドライベリーマイト（ｄｒｙｂｅｒｒｙ  ｍｉｔｅ）、マンゴーサビダニ（ｍａｎｇｏ  ｒｕｓｔ  ｍｉｔｅ）、アザレアサビダニ（ａｚａｌｅａ  ｒｕｓｔ  ｍｉｔｅ）、モモサビダニ（ｐｌｕｍ  ｒｕｓｔ  ｍｉｔｅ）、モモサビダニ（ｐｅａｃｈ  ｓｉｌｖｅｒ  ｍｉｔｅ）、リンゴサビダニ、トマトサビダニ、ミカンサビダニ（ｐｉｎｋ  ｃｉｔｒｕｓ  ｒｕｓｔ  ｍｉｔｅ）、穀類サビダニ（ｃｅｒｅａｌ  ｒｕｓｔ  ｍｉｔｅ）、イネサビダニ（ｒｉｃｅ  ｒｕｓｔ  ｍｉｔｅ）、及び、これらの組合せ。加えて、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は他のダニ防除剤に対して抵抗性のダニに対する活性を有する。１つの実施形態において、菌株はアバメクチン−抵抗性のダニに対する活性を有する。
</span>
&nbsp;&nbsp;Thus, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant strain may have activity against a tick selected from the group consisting of: clover spider mite, Spider mite, hazelnut spider mite, asparagus spider mite, homono spider mite, legume mite, oxalit mite, exotic mite, box mite Citrus ticks (Oriental red mite), Citrus ticks, apple ticks, key Spider mite, fig spider mite, Lewis spider mite, six-spider spider mite, Willamette mite, Willamette mite (Web-spinning mite), pineapple mite, citrus green mite, honey-locus spider mite, tea red spider mite (tea red spider mite), tea red spider mite (tea red spider mite), tea red spider mite (tea red spider mite) brown mite, todomatsuno mite, avocado red mite (avocado red mite), Banks glass mite (Banks glass mite), spider mite, ashinowa spider mite, vegable spider mite spider mite Strawberry spider mite, Nami spider mite, McDaniel mite, Pacific spider mite, Pacific spider mite, Four-potted spider mite (four-spotted spider mite) ), Chilean spider mite (Chilean false spider mite), White Scarlet Mite (flat scarlet mite), White-tailed mite (white-tailed mite), Pineapple rice tick West Indian sugar cane mite, bulb scale mite, cyclamen dust mite, tea dust mite, wheat mite, red-legged earth mite, red-legged earth-bite bite Platypus mite, pea blister leaf mite (apple blister leaf mite), apple leaf edge roller mite (apple leaf edgeroller mite), peach mosaic vector mite (peach mosaic vector mite), alder bead gale mite (alder bee wald melder wald) Goalmite (Perian walnut leaf gall mite), Pecan leaf edge roll mite (pecan leaf edgeroll mite), Fig bud mite (five bud mite), Olive bud mite mite (olive bud mite mite) Litchi erineum mite, tulip rustic mite, coconut flower and nut mite, sugar cane blister mite, buffalo grass mite (buffalo grassite) bermuda glass mite, carrot bud mite, sweet potato leaf gall mite, pomegranate leaf curm mite pomegranate leaf mite gle gall mite), maple blooder gall mite, alder erineum mite, red berry mite, cotton blister berry batter mite), green rust mite, green rust mite, gray citrus mite, sweet potato mite, horse chestnut rust mite, horse chestnut rust mite Tick, prickly tick, flat needle sea pine mite, wild rosebud and fruit mite, dryberry mite, mango mite mite Rust mite (azale rust mite), Plum rust mite (Peach silver mite), Apple rust mite, Tomato rust mite, Pink citrus rust mite, cereal mite And combinations thereofIn addition, Streptomyces microflavus NRRL B-50550 or its phytophagous-acaricidal mutant has activity against ticks that are resistant to other tick control agents. In one embodiment, the strain has activity against abamectin-resistant mites.
</span>
    </p>
    <p num="0047" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は殺虫活性も有し得る。標的の昆虫は、ジアブロチカ（ｄｉａｂｒｏｔｉｃａ）であり得る。ジアブロチカ（Ｄｉａｂｒｏｔｉｃａ）は、バンデッドキューカンバビートル（ｂａｎｄｅｄ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・バルテアタ（Ｄｉａｂｒｏｔｉｃａ  ｂａｌｔｅａｔａ））、ウエスタンスポッテドキューカンバービートル（Ｗｅｓｔｅｒｎ  ｓｐｏｔｔｅｄ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・ウンデシンプンクタタ・ウンデシンプンクタタ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ））、又は、コーンルートワーム、例えば、ノーザンコーンルートワーム（Ｎｏｒｔｈｅｒｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・バルベリ（Ｄｉａｂｒｏｔｉｃａ  ｂａｒｂｅｒｉ））、サウザンコーンルートワーム（Ｓｏｕｔｈｅｒｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・ウンデシンプンクタタ・ホワーディ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ  ｈｏｗａｒｄｉ））、ウェスタンキューカンバビートル（Ｗｅｓｔｅｒｎ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・ウンデシンプンクタタ・テネラ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ  ｔｅｎｅｌｌａ））、ウェスタンコーンルートワーム（Ｗｅｓｔｅｒｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・ビルギフェラ・ビルギフェラ（Ｄｉａｂｒｏｔｉｃａ  ｖｉｒｇｉｆｅｒａ  ｖｉｒｇｉｆｅｒａ））、メキシカンコーンルートワーム（Ｍｅｘｉｃａｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・ビルギフェラ・ゼアエ（Ｄｉａｂｒｏｔｉｃａ  ｖｉｒｇｉｆｅｒａ  ｚｅａｅ））、及び、そのようなジアブロチカ（Ｄｉａｂｒｏｔｉｃａ）の組合せであり得る。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の突然変異株単独又はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０と比較した殺虫活性は実施例１０に記載する方法を用いてコーンルートワームに対して決定することができる。
</span>
&nbsp;&nbsp;In another aspect of the invention, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant strain may also have insecticidal activity. The target insect may be diabrotica. Diabrotica is a banded cucumber beetle (Diabrotica balteata), Western spotted cucumber buncunt undecimpunctata)), or corn root worms such as Northern corn rootworm (Diabrotica barberi), Southern corn root worm (Southern co nrootworm (Diabrotica undecimunctatta howl), Western cucumber beetle (Western cucumber beetle) root (Diabrotica virgifera virgifera), Mexican corn rootworm (Diabrotica virghifera zeae (Diabrotica vivae) era zeae)), and it may be a combination of such Diabrotica (Diabrotica). Insecticidal activity compared to Streptomyces microflavus NRRL B-50550 mutant alone or Streptomyces microflavus NRRL B-50550 using the route described in Example 10 Can be determined against the worm.
</span>
    </p>
    <p num="0048" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の別の態様において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株は殺菌活性、すなわち菌類によって引き起こされる植物病害に対する活性を有する。この植物病害は白カビ（ｍｉｌｄｅｗ）又はさび病であり得る。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株で処理することができる白カビ（ｍｉｌｄｅｗ）の例としては、限定されるものではないが、うどんこ病、例えば、スフェロテカ・フリギネア（Ｓｐｈａｅｒｏｔｈｅｃａ  ｆｕｌｉｇｉｎｅａ）により引き起こされるキュウリうどんこ病、又は、ベと病、例えば、ペロノスポラ・パラシチカ（Ｐｅｒｏｎｏｓｐｏｒａ  ｐａｒａｓｉｔｉｃａ）により引き起こされるアブラナ科ベと病などがある。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はその植物食性−殺ダニ性突然変異株で処理し得るさび病の例としては、限定されるものではないが、プッシニア・トリシチナ（Ｐｕｃｃｉｎｉａ  ｔｒｉｔｉｃｉｎａ）〔プッシニア・レコンジタ（Ｐ．ｒｅｃｏｎｄｉｔａ）としても知られている〕により引き起こされるコムギ赤さび病、プッシニア・グラミニス（Ｐｕｃｃｉｎｉａ  ｇｒａｍｍｉｓ）により引き起こされるコムギ黒さび病、プッシニア・ストリイホルミス（Ｐｕｃｃｉｎｉａ  ｓｔｒｉｉｆｏｒｍｉｓ）により引き起こされるコムギ黄さび病、プッシニア・ホルデイ（Ｐｕｃｃｉｎｉａ  ｈｏｒｄｅｉ）により引き起こされるオオムギの小さび病、プッシニア・レコンジタ（Ｐｕｃｃｉｎｉａ  ｒｅｃｏｎｄｉｔａ）により引き起こされるライ麦の赤さび病、赤さび病（ｂｒｏｗｎ  ｌｅａｆ  ｒｕｓｔ）、冠さび病（ｃｒｏｗｎ  ｒｕｓｔ）及び黒さび病（ｓｔｅｍ  ｒｕｓｔ）などがある。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の突然変異株単独又はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０と比較した殺菌活性は実施例９に記載する方法を用いてキュウリうどんこ病に対して決定することができる。殺菌活性は実施例９の条件下で数日（例えば、約７日）後でも観察することができる。本発明の１つの態様において、殺菌活性は処理後約１、２、３、４、５、６、７、８、９、１０、１１、１２、１３、１４、及び／又は１５日に観察することができる（存在する）。
</span>
&nbsp;&nbsp;In another aspect of the present invention, the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant has activity against plant diseases caused by fungi. The plant disease can be mildew or rust. Examples of mildew that can be treated with Streptomyces microflavus NRRL B-50550 or its phytophagous-acaricidal mutant strain include, but are not limited to, udon This disease includes, for example, cucumber powdery mildew caused by Sphaerotheca furiginea, or downy mildew, for example, cruciferous root disease caused by downy mildew, for example, Peronospora parasitica. Examples of rust that can be treated with the Streptomyces microflavus NRRL B-50550 strain or its phytophagous-acaricidal mutant strain include, but are not limited to, Puccinia triticina. ) [Also known as P. recondita] wheat red rust caused by Puccinia gramis, wheat black rust caused by Puccinia striformis Yellow rust, barley scab caused by Puccinia hordei Puccinia recondita rye brown rust caused by (Puccinia recondita), leaf rust (brown leaf rust), crown rust (crown rust) and stem rust (stem rust), and the like. The bactericidal activity compared to Streptomyces microflavus NRRL B-50550 mutant strain alone or Streptomyces microflavus NRRL B-50550 using the method described in Example 9 Can be determined for this disease. The bactericidal activity can be observed even after several days (eg about 7 days) under the conditions of Example 9. In one embodiment of the invention, bactericidal activity is observed about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, and / or 15 days after treatment. Can (exists).
</span>
    </p>
    <p num="0049" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株も提供する。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）はストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）細菌のＳ．グリセウス（Ｓ．ｇｒｉｓｅｕｓ）クレードの一員である。Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）は好気性でグラム陽性の糸状細菌である。鎖当たり１０〜５０超の胞子を有する中程度に長い成熟した胞子鎖を産生する。胞子組織は滑らかであり、オートミール系寒天上で増殖させるとコロニーは黄色〜赤味がかった色を呈する。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株は北米大陸のアメリカ合衆国で収集した土壌サンプルから単離された。菌株Ａの発酵産物は実施例１８に記載するように殺ダニ性の性質を有する。１つの実施形態において、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株の植物食性−殺ダニ性及び／又は殺真菌性の突然変異株が提供される。用語「突然変異体」とは、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株に由来する遺伝的変異体をいう。１つの実施形態において、突然変異体はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株を同定するための（機能上の）特性の１以上又は全てを有する。特定の例において、突然変異体又はその発酵産物は（同定する機能上の特性として）少なくとも親のストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株と同じ程度にダニを防除する。かかる突然変異体はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株に対して約８５％より大きい、約９０％より大きい、約９５％より大きい、約９８％より大きい、又は約９９％より大きい配列同一性を有するゲノム配列を有する遺伝的変異体であり得る。突然変異体は、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株細胞を化学物質若しくは照射で処理することにより、又はＡ細胞の集団から（ファージ抵抗性又は抗生物質抵抗性の突然変異体のような）自然突然変異体を選択することにより、又は当業者に周知の他の手段、例えばストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０に関連して上記及び実施例１６記載される手段により、得ることができる。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株は、タンパク質ＧｏｕＢ−ＧｏｕＭをコードするグーゲロチン遺伝子クラスターを含有しており、かつＧｏｕＡを含有すると予期される。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株のタンパク質ＧｏｕＢ−ＧｏｕＭはストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０に由来のストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０に由来のオルソロガスなタンパク質に対して少なくとも９０％の配列同一性を有する。
</span>
&nbsp;&nbsp;The present invention also provides a Streptomyces puniceus A strain or a phytophagous-acaricidal and / or fungicidal mutant derived therefrom. Streptomyces puniceus is the S. bacterium of Streptomyces bacterium. He is a member of the S. grieseus clade. S. S. puniceus is an aerobic, gram-positive filamentous bacterium. Produces moderately long mature spore chains with more than 10-50 spores per chain. The spore tissue is smooth and the colonies exhibit a yellow to reddish color when grown on oatmeal agar. Streptomyces puniceus strain A was isolated from a soil sample collected in the United States of America on the North American continent. The fermentation product of strain A has acaricidal properties as described in Example 18. In one embodiment, a phytophagocytic-acaricidal and / or fungicidal mutant of a Streptomyces puniceus A strain is provided. The term “mutant” refers to a genetic variant derived from a Streptomyces puniceus A strain. In one embodiment, the mutant has one or more or all of the (functional) properties for identifying a Streptomyces puniceus A strain. In a specific example, the mutant or its fermentation product controls (as a functional characteristic to identify) at least as much as the parent Streptomyces puniceus strain A. Such mutants have a sequence greater than about 85%, greater than about 90%, greater than about 95%, greater than about 98%, or greater than about 99% relative to a Streptomyces puniceus A strain. It may be a genetic variant having a genomic sequence with identity. Mutants can be obtained by treating Streptomyces puniceus strain A cells with chemicals or irradiation, or from populations of A cells (such as phage resistant or antibiotic resistant mutants). ) By selecting natural mutants, or by other means well known to those skilled in the art, such as those described above and in connection with Example 16 Streptomyces microflavus NRRL B-50550, Can be obtained. The Streptomyces puniceus A strain contains the gougerotin gene cluster that encodes the protein GouB-GouM and is expected to contain GouA. The protein GouB-GouM of Streptomyces pniceus A strain is derived from Streptomyces microflavus NRRL B-50550 from Streptomyces microflavus NRB50-50. Have at least 90% sequence identity to any protein.
</span>
    </p>
    <p num="0050" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）のグーゲロチンを含有する発酵ブロス、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株若しくはその植物食性−殺ダニ性若しくは殺真菌性の突然変異株若しくはその無細胞調製物若しくはその代謝産物、又はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株若しくはその植物食性−殺ダニ性突然変異株若しくはその無細胞調製物若しくはその代謝産物の１種以上を、植物又は葉、茎、花、果実、根、若しくは種子のような植物の部分に投与することにより、又は植物若しくは植物の部分が成長する生育場所、例えば土壌に施用することにより、植物を処理して植物害虫及び病害を防除する方法も包含する。本発明の方法及び発酵産物に適した追加のグーゲロチン産生性菌株は本明細書に記載されている。
</span>
&nbsp;&nbsp;The present invention also provides a fermentation broth containing Streptomyces gougerotin, Streptomyces microflavus NRRL B-50550 or a phytophagous-acaricidal or fungicidal mutant thereof or One or more of the cell-free preparation or metabolite thereof, or the Streptomyces puniceus A strain or its phytophagic-acaricidal mutant or its cell-free preparation or its metabolite, Or treating a plant by administering it to a plant part such as a leaf, stem, flower, fruit, root, or seed, or by applying it to a habitat where the plant or part of the plant grows, such as soil. Also encompasses a method for controlling an object pests and diseases. Additional gougerotin producing strains suitable for the methods and fermentation products of the present invention are described herein.
</span>
    </p>
    <p num="0051" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書で使用されている用語「植物」とは、植物界（すなわち、植物界のあらゆる属／種）に属する全ての生きている有機体をいう。これには、限定されるものではないが、樹木、薬草、灌木、牧草、ブドウ、シダ、コケ及び緑藻類のようなありふれた有機体が含まれる。この用語は単子葉の植物（単子葉植物）と、双子葉の植物（双子葉植物）の両方を指す。植物は幾つかの実施形態において経済上重要である。幾つかの実施形態において植物は人間が育てる植物、例えば栽培植物であり、農業、林業又は園芸植物であり得る。特定の植物の例としては、限定されるものではないが、二、三の名前を挙げるとトウモロコシ、ジャガイモ、バラ、リンゴ樹木、ヒマワリ、コムギ、イネ、バナナ、トマト、オポ（ｏｐｏ）、カボチャ、トウナス、マメ（例えば、ライマメ）、レタス、キャベツ、オーク樹木、グズマニア、ゼラニウム、ハイビスカス、クレマチス、ポインセチア、サトウキビ、タロイモ、アオウキクサ、マツ樹木、ケンタッキーブルーグラス、シバ、ココナツ樹木、アブラナ科の葉野菜〔例えば、ブロッコリ、ブロッコリラーブ、芽キャベツ、キャベツ、白菜（チンゲンサイ及び白菜（Ｎａｐａ））、カリフラワー、カバロ（ｃａｖａｌｏ）、コラード、ハゴロモカンラン、コールラビ、マスタードグリーン、レイプグリーン（ｒａｐｅ  ｇｒｅｅｎｓ）、及び、他のアブラナ科葉野菜作物〕、鱗茎野菜（例えば、ニンニク、ニラ、タマネギ（乾球（ｄｒｙ  ｂｕｌｂ）、未成熟（ｇｒｅｅｎ）、及び、Ｗｅｌｃｈ）、エシャロット、及び他の鱗茎野菜作物）、柑橘類果実（例えば、グレープフルーツ、レモン、ライム、オレンジ、タンジェリン、柑橘類ハイブリッド、ポメロ、及び他の柑橘類果実作物）、ウリ科野菜（例えば、キュウリ、シトロンメロン、食用ヒョウタン、ガーキン、マスクメロン（例えば、メロンの交配種及び／又は栽培品種）、スイカ、カンタループ、及び他のウリ科野菜作物）、結果野菜（例えば、ナス、酸漿、ペピーノ、コショウ、トマト、トマティーヨ、及び他の結果野菜作物）、ブドウ、葉野菜（例えば、チシャ）、根／塊茎及び球茎野菜（例えば、ジャガイモ）、ヒラマメ、発芽アルファルファ種子、クローバー及び樹木の実（アーモンド、ペカン、ピスタチオ、及びクルミ）、ベリー（例えば、トマト、メギ、フサスグリ、ニワトコの実、グーズベリー、スイカズラ、ポドフィルム、ナニーベリー（ｎａｎｎｙｂｅｒｒｉｅｓ）、オレゴン−ブドウ、シーバックソン（ｓｅｅ−ｂｕｃｋｔｈｏｒｎｓ）、エノキの実、ウワウルシ、リンゴンベリー、イチゴ、ホンダワラ、ブラックベリー、クラウドベリー、ローガンベリー、キイチゴ、サーモンベリー、クロイチゴ、及びワインベリー）、穀類作物（例えば、トウモロコシ、コメ、コムギ、オオムギ、モロコシ、キビ、エンバク、ライ麦、ライコムギ、ソバ、フォニオ、及びキノア）、ナシ果実（例えば、リンゴ、西洋ナシ）、核果（例えば、コーヒー、ナツメ、マンゴ、オリーブ、ココナツ、アブラヤシ、ピスタチオ、アーモンド、アプリコット、サクランボ、ダムソン、ネクタリン、モモ及びプラム）、ブドウ（例えば、テーブルブドウ、ブドウ）、繊維作物（例えば、麻、綿）、観賞植物などがある。幾つかの実施形態において、植物は家庭用／家庭用植物、温室植物、農業植物、又は園芸植物であり得る。既に上で指摘したように、幾つかの実施形態において植物は、アカシア、ユーカリ、シデ、ブナ、マホガニー、クルミ、オーク、トネリコ、ヤナギ、ヒッコリー、カバノキ、クリ、ポプラ、ハンノキ、カエデ、アメリカスズカケノキ、イチョウ、ヤシノキ及びスイートガムの１つのような広葉樹であり得る。幾つかの実施形態において、植物はイトスギ、ベイマツ、モミ、セコイア、ツガ、ヒマラヤスギ、セイヨウネズ、カラマツ、マツ、アメリカスギ、トウヒ及びイチイのような針葉樹であり得る。幾つかの実施形態において植物はリンゴ、プラム、西洋ナシ、バナナ、オレンジ、キウイ、レモン、サクランボ、ブドウ、パパイヤ、落花生、及びイチジクのような結果性木本植物であり得る。幾つかの実施形態において植物は綿、竹及びゴム植物のような木本植物であり得る。植物は幾つかの実施形態において農業、林業及び／又は観賞植物、すなわち、造園で、例えば公園、庭園及びバルコニーで一般に使われる植物であり得る。例は、非常に多くの観賞植物の中の二、三のみを挙げると、芝生、ゼラニウム、ペラルゴニア（ｐｅｌａｒｇｏｎｉａ）、ペチュニア、ベゴニア、及びフクシアである。用語「植物」はまたあらゆる植物繁殖体を包含することが意図されている。
</span>
&nbsp;&nbsp;As used herein, the term “plant” refers to all living organisms belonging to the plant kingdom (ie, any genus / species of the plant kingdom). This includes, but is not limited to, common organisms such as trees, medicinal plants, shrubs, pastures, grapes, ferns, moss and green algae. The term refers to both monocotyledonous plants (monocotyledonous plants) and dicotyledonous plants (dicotyledonous plants). Plants are economically important in some embodiments. In some embodiments, the plant is a human-grown plant, such as a cultivated plant, and may be an agricultural, forestry or horticultural plant. Examples of specific plants include, but are not limited to, corn, potato, rose, apple tree, sunflower, wheat, rice, banana, tomato, opo, pumpkin, to name a few. Touna, bean (for example, lima bean), lettuce, cabbage, oak tree, guzmania, geranium, hibiscus, clematis, poinsettia, sugar cane, taro, duckweed, pine tree, Kentucky bluegrass, buckwheat, coconut tree, cruciferous leaf vegetable [ For example, broccoli, broccoli rarub, brussels sprouts, cabbage, Chinese cabbage (Chingensai and Chinese cabbage (Napa)), cauliflower, cavalo, collard, hagoromokanran, kohlrabi, mustard green, rape greens, And other cruciferous leaf vegetable crops], bulbous vegetables (eg garlic, leek, onion (dry bulb, green and Welch), shallots and other bulbous vegetable crops), Citrus fruits (eg, grapefruit, lemon, lime, orange, tangerine, citrus hybrid, pomelo, and other citrus fruit crops), Cucurbitaceae vegetables (eg, cucumber, citron melon, edible gourd, gherkin, muskmelon (eg, melon) Hybrids and / or cultivars), watermelon, cantaloupe, and other Cucurbitaceae vegetable crops), resulting vegetables (eg, eggplant, sour, pepino, pepper, tomato, tomatillo, and other resulting vegetable crops), grapes Leafy vegetables (eg, chisha), root / tuber and corm vegetables (eg, potatoes), Lame, germinated alfalfa seed, clover and tree nut (almond, pecan, pistachio, and walnut), berry (e.g., tomato, barberry, redcurrant, elderberry, gooseberry, honeysuckle, podofilm, nannyberry, oregon-grape, Sea buckson, enoki seed, walrus, lingonberry, strawberry, hondawala, blackberry, cloudberry, loganberry, raspberry, salmonberry, blackberry, and wineberry), cereal crops (eg, corn, Rice, wheat, barley, sorghum, millet, oat, rye, triticale, buckwheat, fonio, and quinoa), pear fruit (eg, apple, pear), drupe (eg, coffee) Jujube, mango, olive, coconut, oil palm, pistachio, almond, apricot, cherry, damson, nectarine, peach and plum), grape (eg table grape, grape), textile crop (eg hemp, cotton), ornamental plant, etc. There is. In some embodiments, the plant can be a home / household plant, a greenhouse plant, an agricultural plant, or a horticultural plant. As already pointed out above, in some embodiments the plant is acacia, eucalyptus, hornbeam, beech, mahogany, walnut, oak, ash, willow, hickory, birch, chestnut, poplar, alder tree, maple, American sycamore, It can be a broadleaf tree such as one of ginkgo, palm tree and sweet gum. In some embodiments, the plant can be a conifer such as cypress, pine, fir, sequoia, tsuga, cedar, corn, larch, pine, cedar, spruce and yew. In some embodiments, the plant can be a consequent woody plant such as apples, plums, pears, bananas, oranges, kiwis, lemons, cherries, grapes, papayas, peanuts, and figs. In some embodiments, the plant may be a woody plant such as cotton, bamboo and rubber plants. The plant may in some embodiments be an agricultural, forestry and / or ornamental plant, ie a plant commonly used in landscaping, for example in parks, gardens and balconies. Examples are lawn, geranium, pelargonia, petunia, begonia, and fuchsia to name just a few of the many ornamental plants. The term “plant” is also intended to encompass any plant propagation material.
</span>
    </p>
    <p num="0052" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  用語「植物」は通常、１以上の育種、突然変異誘発及び遺伝子工学によって改変されている植物を包含する。遺伝子工学は組換えＤＮＡ技術の使用に関する。組換えＤＮＡ技術によると、天然の状況下での交雑育種、突然変異又は天然の組換えでは容易に得ることができない改変が可能になる。幾つかの実施形態において遺伝子工学で得られた植物はトランスジェニック植物であり得る。
</span>
&nbsp;&nbsp;The term “plant” usually includes plants that have been modified by one or more breeding, mutagenesis and genetic engineering. Genetic engineering relates to the use of recombinant DNA technology. Recombinant DNA technology allows for cross breeding under natural conditions, mutations or modifications that are not readily obtainable by natural recombination. In some embodiments, the genetically engineered plant can be a transgenic plant.
</span>
    </p>
    <p num="0053" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書で使用されている場合、用語「植物の部分」とは、限定されるものではないが、苗条、根、茎、種子、托葉、葉、花弁、花、胚珠、包葉、枝、葉柄、節間、樹皮、木部、塊茎、綿毛、分げつ、根茎、葉状体、葉身、花粉、雄ずい、小胞子、果実及び種子をはじめとして、植物のあらゆる部分をいう。土壌のような当業界で使用される典型的な培地で増殖させた植物の２つの主要な部位は、多くの場合、「苗条」といわれることが多い「地上」部分と、「根部」といわれることが多い「地下」部分といわれる。
</span>
&nbsp;&nbsp;As used herein, the term “plant part” includes, but is not limited to, shoots, roots, stems, seeds, leaves, leaves, petals, flowers, ovules, foliage, branches , Petiole, internode, bark, xylem, tuber, fluff, tiller, rhizome, frond, leaf blade, pollen, stamen, microspore, fruit and seed. The two main parts of a plant grown on typical media used in the industry, such as soil, are often referred to as the “ground” part, often referred to as “shoots”, and the “root”. Often referred to as the “underground” part.
</span>
    </p>
    <p num="0054" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明による方法において、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性の突然変異株を含有する組成物は、植物を増殖させるのに使用されたあらゆる種類の培地（例えば、土壌、バーミキュライト、細断した厚紙、及び水）で増殖させたあらゆる植物又はあらゆる植物のあらゆる部分に施用することができ、又はラン又はビカクシダのように空中で増殖させた植物又は植物の部分に施用することができる。組成物は、例えば、散布、噴霧、気化、ばらまき、散粉、潅水、噴出、まき散らし、流し込み又は燻蒸により施用することができる。既に上で指摘したように、施用は、対象の植物が置かれているあらゆる所望の位置、例えば農業、園芸、森林、プランテーション、果樹園、苗床、有機増殖した作物、芝草及び都市環境で実施することができる。
</span>
&nbsp;&nbsp;In the method according to the present invention, a composition containing Streptomyces microflavus NRRL B-50550 or its phytophagocytic-acaricidal mutant is used for any kind of plant used to grow plants. Can be applied to any plant or any part of any plant grown in medium (eg soil, vermiculite, shredded cardboard, and water), or a plant or plant grown in the air, such as orchids It can be applied to the part. The composition can be applied, for example, by spraying, spraying, vaporizing, spreading, dusting, irrigation, spraying, dusting, pouring or fumigation. As already pointed out above, the application is carried out in any desired location where the plant of interest is located, such as agriculture, horticulture, forests, plantations, orchards, nurseries, organically grown crops, turfgrass and urban environments be able to.
</span>
    </p>
    <p num="0055" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の組成物は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はそれから誘導される突然変異体を、深部発酵、固相発酵又は液面培養のような慣用の大規模な微生物発酵プロセス、例えば、米国特許第３，８４９，３９８号、英国特許第１  ５０７  １９３号、Ｔｏｓｈｉｋｏ  Ｋａｎｚａｋｉ  ｅｔ  ａｌ．、Ｊｏｕｒｎａｌ  ｏｆ  Ａｎｔｉｂｉｏｔｉｃｓ、Ｓｅｒ．  Ａ、Ｖｏｌ．  １５、Ｎｏ．２、Ｊｕｎ．  １９６１、ｐａｇｅｓ  ９３  ｔｏ  ９７、又はＴｏｒｕ  Ｉｋｅｕｃｈｉ  ｅｔ  ａｌ．、Ｊｏｕｒｎａｌ  ｏｆ  Ａｎｔｉｂｉｏｔｉｃｓ、（Ｓｅｐｔ．  １９７２）、ｐａｇｅｓ  ５４８  ｔｏ  ５５０に記載されている方法を用いて培養することによって得ることができる。発酵は、胞子を含めた生きているバイオマス及び望ましい二次代謝物質を高レベルで発酵容器中に得るように設定されている。高レベルの胞子形成、ｃｆｕ（コロニー形成単位）、及び二次代謝物質を達成するために本発明の菌株に適した具体的な発酵方法は実施例の欄に記載されている。
</span>
&nbsp;&nbsp;The compositions of the present invention can be used to produce Streptomyces microflavus NRRL B-50550 or mutants derived therefrom from conventional large scale microbial fermentations such as deep fermentation, solid phase fermentation or liquid surface culture. Processes such as U.S. Pat. No. 3,849,398, British Patent No. 1507 193, Toshiko Kanzaki et al. , Journal of Antibiotics, Ser. A, Vol. 15, no. 2, Jun. 1961, pages 93 to 97, or Toru Ikeuchi et al. , Journal of Antibiotics, (Sept. 1972), pages 548 to 550. Fermentation is set up to obtain high levels of live biomass, including spores, and the desired secondary metabolites in the fermentation vessel. Specific fermentation methods suitable for the strains of the present invention to achieve high levels of sporulation, cfu (colony forming units), and secondary metabolites are described in the Examples section.
</span>
    </p>
    <p num="0056" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  発酵で得られる培養ブロス（「全ブロス」又は「発酵ブロス」）中の細菌細胞、胞子及び代謝物質は直接使用してもよいし、又は遠心分離、ろ過、及び蒸発のような慣用の工業的方法で濃縮してもよいし、又は、例えば噴霧乾燥、ドラム乾燥及び凍結乾燥によって乾燥粉末及び顆粒に加工してもよい。
</span>
&nbsp;&nbsp;Bacterial cells, spores and metabolites in the culture broth obtained by fermentation (“whole broth” or “fermentation broth”) may be used directly or by conventional industrial methods such as centrifugation, filtration and evaporation. It may be concentrated by the process or may be processed into dry powders and granules, for example by spray drying, drum drying and freeze drying.
</span>
    </p>
    <p num="0057" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書で使用されている用語「全ブロス」及び「発酵ブロス」とは、（少なくとも約１ｇ／Ｌの濃度のグーゲロチンを含有する培養ブロスの生産を含めて）発酵の結果得られ、下流の後処理をする前の培養ブロスをいう。この全ブロスは、微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性の突然変異株）及びその構成部分、未使用の生の基質、並びに発酵中に微生物が産生した代謝物質を含む。本明細書で使用されている用語「ブロス濃縮液」とは、上記のように慣用の工業的方法によって濃縮されてはいるが、液体形態のままである全ブロス（発酵ブロス）をいう。本明細書で使用されている用語「発酵固体」とは乾燥された発酵ブロスをいう。本明細書で使用されている用語「発酵産物」とは、全ブロス、ブロス濃縮液及び／又は発酵固体を指す。本発明の組成物は発酵産物を包含する。幾つかの実施形態において、濃縮された発酵ブロスは、残留する発酵ブロス及び代謝物質を除去するために、例えば透析ろ過プロセスによって洗浄される。
</span>
&nbsp;&nbsp;As used herein, the terms “total broth” and “fermentation broth” are the results of fermentation (including production of a culture broth containing a concentration of at least about 1 g / L of gougerotin) This refers to the culture broth before post-treatment. This whole broth is composed of microorganisms (eg, Streptomyces microflavus NRRL B-50550 or its phytophagic-acaricidal mutants) and components thereof, unused raw substrates, and during fermentation Contains metabolites produced by microorganisms. As used herein, the term “broth concentrate” refers to a whole broth (fermented broth) that has been concentrated by conventional industrial methods as described above, but remains in liquid form. As used herein, the term “fermented solid” refers to a dried fermentation broth. As used herein, the term “fermentation product” refers to whole broth, broth concentrate and / or fermentation solid. The composition of the present invention includes a fermentation product. In some embodiments, the concentrated fermentation broth is washed, for example by a diafiltration process, to remove residual fermentation broth and metabolites.
</span>
    </p>
    <p num="0058" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">５</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。別の実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">６</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。さらに別の実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">７</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。もう１つ別の実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">８</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。もう１つ別の実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">９</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。もう１つ別の実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">１０</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。もう１つ別の実施形態において、発酵ブロスは、ブロス１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">１１</sup>コロニー形成単位（ＣＦＵ）の微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）を含有する。当業者には理解されるように、上記の濃度は、発酵完了のすぐ後に測定されたＣＦＵであるが、ＣＦＵレベルは貯蔵条件に従って経時的に低下する。本明細書に記載した微生物の未処方の発酵産物ｓのＣＦＵレベルは、その産物を冷たい貯蔵（例えば、約４℃）に維持したときは安定であるが室温では低下する。
</span>In one embodiment, the fermentation broth comprises at least about 1 × 10 <sup class="style-scope patent-text">5</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or its phytophagous-acaricide) per mL of broth. Sex mutant). In another embodiment, the fermentation broth is at least about 1 × 10 <sup class="style-scope patent-text">6</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or its phytophagous-acaricide) per mL of broth. Sex mutant). In yet another embodiment, the fermentation broth comprises at least about 1 × 10 <sup class="style-scope patent-text">7</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or its phytophagous-killing per mL of broth. Tick mutant). In another embodiment, the fermentation broth comprises at least about 1 × 10 <sup class="style-scope patent-text">8</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or phytophagous thereof per mL of broth. -Acaricidal mutant). In another embodiment, the fermentation broth comprises at least about 1 × 10 <sup class="style-scope patent-text">9</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or its phytophagous per mL of broth. -Acaricidal mutant). In another embodiment, the fermentation broth comprises at least about 1 × 10 <sup class="style-scope patent-text">10</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or phytophagous thereof per mL of broth. -Acaricidal mutant). In another embodiment, the fermentation broth comprises at least about 1 × 10 <sup class="style-scope patent-text">11</sup> colony forming units (CFU) of microorganism (eg, Streptomyces microflavus NRRL B-50550 or its phytophagous per mL of broth. -Acaricidal mutant). As will be appreciated by those skilled in the art, the above concentrations are CFU measured immediately after completion of fermentation, but CFU levels decrease over time according to storage conditions. The CFU level of the unformulated fermentation product s of microorganisms described herein is stable when the product is maintained in cold storage (eg, about 4 ° C.), but decreases at room temperature.</span>
    </p>
    <p num="0059" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、発酵ブロス又はブロス濃縮液は、安定剤、保存剤、補佐剤、及び／又は着色剤を添加して液体懸濁液、液体濃縮液、乳剤濃縮液、又は水和剤に処方することができる。
</span>
&nbsp;&nbsp;In one embodiment, the fermentation broth or broth concentrate is added to a liquid suspension, liquid concentrate, emulsion concentrate, or wettable powder with the addition of stabilizers, preservatives, adjuvants, and / or colorants. Can be prescribed.
</span>
    </p>
    <p num="0060" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  別の実施形態において、発酵ブロス又はブロス濃縮液は、担体、不活性成分、又は添加剤を添加して、又はしないで、慣用の乾燥プロセス又は噴霧乾燥、凍結乾燥、トレー乾燥、流動床乾燥、ドラム乾燥、若しくは蒸発のような方法を用いて乾燥することができる。
</span>
&nbsp;&nbsp;In another embodiment, the fermentation broth or broth concentrate is a conventional drying process or spray drying, lyophilization, tray drying, fluid bed drying, with or without the addition of carriers, inert ingredients, or additives, It can be dried using methods such as drum drying or evaporation.
</span>
    </p>
    <p num="0061" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  幾つかの実施形態においては、発酵ブロス、ブロス濃縮液又は発酵固体を、微生物を死滅させるために処理して、死滅した微生物、その代謝物質及び残留発酵培地からなる発酵産物を得る。これを達成するのに適した処理は当業者に公知であり、例えば、熱処理などがある。
</span>
&nbsp;&nbsp;In some embodiments, the fermentation broth, broth concentrate or fermentation solid is treated to kill the microorganisms to obtain a fermentation product consisting of the killed microorganisms, their metabolites and residual fermentation medium. Suitable treatments for accomplishing this are known to those skilled in the art and include, for example, heat treatment.
</span>
    </p>
    <p num="0062" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  発酵ブロス又はブロス濃縮液を凍結乾燥する実施形態では、１ガロンの発酵ブロスから約０．２ｌｂ（ポンド）〜約１ｌｂの凍結乾燥粉末が得られる。特定の例においては、１ガロンの発酵ブロスから約０．４ｌｂ〜約０．６ｌｂの凍結乾燥粉末が得られる。別の例においては、１ガロンの発酵ブロスから約０．５ｌｂの凍結乾燥粉末が得られる。
</span>
&nbsp;&nbsp;In an embodiment where the fermentation broth or broth concentrate is lyophilized, from about 0.2 lb (pound) to about 1 lb of lyophilized powder is obtained from 1 gallon of fermentation broth. In a particular example, about 0.4 lb to about 0.6 lb of lyophilized powder is obtained from 1 gallon of fermentation broth. In another example, about 0.5 lb of lyophilized powder is obtained from 1 gallon of fermentation broth.
</span>
    </p>
    <p num="0063" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに別の実施形態においては、得られた乾燥生成物を、不活性成分又は添加剤を添加して、又はしないで粉砕又は造粒などによりさらに加工処理して農業適用に望ましい特定の粒度又は物理的フォーマット若しくは物理的性質を達成し得る。
</span>
&nbsp;&nbsp;In yet another embodiment, the resulting dried product is further processed, such as by grinding or granulation, with or without inert ingredients or additives, to obtain a specific particle size or physical property desired for agricultural applications. Format or physical properties may be achieved.
</span>
    </p>
    <p num="0064" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  全ブロス又はブロス濃縮液の使用に加えて、発酵ブロスの抽出、遠心分離及び／又はろ過のような当業界で公知の何らかの手段により、本発明のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）の新規な変異体及び菌株の発酵ブロスの無細胞調製物を得ることができる。当業者には理解されるように、いわゆる無細胞調製物は細胞が全くないわけではないが、細胞を除去するのに用いた技術（例えば、遠心分離の速度）に応じて殆どが無細胞又は本質的に無細胞である。得られた無細胞調製物はその施用を補助する成分と共に乾燥及び／又は処方し得る。発酵ブロスについて上に記載した濃縮方法及び乾燥技術は無細胞調製物にも適用可能である。
</span>
&nbsp;&nbsp;In addition to the use of whole broth or broth concentrate, the novel variants of Streptomyces of the present invention and by any means known in the art such as fermentation broth extraction, centrifugation and / or filtration A cell-free preparation of the fermentation broth of the strain can be obtained. As will be appreciated by those skilled in the art, so-called cell-free preparations are not free of cells at all, but depending on the technique used to remove the cells (eg, the speed of centrifugation) It is essentially cell-free. The resulting cell-free preparation can be dried and / or formulated with ingredients to aid its application. The concentration methods and drying techniques described above for the fermentation broth are also applicable to cell-free preparations.
</span>
    </p>
    <p num="0065" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の組成物は、有効性、安定性、及び物理的性質、有用性を改良し、及び／又は加工処理、包装及び最終用途適用を容易にするために細胞、無細胞調製物又は代謝産物を含む組成物に添加される配合成分を含み得る。かかる配合成分としては、個別に又は組み合わせて添加され得る担体、不活性成分、安定剤、保存剤、栄養分、又は物理的性質改良剤を挙げることができる。幾つかの実施形態において、担体には水、油、及び他の有機又は無機溶剤のような液体物質及び鉱物、ポリマー、又は生物学的に若しくは化学合成により誘導されたポリマー複合体のような固体物質が包含され得る。幾つかの実施形態において、成分は結合剤、補佐剤、又は葉、種子、若しくは根のような植物の部分に対する組成物の付着を促進する粘着剤である。例えば、Ｔａｙｌｏｒ、Ａ．Ｇ．、ｅｔ  ａｌ．、「Ｃｏｎｃｅｐｔｓ  ａｎｄ  Ｔｅｃｈｎｏｌｏｇｉｅｓ  ｏｆ  Ｓｅｌｅｃｔｅｄ  Ｓｅｅｄ  Ｔｒｅａｍｅｎｔｓ」  Ａｎｎｕ．  Ｒｅｖ．  Ｐｈｙｔｏｐａｔｈｏｌ．  ２８：  ３２１−３３９  （１９９０）参照。安定剤には凝結防止剤、酸化防止剤、防湿剤、保護剤又は保存剤が包含され得る。栄養分には糖類、多糖類、油、タンパク質、アミノ酸、脂肪酸及びホスフェートのような炭素、窒素、及びリンの供給源が包含され得る。物理的性質改良剤には増量剤、湿潤剤、増粘剤、ｐＨ改良剤、レオロジー改良剤、分散剤、補佐剤、界面活性剤、凍結防止剤又は着色剤が包含され得る。幾つかの実施形態において、発酵により生成した細胞、無細胞調製物又は代謝物質を含む組成物は、他の配合製剤を全く加えないで、場合により希釈剤としての水と共に直接使用することができる。特定の実施形態においては、湿潤剤が凍結乾燥又は噴霧乾燥粉末のような発酵固体に添加される。湿潤剤は表面に施用されたとき（希釈された）活性成分の展延性及び浸透性を増大する。代表的な湿潤剤は当業者に公知であり、例えば、ＭＯＮＡＷＥＴ  ＭＯ−７０（Ｃｒｏｄａ  Ｉｎｃ．、Ｅｄｉｓｏｎ、ＮＪ）のようなスルホスクシネート及び誘導体、ＢＲＥＡＫＴＨＲＵ（Ｅｖｏｎｉｋ、Ｇｅｒｍａｎｙ）のようなトリシロキサン、ＡＬＴＯＸ  ４８９４（Ｃｒｏｄａ  Ｉｎｃ．、Ｅｄｉｓｏｎ、ＮＪ）のような非イオン性化合物、ＴＥＲＷＥＴ  ３００１（Ｈｕｎｔｓｍａｎ  Ｉｎｔｅｒｎａｔｉｏｎａｌ  ＬＬＣ、Ｔｈｅ  Ｗｏｏｄｌａｎｄｓ、Ｔｅｘａｓ）のようなアルキルポリグルコシド、ＴＥＲＧＩＴＯＬ  １５−ｓ−１５（Ｔｈｅ  Ｄｏｗ  Ｃｈｅｍｉｃａｌ  Ｃｏｍｐａｎｙ、Ｍｉｄｌａｎｄ、Ｍｉｃｈｉｇａｎ）のようなＣ１２−Ｃ１４第二級アルコールエトキシレート、ＲＨＯＤＡＦＡＣ  ＢＧ−５１０（Ｒｈｏｄｉａ、Ｉｎｃ．）のようなリン酸エステル、及びＥＭＵＬＳＯＧＥＮ−ＬＳ（Ｃｌａｒｉａｎｔ  Ｃｏｒｐｏｒａｔｉｏｎ、Ｎｏｒｔｈ  Ｃａｒｏｌｉｎａ）のようなアルキルエーテルカルボキシレートなどがある。
</span>
&nbsp;&nbsp;The compositions of the present invention improve the effectiveness, stability, and physical properties, utility, and / or cell, cell-free preparations or metabolites to facilitate processing, packaging and end-use applications. The compounding component added to the composition containing this may be included. Such compounding ingredients can include carriers, inert ingredients, stabilizers, preservatives, nutrients, or physical property improvers that can be added individually or in combination. In some embodiments, the carrier is a liquid material such as water, oil, and other organic or inorganic solvents and solids such as minerals, polymers, or polymer complexes derived from biological or chemical synthesis. Substances can be included. In some embodiments, the component is a binder, an adjuvant, or an adhesive that promotes adhesion of the composition to plant parts such as leaves, seeds, or roots. For example, Taylor, A. et al. G. Et al. "Concepts and Technologies of Selected Seed Elements" Annu. Rev. Phytopathol. 28: 321-339 (1990). Stabilizers can include anti-caking agents, antioxidants, moisture barriers, protective agents, or preservatives. Nutrients can include sources of carbon, nitrogen, and phosphorus, such as sugars, polysaccharides, oils, proteins, amino acids, fatty acids and phosphates. Physical property modifiers can include extenders, wetting agents, thickeners, pH modifiers, rheology modifiers, dispersants, adjuvants, surfactants, antifreeze agents, or colorants. In some embodiments, the fermented cells, cell-free preparation or metabolite-containing composition can be used directly with water as a diluent, optionally without any other formulation. . In certain embodiments, a wetting agent is added to the fermentation solid, such as a lyophilized or spray dried powder. Wetting agents increase the spreadability and permeability of the active ingredient (diluted) when applied to the surface. Exemplary wetting agents are known to those skilled in the art, for example, sulfosuccinates and derivatives such as MONAWET MO-70 (Croda Inc., Edison, NJ), trisiloxanes such as BREATHRURU (Evonik, Germany), Nonionic compounds such as ALTOX 4894 (Croda Inc., Edison, NJ), alkylpolyglucosides such as TERWET 3001 (Huntsman International LLC, The Woodlands, Texas), TERGITL 15-s-15 Coh, The Dow C12-C14 secondary alcohol ethoxylates such as Midland, Michigan), RHODAFAC BG-510 (Rh dia, Inc. phosphate esters such as), and EMULSOGEN-LS (Clariant Corporation, and the like alkyl ether carboxylates, such as North Carolina).
</span>
    </p>
    <p num="0066" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  幾つかの実施形態において、配合不活性成分は発酵ブロスを濃縮した後、乾燥中及び／又はその後に添加される。
</span>
&nbsp;&nbsp;In some embodiments, the blended inert ingredients are added after concentrating the fermentation broth, during and / or after drying.
</span>
    </p>
    <p num="0067" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明は少なくとも約１ｇ／Ｌの濃度でグーゲロチンを含有する発酵ブロスを包含する幾つかの実施形態においてかかる全ブロス培養物はストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）のグーゲロチン産生株に由来する。特定の実施形態において、かかるグーゲロチン産生株はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）、又はストレプトマイセス・グラミネアルス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｇｒａｍｉｎｅａｒｕｓ）である。別の実施形態において、グーゲロチン産生株はＳ．グリセウス（Ｓ．ｇｒｉｓｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、又はＳ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）である。さらに別の特定の実施形態において、かかるグーゲロチン産生株は中国普通微生物菌種保藏管理中心（Ｃｈｉｎａ  Ｇｅｎｅｒａｌ  Ｍｉｃｒｏｂｉｏｌｏｇｉｃａｌ  Ｃｕｌｔｕｒｅ  Ｃｏｌｌｅｃｔｉｏｎ  Ｃｅｎｔｅｒ）ＣＧＭＣＣに寄託されているストレプトマイセス・グラミネアルス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｇｒａｍｉｎｅａｒｕｓ）ＣＧＭＣＣ  ４．５０６である。
</span>
&nbsp;&nbsp;In some embodiments, wherein the present invention includes a fermentation broth containing gougerotin at a concentration of at least about 1 g / L, such whole broth culture is derived from a gougelotin producing strain of Streptomyces. In certain embodiments, such a gougerotin-producing strain is Streptomyces microflavus, Streptomyces puniceus, or Streptomyces gramnegus. In another embodiment, the gougerotin producing strain is S. cerevisiae. S. griseus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. Arboviridis, or S. alboviridis S. puniceus. In yet another specific embodiment, such a gougerotin-producing strain is Streptomyces graminececG6G6 at Streptomyces GraminaceG6C, deposited with the China General Microbiological Cultural Center CGMCC. is there.
</span>
    </p>
    <p num="0068" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）由来のグーゲロチン生合成遺伝子クラスター、当該遺伝子クラスター内の個々の遺伝子の特性決定、及びそれによりコードされるタンパク質も提供する。グーゲロチン遺伝子クラスターが開示されており、この遺伝子クラスターはそれぞれＯＲＦ４２５１〜４２５３、４２５５〜４２５９、４２６１〜４２６５、及び４２７１（それぞれ配列番号：１、３、５、９、１１、１３、１５、１７、２１、２３、２５、２７、２９、及び４１）と称され、本明細書ではそれぞれＧｏｕＡ、ＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、ＧｏｕＭ、及びＧｏｕＮと称される１４のオープンリーディングフレーム（ＯＲＦ）を含む。対応するタンパク質はそれぞれ配列番号：２、４、６、１０、１２、１４、１６、１８、２２、２４、２６、２８、３０、及び４２に提供される。グーゲロチン生合成遺伝子クラスター及び幾つかのフランキング領域を含むゲノムＤＮＡ配列が配列番号：４３に提供され、遺伝子ＧｏｕＡ〜ＧｏｕＮの位置が記載されている。本開示は、ある遺伝子座内に位置するグーゲロチン遺伝子クラスターの核酸配列、そこに含まれるＯＲＦ、及びそれによりコードされるタンパク質を提供する。この情報により、例えば、他のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属の菌が有するようなグーゲロチン遺伝子クラスター及び対応するＯＲＦのホモログをコードする関連の核酸分子の単離が可能になる。
</span>
&nbsp;&nbsp;The present invention also provides a gougerotin biosynthetic gene cluster from Streptomyces microflavus, characterization of individual genes within the gene cluster, and proteins encoded thereby. Gougerotin gene clusters are disclosed, which are ORF 4251-4253, 4255-4259, 4261-4265, and 4271 (SEQ ID NOs: 1, 3, 5, 9, 11, 13, 15, 17, 21 respectively. , 23, 25, 27, 29, and 41), and are referred to herein as GouA, GouB, GouC, GouD, GouE, GouF, GouG, GouH, GouI, GouJ, GouK, GouL, GouM, and GouN, respectively. 14 open reading frames (ORFs). The corresponding proteins are provided in SEQ ID NOs: 2, 4, 6, 10, 12, 14, 16, 18, 22, 24, 26, 28, 30, and 42, respectively. A genomic DNA sequence including a gougerotin biosynthetic gene cluster and several flanking regions is provided in SEQ ID NO: 43, which describes the location of the genes GouA-GouN. The present disclosure provides the nucleic acid sequence of the gougerotin gene cluster located within a locus, the ORFs contained therein, and the proteins encoded thereby. This information allows for the isolation of related nucleic acid molecules encoding, for example, the gougerotin gene cluster and the corresponding ORF homologs, as possessed by other Streptomyces spp.
</span>
    </p>
    <p num="0069" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）菌株から同定された配列番号：４３（ヌクレオチド残基１−２１９３３）に含まれるグーゲロチン遺伝子クラスターは、ＯＲＦ４２４８〜４２７１と称される２４のＯＲＦを含んでいる。ＯＲＦ４２５１、４２５２、４２５３、４２５５、４２５６、４２５７、４２５８、４２５９、４２６１、４２６２、４２６３、４２６４、４２６５、及び４２７１はそれぞれ１３の遺伝子ｇｏｕＡ、ｇｏｕＢ、ｇｏｕＣ、ｇｏｕＤ、ｇｏｕＥ、ｇｏｕＦ、ｇｏｕＧ、ｇｏｕＨ、ｇｏｕＩ、ｇｏｕＪ、ｇｏｕＫ、ｇｏｕＬ、ｇｏｕＭ、及びｇｏｕＮである。配列番号：８９−１００（ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）菌株から同定された）はそれぞれオルソロガスな遺伝子ｇｏｕＢ、ｇｏｕＣ、ｇｏｕＤ、ｇｏｕＥ、ｇｏｕＦ、ｇｏｕＧ、ｇｏｕＨ、ｇｏｕＩ、ｇｏｕＪ、ｇｏｕＫ、ｇｏｕＬ、ｇｏｕＭを提供することに留意されたい。これらの遺伝子の潜在的な機能及びグーゲロチン合成における可能な役割を表２に提供する。<br class="style-scope patent-text">
<tables num="2" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000007" he="234" wi="170" file="2015534950.tif" img-format="tif" img-content="drawing" width="680" height="936" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
The gougerotin gene cluster contained in SEQ ID NO: 43 (nucleotide residues 1-21933) identified from the Streptomyces microflavus strain contains 24 ORFs designated ORF 4248-4271. ORF 4251, 4252, 4253, 4255, 4256, 4257, 4258, 4259, 4261, 4262, 4263, 4264, 4265, and 4271 are the 13 genes goA, goB, gouC, gouD, gouE, gouF, gouG, goH, gouI, respectively. , GouJ, gouK, gouL, gouM, and gouN. SEQ ID NOs: 89-100 (identified from Streptomyces puniceus strains) are orthologous genes guB, guC, guD, guE, guF, guG, guH, guI, guJ, guL Note that we provide The potential functions of these genes and possible roles in gougerotin synthesis are provided in Table 2. <br class="style-scope patent-text"> <tables num="2" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000007" he="234" wi="170" file="2015534950.tif" img-format="tif" img-content="drawing" width="680" height="936" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
    <p class="style-scope patent-text"></p>
    <p num="0070" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  従って、さらに別の実施形態において、少なくとも約０．５ｇ／Ｌのグーゲロチン又は少なくとも約１ｇ／Ｌのグーゲロチンを有する発酵ブロスを含む本発明の発酵産物は、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約７５％、少なくとも約８０％、少なくとも約８５％、少なくとも約９０％、少なくとも約９５％又は少なくとも約９９％の配列同一性を有するアミノ酸配列をコードする核酸配列を有するグーゲロチン産生性のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株に由来する。さらにもう１つ別の実施形態において、少なくとも約０．５ｇ／Ｌのグーゲロチン又は少なくとも約１ｇ／Ｌのグーゲロチンを有する発酵ブロスを含む発酵産物は、配列番号：４３のヌクレオチド配列又は配列番号：４３のヌクレオチド配列のタンパク質ＧｏｕＡ、ＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、及び／又はＧｏｕＭをコードする領域に対して少なくとも約７５％、少なくとも約８０％、少なくとも約８５％、少なくとも約９０％、少なくとも約９５％、少なくとも約９６％、少なくとも約９７％、少なくとも約９８％、又は少なくとも約９９％の配列同一性を有するヌクレオチド配列を有するグーゲロチン産生性のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株に由来する。
</span>
&nbsp;&nbsp;Thus, in yet another embodiment, the fermentation product of the present invention comprising a fermentation broth having at least about 0.5 g / L gougerotin or at least about 1 g / L gougerotin is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 28 No. 30 and at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95% or at least about at least one amino acid sequence selected from the group consisting of SEQ ID NO: 42 Gougerotin-producing Streptomyces having a nucleic acid sequence encoding an amino acid sequence having about 99% sequence identity (Strep Derived from the omyces) strain. In yet another embodiment, the fermentation product comprising a fermentation broth having at least about 0.5 g / L gougerotin or at least about 1 g / L gougerotin is a nucleotide sequence of SEQ ID NO: 43 or SEQ ID NO: 43. At least about 75%, at least about 80%, at least about the region encoding the nucleotide sequence proteins GouA, GouB, GouC, GouD, GouE, GouF, GouG, GouH, GouI, GouJ, GouK, GouL, and / or GouM. Gougerotin-producing streptomycin having a nucleotide sequence having a sequence identity of about 85%, at least about 90%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or at least about 99% Seth (Strep Derived from the omyces) strain.
</span>
    </p>
    <p num="0071" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特定の実施形態において、上記核酸配列を有するかかるグーゲロチン産生株はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）又はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）である。１つの特定の例はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異体である。１つの例において、かかる植物食性−殺ダニ性突然変異体はｉｓ  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｍ株である。別の例において、かかるグーゲロチン産生株はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はその植物食性−殺ダニ性突然変異体である。
</span>
&nbsp;&nbsp;In a particular embodiment, such a gougerotin producing strain having the nucleic acid sequence is Streptomyces microflavus or Streptomyces pniceus. One particular example is Streptomyces microflavus NRRL B-50550 or a phytophagocytic-acaricidal mutant thereof. In one example, such a phytophagic-acaricidal mutant is the is Streptomyces microflavus strain M. In another example, such a gougerotin producing strain is a Streptomyces puniceus A strain or a phytophagocytic-acaricidal mutant thereof.
</span>
    </p>
    <p num="0072" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  少なくとも約１ｇ／Ｌのグーゲロチンを含有する発酵ブロスは、親の菌株より高いレベルのグーゲロチンを産生する突然変異株を獲得するための親のグーゲロチン産生株の発酵最適化及び／又は突然変異誘発のような幾つかの方法で得ることができる。
</span>
&nbsp;&nbsp;Fermentation broth containing at least about 1 g / L of gougerotin can be used for fermentation optimization and / or mutagenesis of the parent gougerotin producing strain to obtain mutant strains that produce higher levels of gougerotin than the parent strain. Can be obtained in several ways.
</span>
    </p>
    <p num="0073" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  従って、本発明はまた、グーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスで、少なくとも約０．５ｇ／Ｌのグーゲロチンを含有する発酵ブロスを製造する方法も包含する。この方法は、消化可能な炭素源及び消化可能な窒素源を含有する培地において好気性条件下でストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することを含み、ここで培地はシトシンのようなグーゲロチンの前駆体、ヌクレオ塩基、及び／又は少なくとも０．５ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度のアミノ酸を含有する。
</span>
&nbsp;&nbsp;Accordingly, the present invention also encompasses a method of producing a fermentation broth containing at least about 0.5 g / L of gougerotin with a fermentation broth of a Guguerotin-producing Streptomyces strain. The method includes culturing a Streptomyces strain under aerobic conditions in a medium containing a digestible carbon source and a digestible nitrogen source, wherein the medium is a precursor of gougerotin such as cytosine. Body, nucleobase, and / or amino acid at a concentration effective to achieve a gougerotin concentration of at least 0.5 g / L.
</span>
    </p>
    <p num="0074" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  幾つかの実施形態において、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、培地が少なくとも約０．５ｇ／Ｌ、少なくとも約１ｇ／Ｌ、少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、約少なくとも７ｇ／Ｌ又は少なくとも約８ｇ／Ｌのグーゲロチンの濃度でグーゲロチンを含有するようになるまで培地中で培養する。
</span>
&nbsp;&nbsp;In some embodiments, the Streptomyces strain has a medium of at least about 0.5 g / L, at least about 1 g / L, at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, Culture in medium until it contains gougerotin at a concentration of at least about 5 g / L, at least about 6 g / L, at least about 7 g / L, or at least about 8 g / L.
</span>
    </p>
    <p num="0075" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他の実施形態において、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株は、培地が約０．５ｇ／Ｌ〜約２５ｇ／Ｌのグーゲロチンの範囲の濃度でグーゲロチンを含有するようになるまで、すなわち、発酵ブロスが通例約０．５ｇ／Ｌ〜約１５ｇ／Ｌのグーゲロチン、発酵完了後約０．５ｍｇ／ｇ〜約１５ｍｇ／ｇのグーゲロチンの範囲の濃度でグーゲロチンを含有するようなるまで、培地中で培養する。
</span>
&nbsp;&nbsp;In other embodiments, the Streptomyces strain is used until the medium contains gougerotin at a concentration in the range of about 0.5 g / L to about 25 g / L of gougerotin, ie, the fermentation broth is typically. Incubate in the medium until it contains gougerotin at a concentration ranging from about 0.5 g / L to about 15 g / L of gougerotin, after completion of the fermentation, from about 0.5 mg / g to about 15 mg / g of gougerotin.
</span>
    </p>
    <p num="0076" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  これに関連して、少なくとも約０．５ｇ／Ｌ又は少なくとも約１ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度で添加されるアミノ酸は、アミノ酸がオリゴペプチドや部分的に加水分解したタンパク質のような他の化合物との混合物として存在し得る酵母エキス又はタンパク質加水分解物（例えば、二、三の名前だけを挙げるとカゼイン加水分解物、大豆粉加水分解物、大豆ペプトン、大豆酸加水分解物）のような組成物の一部としてではなく、明確に規定された濃度の別個の成分として培地に供給されることに注意されたい。従って、発酵ブロス中の「少なくとも１ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度」とは、かかるグーゲロチン濃度を提供するように特に選択される培地中のアミノ酸濃度を意味する。幾つかの実施形態において、所望のグーゲロチン濃度を達成するのに有効な濃度は少なくとも約１ｇ／Ｌの培地中アミノ酸濃度である。従って、この「有効な濃度」は２ｇ／Ｌより高い可能性があり、例えば約２ｇ／Ｌ〜約１５ｇ／Ｌの範囲であり得る。この濃度は約３ｇ／Ｌ、約４ｇ／Ｌ、約５ｇ／Ｌ、約６ｇ／Ｌ、約７ｇ／Ｌ、約８ｇ／Ｌ、約９ｇ／Ｌ、約１０ｇ／Ｌ、約１１ｇ／Ｌ、約１２ｇ／Ｌ、約１３ｇ／Ｌ、又は約１４ｇ／Ｌであり得る。
</span>
&nbsp;&nbsp;In this regard, the amino acid added at a concentration effective to achieve a gougerotin concentration of at least about 0.5 g / L or at least about 1 g / L is an amino acid of an oligopeptide or partially hydrolyzed protein. Yeast extract or protein hydrolyzate that may exist as a mixture with other compounds such as casein hydrolyzate, soy flour hydrolyzate, soy peptone, soy acid hydrolyzate to name only a few Note that the medium is not supplied as part of a composition such as) but as a separate component with a well-defined concentration. Thus, “a concentration effective to achieve a gougerotin concentration of at least 1 g / L” in the fermentation broth means an amino acid concentration in the medium that is specifically selected to provide such gougerotin concentration. In some embodiments, the concentration effective to achieve the desired gougerotin concentration is an amino acid concentration in the medium of at least about 1 g / L. Thus, this “effective concentration” can be higher than 2 g / L, and can range, for example, from about 2 g / L to about 15 g / L. This concentration is about 3 g / L, about 4 g / L, about 5 g / L, about 6 g / L, about 7 g / L, about 8 g / L, about 9 g / L, about 10 g / L, about 11 g / L, about 12 g. / L, about 13 g / L, or about 14 g / L.
</span>
    </p>
    <p num="0077" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アミノ酸は、少なくとも約０．５ｇ／Ｌのグーゲロチンの濃度又はより高い濃度、例えば少なくとも約１ｇ／Ｌ、少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、請求項６〜８のいずれかの方法を提供する任意のアミノ酸であり得る。幾つかの実施形態において、アミノ酸はグリシン、Ｌ−グルタミン酸、Ｌ−グルタミン、Ｌ−アスパラギン酸、Ｌ−セリン、又はこれらの混合物である。幾つかの実施形態において、培地は約５ｇ／Ｌ〜約１５ｇ／Ｌの濃度でグリシンを含有するが、他の実施形態において培地は約５ｇ／Ｌ〜約１５ｇ／Ｌの初期濃度でグルタミン酸を含有する。また、培地がグリシンとＬ−グルタミン酸（又はＬ−グルタミン）の両方を約５ｇ／Ｌ〜約１５ｇ／Ｌの濃度で含有することも可能である。
</span>
&nbsp;&nbsp;The amino acid has a concentration of at least about 0.5 g / L of gougerotin or higher, such as at least about 1 g / L, at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, At least about 6 g / L, which can be any amino acid that provides the method of any of claims 6-8. In some embodiments, the amino acid is glycine, L-glutamic acid, L-glutamine, L-aspartic acid, L-serine, or a mixture thereof. In some embodiments, the medium contains glycine at a concentration of about 5 g / L to about 15 g / L, while in other embodiments the medium contains glutamic acid at an initial concentration of about 5 g / L to about 15 g / L. To do. The medium can also contain both glycine and L-glutamic acid (or L-glutamine) at a concentration of about 5 g / L to about 15 g / L.
</span>
    </p>
    <p num="0078" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株が消化可能な（従って利用可能な）あらゆる炭素源を本明細書に記載する発酵ブロスの製造方法（又は発酵方法）に使用することができる。適切な炭素源に例としては、二、三の名前だけを挙げるとグルコース、フルクトース、マンノース、ガラクトース、スクロース、マルトース、ラクトース、モラッセ、デンプン（多糖類の一例）、デキストリン、マルトデキストリン（オリゴ糖の一例）又はグリセリンがある。炭素源（複数でもよい）の総初期濃度は、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）の適切な増殖及び所望の濃度のグーゲロチンの産生を提供するいかなる濃度でもよく、実験的に決定され得る（使用した炭素源（複数でもよい）の濃度に依存する発酵ブロス内のグーゲロチンの最終濃度を測定する）。炭素源総初期濃度は、例えば約１０ｇ／Ｌ〜約１５０ｇ／Ｌの範囲であり得、例えば約１０ｇ／Ｌ、約２０ｇ／Ｌ、約３０ｇ／Ｌ、約４０ｇ／Ｌ、約５０ｇ／Ｌ、約６０ｇ／Ｌ、約７０ｇ／Ｌ、約８０ｇ／Ｌ、約９０ｇ／Ｌ、約１００ｇ／Ｌ、約１１０ｇ／Ｌ又は約１２０ｇ／Ｌであり得る。幾つかの実施形態において、炭素源は２以上の炭素源の混合物、例えば、グルコースとデンプンのような多糖類との混合物、グルコースとデキストリン若しくはマルトデキストリンのようなオリゴ糖との混合物、又はグルコース、デンプン及びデキストリンの混合物であってもよい。幾つかの実施形態において、培地は炭素源としてグルコースとオリゴ糖の混合物を含有する。オリゴ糖はマルトデキストリン又はデキストリンであり得る。かかる実施形態において、培地中の初期のマルトデキストリン濃度は約５０ｇ／Ｌ〜約１００ｇ／Ｌ又は約６０ｇ／Ｌ〜約８０ｇ／Ｌであり得る。培地中の初期のグルコース濃度は約２０ｇ／Ｌ〜約８０ｇ／Ｌ、例えば、約３０ｇ／Ｌ、約４０ｇ／Ｌ、約５０ｇ／Ｌ、約６０ｇ／Ｌ又は約７０ｇ／Ｌであり得る。炭素源としてマルトデキストリン又はデキストリンと共にグルコースを使用する他の実施形態において、グルコース濃度は約２０ｇ／Ｌ〜６０ｇ／Ｌ又は約３０ｇ／Ｌ〜約５０ｇ／Ｌであり得る。
</span>
&nbsp;&nbsp;Any carbon source that can be digested (and thus available) by a Streptomyces strain can be used in the fermentation broth production process (or fermentation process) described herein. Examples of suitable carbon sources include glucose, fructose, mannose, galactose, sucrose, maltose, lactose, molasses, starch (an example of a polysaccharide), dextrin, maltodextrin (of oligosaccharides) An example) or glycerin. The total initial concentration of carbon source (s) can be any concentration that provides for proper growth of Streptomyces and production of the desired concentration of gougerotin and can be determined experimentally (the carbon source used Measure the final concentration of gougerotin in the fermentation broth depending on the concentration (s)). The total initial carbon source concentration can range, for example, from about 10 g / L to about 150 g / L, such as about 10 g / L, about 20 g / L, about 30 g / L, about 40 g / L, about 50 g / L, about It can be 60 g / L, about 70 g / L, about 80 g / L, about 90 g / L, about 100 g / L, about 110 g / L, or about 120 g / L. In some embodiments, the carbon source is a mixture of two or more carbon sources, such as a mixture of glucose and a polysaccharide such as starch, a mixture of glucose and an oligosaccharide such as dextrin or maltodextrin, or glucose, It may be a mixture of starch and dextrin. In some embodiments, the medium contains a mixture of glucose and oligosaccharides as a carbon source. The oligosaccharide can be maltodextrin or dextrin. In such embodiments, the initial maltodextrin concentration in the medium can be from about 50 g / L to about 100 g / L or from about 60 g / L to about 80 g / L. The initial glucose concentration in the medium can be about 20 g / L to about 80 g / L, such as about 30 g / L, about 40 g / L, about 50 g / L, about 60 g / L, or about 70 g / L. In other embodiments using glucose with maltodextrin or dextrin as the carbon source, the glucose concentration can be from about 20 g / L to 60 g / L or from about 30 g / L to about 50 g / L.
</span>
    </p>
    <p num="0079" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  消化可能ないかなる窒素源も本明細書に記載する発酵方法で使用することができる。窒素源は単一の供給源でも複数の供給源の混合物でも可能である。例示的な実施形態において窒素源は（少なくとも部分的に）大豆ペプトン、大豆酸加水分解物、大豆粉加水分解物、カゼイン加水分解物、酵母エキス、及びこれらの混合物からなる群から選択される。窒素源（複数でもよい）の総初期濃度はストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）の適切な増殖及び所望の濃度のグーゲロチンの産生を提供するいかなる濃度でもよく、実験的に決定し得る。培地中の適切な総濃度は、例えば、約１０ｇ／Ｌ〜約６０ｇ／Ｌの範囲であり得、例えば、約２０ｇ／Ｌ、約３０ｇ／Ｌ、約４０ｇ／Ｌ、約５０ｇ／Ｌであり得る。例示的な実施形態において、窒素源はカゼイン加水分解物と大豆粉水和物の混合物又は酵母エキスと大豆酸加水分解物の混合物であり得、ここで例えば酵母エキスは培地中に１０ｇ／Ｌの濃度（又は量）で使用され、大豆酸加水分解物は２０ｇ／Ｌの濃度／量で使用される。
</span>
&nbsp;&nbsp;Any digestible nitrogen source can be used in the fermentation methods described herein. The nitrogen source can be a single source or a mixture of multiple sources. In an exemplary embodiment, the nitrogen source is selected from the group consisting of (at least in part) soy peptone, soy acid hydrolyzate, soy flour hydrolysate, casein hydrolyzate, yeast extract, and mixtures thereof. The total initial concentration of the nitrogen source (s) may be any concentration that provides for proper growth of Streptomyces and production of the desired concentration of gougerotin and can be determined experimentally. Suitable total concentrations in the medium can range, for example, from about 10 g / L to about 60 g / L, such as about 20 g / L, about 30 g / L, about 40 g / L, about 50 g / L. . In an exemplary embodiment, the nitrogen source can be a mixture of casein hydrolyzate and soy flour hydrate or a mixture of yeast extract and soy acid hydrolyzate, where for example yeast extract is 10 g / L in the medium. Used in concentration (or amount), soy acid hydrolyzate is used in a concentration / amount of 20 g / L.
</span>
    </p>
    <p num="0080" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  培地はさらに塩化カルシウム、又は炭酸カルシウムのようなカルシウム供給源を含有することができる。存在する場合、培地は炭酸カルシウムのようなカルシウム供給源を約１ｇ／Ｌ〜３ｇ／Ｌの初期濃度で含有し得る。
</span>
&nbsp;&nbsp;The medium can further contain a calcium source such as calcium chloride or calcium carbonate. If present, the medium may contain a calcium source, such as calcium carbonate, at an initial concentration of about 1 g / L to 3 g / L.
</span>
    </p>
    <p num="0081" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  これに関連して、培地の全ての成分の濃度は他に断らない限り発酵の始めの濃度（初期濃度）であることに注意されたい。濃度は発酵に使用する後の接種容量に基づく。本明細書に挙げる初期濃度は発酵中連続的な栄養分の供給によって維持することができる。或いは、発酵の始めにだけ成分（炭素源、窒素源、アミノ酸）を加えることができる。しかし、培地／発酵ブロスのｐＨは通例連続的にモニターされ、適切な酸（例えば硫酸又はクエン酸）及び／又は適切な塩基（例えば水酸化ナトリウム又はアンモニア溶液又は水酸化カリウム）の添加によって制御される。適当なｐＨは経験的に決定することができる。典型的な実施形態において培地／発酵ブロスのｐＨは６．５〜７．５、例えば、６．８〜７．０の範囲である。また、温度及び通気速度プロセスパラメーターも通常発酵プロセス中制御される。ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の培養は好気性条件下で行われるので、発酵ブロスは通例空気、酸素富化空気又は必要であれば純粋な酸素で曝気する。温度は通常２０℃〜３０℃の範囲内になるように選択されるが、本発明ではそれより高い温度も使用することが考えられる。消泡剤のような標準的な発酵試薬を連続的に添加してもよい。発酵ブロスの製造は、例えば、米国特許第３，８４９，３９８号、英国特許第１  ５０７  １９３号、Ｔｏｓｈｉｋｏ  Ｋａｎｚａｋｉ  ｅｔ  ａｌ．、Ｊｏｕｒｎａｌ  ｏｆ  Ａｎｔｉｂｉｏｔｉｃｓ、Ｓｅｒ．  Ａ、Ｖｏｌ．  １５、Ｎｏ．２、Ｊｕｎ．  １９６１、ｐａｇｅｓ  ９３  ｔｏ  ９７、又はＴｏｒｕ  Ｉｋｅｕｃｈｉ  ｅｔ  ａｌ．、Ｊｏｕｒｎａｌ  ｏｆ  Ａｎｔｉｂｉｏｔｉｃｓ、（Ｓｅｐｔ．  １９７２）、ｐａｇｅｓ  ５４８  ｔｏ  ５５０に記載されている方法を含めて、深部発酵、固相発酵又は液面培養のような慣用の大規模な微生物発酵プロセスを用いて行うことができる。
</span>
&nbsp;&nbsp;In this connection, it should be noted that the concentrations of all components of the medium are the initial concentrations of fermentation (initial concentration) unless otherwise stated. The concentration is based on the inoculum volume after use for fermentation. The initial concentrations listed herein can be maintained by continuous nutrient supply during fermentation. Alternatively, ingredients (carbon source, nitrogen source, amino acid) can be added only at the beginning of the fermentation. However, the pH of the medium / fermentation broth is usually monitored continuously and controlled by the addition of a suitable acid (eg sulfuric acid or citric acid) and / or a suitable base (eg sodium hydroxide or ammonia solution or potassium hydroxide). The The appropriate pH can be determined empirically. In an exemplary embodiment, the pH of the medium / fermentation broth ranges from 6.5 to 7.5, such as 6.8 to 7.0. Temperature and aeration rate process parameters are also typically controlled during the fermentation process. Since the culture of Streptomyces strains is carried out under aerobic conditions, the fermentation broth is typically aerated with air, oxygen-enriched air or, if necessary, pure oxygen. The temperature is usually selected to be in the range of 20 ° C. to 30 ° C., but higher temperatures may be used in the present invention. Standard fermentation reagents such as antifoams may be added continuously. The production of fermentation broth is described, for example, in US Pat. No. 3,849,398, British Patent No. 1507 193, Toshiko Kanzaki et al. , Journal of Antibiotics, Ser. A, Vol. 15, no. 2, Jun. 1961, pages 93 to 97, or Toru Ikeuchi et al. , Journal of Antibiotics, (Sept. 1972), pages 548 to 550, and using conventional large scale microbial fermentation processes such as deep fermentation, solid phase fermentation or liquid surface culture. be able to.
</span>
    </p>
    <p num="0082" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  任意のグーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を、本明細書に開示されているグーゲロチンを含有する発酵ブロスを製造するために使用することができる。例示的な実施形態において、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株はストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）菌株、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）菌株又はストレプトマイセス・グラミネアルス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｇｒａｍｉｎｅａｒｕｓ）菌株である。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）は、例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株であり得る。さらに、低レベルであってもグーゲロチンを産生することができる、様々なＳｔｒｅｐｔｏｍｙｃｅｔｅｓ（例えば、限定されるものではないが、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）及びストレプトマイセス・グラミネアルス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｇｒａｍｉｎｅａｒｕｓ））及び桿菌（Ｂａｃｉｌｌｉ）のような親の細菌株を、グーゲロチン産生を高めるために変異誘発することができる。実施例１４はかかる突然変異体及びその結果得られる少なくとも１ｇ／Ｌのグーゲロチンを含有する発酵ブロスを製造する１つの方法を記載する。
</span>
&nbsp;&nbsp;Any Guguerotin-producing Streptomyces strain can be used to produce a fermentation broth containing Guguerotin disclosed herein. In an exemplary embodiment, the Streptomyces strain is a Streptomyces microflavus strain, a Streptomyces puniceus strain or a Streptomyces minemisum strain S. The Streptomyces microflavus can be, for example, a Streptomyces microflavus NRRL B-50550 strain or a phytophagic-acaricidal mutant derived therefrom. In addition, various Streptomycetes (eg, but not limited to, Streptomyces microflavus, Streptomyces pnicius and Streptomyces puniceus) that can produce gougerotin even at low levels. Parental bacterial strains such as Streptomyces graminearus and Bacilli can be mutagenized to increase gougerotin production. Example 14 describes one method for producing such a mutant and the resulting fermentation broth containing at least 1 g / L of gougerotin.
</span>
    </p>
    <p num="0083" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  発酵中具体的な炭素及び窒素源並びに他の栄養分の選択を使用してグーゲロチンの産生を最適化することができる。グーゲロチン産生を高めるのに適した炭素源はデンプン、マルトデキストリン、デキストリン、糖及びグルコースである。特定の実施形態においてグルコースとオリゴ糖の組合せを炭素源及び／又は調達として用いる。グーゲロチン産生を高めるのに適した窒素源は大豆タンパク質加水分解物、カゼイン加水分解物、大豆ペプトン、酵母エキス、及び栄養分がより少ない他の窒素源である。他の適切な窒素源としては、グリシン、Ｌ−グルタミン酸を含むグルタミン酸、Ｌ−アスパラギン酸を含むアスパラギン酸、Ｌ−セリンを含むセリン、及びシトシンのようなアミノ酸及び／又はグーゲロチンの前駆体がある。シトシンは、高いヌクレオ塩基含有率を有する酵母エキスのような高濃度のシトシンを有する培地成分の一部として添加し得る。増大したレベルのグーゲロチンを有する発酵ブロスを製造することができる発酵培地の例を実施例１１、１２及び１３に提供する。
</span>
&nbsp;&nbsp;During the fermentation, specific carbon and nitrogen sources and other nutrient selections can be used to optimize the production of gougerotin. Suitable carbon sources for enhancing gougerotin production are starch, maltodextrin, dextrin, sugar and glucose. In certain embodiments, a combination of glucose and oligosaccharide is used as a carbon source and / or procurement. Suitable nitrogen sources for increasing gougerotin production are soy protein hydrolyzate, casein hydrolyzate, soy peptone, yeast extract, and other nitrogen sources with less nutrients. Other suitable nitrogen sources include glycine, glutamic acid including L-glutamic acid, aspartic acid including L-aspartic acid, serine including L-serine, and precursors of amino acids and / or gougerotin such as cytosine. Cytosine can be added as part of a medium component having a high concentration of cytosine, such as a yeast extract having a high nucleobase content. Examples of fermentation media that can produce fermentation broth with increased levels of gougerotin are provided in Examples 11, 12, and 13.
</span>
    </p>
    <p num="0084" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  もう１つ別の実施形態において、本発明の発酵産物（例えば、発酵ブロス又は発酵固体）は少なくとも４０％、少なくとも５０％、又は少なくとも６０％の効力を有し、ここで効力は以下のようにして測定される。発酵産物を水界面活性剤溶液（界面活性剤製品ラベルに推奨されている界面活性剤の量を用いる）に希釈して５％全ブロス（又は全ブロスに由来の発酵固体を扱う場合は以下に記載するような全ブロス当量）の溶液を得る。希釈した溶液を葉（例えばライマメの葉）の上面と下面に両面が濡れるまで施用するが、流れ出すまでには施用しない。植物を乾燥させた後１０−２０のナミハダニ（テトラニカス・ウルティカエ・コッホ（Ｔｅｔｒａｎｙｃｈｕｓ  ｕｒｔｉｃａｅ  Ｋｏｃｈ）を寄生させる。処理の４日後、処理した葉を検査し、葉の上の生きている成虫と死んだ成虫の雌及び第２若虫を数える。Ｓｕｎ−Ｓｈｅｐａｒｄ式を用いて効力（すなわち、補正した死亡率）を計算する。補正した％＝１００（処理したプロットの低下率％±未処理集団の変化率％）／（１００±未処理集団の変化率％）。この応用で、上記方法で計算された効力を「ハダニ効力」と称する。
</span>
&nbsp;&nbsp;In another embodiment, the fermentation product of the present invention (eg, fermentation broth or fermentation solid) has a potency of at least 40%, at least 50%, or at least 60%, wherein the potency is as follows: Measured. When working with 5% total broth (or fermented solids derived from all broths) by diluting the fermentation product into an aqueous surfactant solution (using the amount of surfactant recommended on the surfactant product label) A solution of all broth equivalents as described) is obtained. Apply the diluted solution until the upper and lower surfaces of the leaves (e.g. Lima bean) are wet on both sides, but not until they flow out. After drying the plant, it infests with 10-20 spider mites (Tetranychus urticae Koch). After 4 days of treatment, the treated leaves are examined and live and dead adults on the leaves are examined. Count the females and second nymphs of the animals, calculate the potency (ie corrected mortality) using the Sun-Shepard equation, corrected% = 100 (% reduction of treated plot ±% change of untreated population) ) / (100 ±% change in untreated population) In this application, the potency calculated by the above method is referred to as “tick potency”.
</span>
    </p>
    <p num="0085" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  幾つかの実施形態において本発明の組成物は幅広い種類の農業及び／又は園芸作物、例えば種子、生産、造園のために増殖させるもの、及び種子生産のために増殖させるものを処理するのに使用される。本発明の組成物を用いて処理することができる代表的な植物には、限定されるものではないが、アブラナ、鱗茎野菜、穀類穀物、柑橘類、綿、ウリ科、結果野菜、葉野菜、マメ科植物、油科種子作物、落花生、ナシ果実、根野菜、塊茎野菜、球茎野菜、核果、タバコ、イチゴ及び他のベリー、並びに各種の観賞植物などがある。
</span>
&nbsp;&nbsp;In some embodiments, the compositions of the present invention are used to treat a wide variety of agricultural and / or horticultural crops, such as seeds, those grown for landscaping, and those grown for seed production. Is done. Representative plants that can be treated with the composition of the present invention include, but are not limited to, rape, bulbous vegetables, cereal grains, citrus, cotton, cucurbitaceae, resulting vegetables, leafy vegetables, beans Plants, oilseed seed crops, peanuts, pear fruits, root vegetables, tuber vegetables, corm vegetables, drupes, tobacco, strawberries and other berries, and various ornamental plants.
</span>
    </p>
    <p num="0086" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の組成物は葉面散布として、土壌処理として、及び／又は種子処理／粉衣として投与することができる。葉面処理として使用する場合、１つの実施形態において、１エーカーに付き約１／１６〜約５ガロンの全ブロスを施用する。土壌処理として使用する場合、１つの実施形態において、１エーカーに付き約１〜約１５ガロン又は約１〜約５ガロンの全ブロスを施用する。又は、処理する種子の大きさ及び発酵産物中のコロニー形成単位の濃度に応じて、約０．１ｍｇ〜約１４ｍｇ、又は約０．２ｍｇ〜約１０ｍｇ、又は約０．２ｍｇ〜約８ｍｇの凍結乾燥産物のような発酵産物を施用する。種子処理として使用する場合１エーカーに付き約１／３２〜約１／４ガロンの全ブロスを施用する。種子処理の場合、最終用途の製剤は１グラムに付き少なくとも１×１０<sup class="style-scope patent-text">８</sup>のコロニー形成単位を含有する。
</span>The composition of the present invention can be administered as foliar application, as soil treatment and / or as seed treatment / dressing. When used as a foliar treatment, in one embodiment, about 1/16 to about 5 gallons of total broth is applied per acre. When used as a soil treatment, in one embodiment, about 1 to about 15 gallons or about 1 to about 5 gallons of total broth is applied per acre. Or lyophilized from about 0.1 mg to about 14 mg, or from about 0.2 mg to about 10 mg, or from about 0.2 mg to about 8 mg, depending on the size of the seed to be treated and the concentration of colony forming units in the fermentation product. Apply fermented products such as products. When used as a seed treatment, apply about 1/32 to about 1/4 gallon of total broth per acre. For seed treatment, the end use formulation contains at least 1 × 10 <sup class="style-scope patent-text">8</sup> colony forming units per gram.</span>
    </p>
    <p num="0087" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  幾つかの実施形態において、本発明の組成物を植物、植物の部分又は植物の場所に施用する前に、処理を必要とする生育場所を確認する。
</span>
&nbsp;&nbsp;In some embodiments, before applying the composition of the present invention to a plant, plant part or plant location, the growth location in need of treatment is identified.
</span>
    </p>
    <p num="0088" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  微生物（例えば、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０又はその植物食性−殺ダニ性突然変異株）／ｍＬの凍結乾燥粉末をはじめとする全ブロス培養物又は発酵固体のような発酵産物を希釈し、植物の葉に施用する。施用率は１エーカー当たりのガロン又はポンドで提供され、（実施例に記載されているマイクロプロットトライアルのような）より小さい施用に比例して調節することができる。実施例で記載するように、より大きい施用の場合、発酵産物は施用前に１００ガロンの水に希釈する。１つの実施形態において、１エーカーに付き約０．５ガロン〜約１５ガロン、約１ガロン〜約１２ガロン又は約１．２５ガロン〜約１０ガロンの全ブロス培養物（水及び、場合により、界面活性剤に希釈）を植物の葉に施用する。別の実施形態において、１エーカーに付き約０．２〜約８ポンドの凍結乾燥粉末、約０．４〜約７ポンド、又は約０．４ｌｂ〜約６ｌｂ（水及び、場合により、界面活性剤に希釈）を植物の葉に施用する。特定の例において、発酵産物は少なくとも約４０％、少なくとも約５０％又は少なくとも約６０％のハダニ効力を有する。別の例において、発酵産物は約０．５％〜約１５％のグーゲロチン、約１％〜約１２％のグーゲロチン、又は約２％〜約１０％のグーゲロチンを有する発酵粉末（噴霧乾燥又は凍結乾燥粉末を含む）であり、ここでパーセントは全て重量／重量である。もう１つ別の例において、発酵産物は約０．０１％〜約０．５％のグーゲロチン（重量／重量）を有する発酵ブロスである。
</span>
&nbsp;&nbsp;Fermentation such as whole broth culture or fermentation solids, including lyophilized powder of microorganisms (e.g. Streptomyces microflavus NRRL B-50550 or its phytophagous-acaricidal mutant) / mL The product is diluted and applied to plant leaves. Application rates are provided in gallons or pounds per acre and can be adjusted proportionally for smaller applications (such as the microplot trials described in the Examples). As described in the examples, for larger applications, the fermentation product is diluted in 100 gallons of water before application. In one embodiment, a total broth culture of about 0.5 gallons to about 15 gallons, about 1 gallon to about 12 gallons, or about 1.25 gallons to about 10 gallons per acre (water and, optionally, interface) Apply to the leaves of the plant). In another embodiment, from about 0.2 to about 8 pounds of lyophilized powder per acre, from about 0.4 to about 7 pounds, or from about 0.4 lb to about 6 lb (water and optionally surfactant) Apply to the leaves of the plant. In certain instances, the fermentation product has a tick efficacy of at least about 40%, at least about 50%, or at least about 60%. In another example, the fermentation product is a fermented powder (spray dried or lyophilized) having from about 0.5% to about 15% gougerotin, from about 1% to about 12% gougerotin, or from about 2% to about 10% gougerotin. Where all percentages are weight / weight. In another example, the fermentation product is a fermentation broth having about 0.01% to about 0.5% gougerotin (weight / weight).
</span>
    </p>
    <p num="0089" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特定の実施形態において、１エーカーに付き１．２５ポンドの凍結乾燥粉末又は噴霧乾燥粉末（水及び、場合により、界面活性剤に希釈）のような発酵産物を植物の葉に施用する。これらの実施形態において、最終用途の製剤は少なくとも約１×１０<sup class="style-scope patent-text">６</sup>のコロニー形成単位／ｍＬ、少なくとも約１×１０<sup class="style-scope patent-text">７</sup>のコロニー形成単位／ｍＬ、少なくとも約１×１０<sup class="style-scope patent-text">８</sup>のコロニー形成単位／ｍＬ、少なくとも約１×１０<sup class="style-scope patent-text">９</sup>コロニー形成単位／ｍＬ、又は少なくとも約１×１０<sup class="style-scope patent-text">１０</sup>コロニー形成単位／ｍＬを含有する出発の発酵ブロスに基づく。別の例において、この発酵産物は少なくとも約１重量％のグーゲロチン、少なくとも約２重量％のグーゲロチン、少なくとも約３重量％のグーゲロチン、少なくとも約４重量％のグーゲロチン、少なくとも約５重量％のグーゲロチン、少なくとも約６重量％のグーゲロチン、少なくとも約７重量％のグーゲロチン、又は少なくとも約８重量％のグーゲロチンを含有する。
</span>In certain embodiments, fermentation products such as 1.25 pounds of freeze-dried powder or spray-dried powder per acre (diluted in water and optionally surfactant) are applied to the leaves of the plant. In these embodiments, the end use formulation comprises at least about 1 × 10 <sup class="style-scope patent-text">6</sup> colony forming units / mL, at least about 1 × 10 <sup class="style-scope patent-text">7</sup> colony forming units / mL, at least about 1 × 10 <sup class="style-scope patent-text">8</sup> colony forming units / mL, Based on starting fermentation broth containing at least about 1 × 10 <sup class="style-scope patent-text">9</sup> colony forming units / mL, or at least about 1 × 10 <sup class="style-scope patent-text">10</sup> colony forming units / mL. In another example, the fermented product comprises at least about 1 wt.% Gougerotin, at least about 2 wt.% Gougerotin, at least about 3 wt.% Gougerotin, at least about 4 wt.% Gougerotin, at least about 5 wt.% Gougerotin, at least Contains about 6% by weight gougerotin, at least about 7% by weight gougerotin, or at least about 8% by weight gougerotin.</span>
    </p>
    <p num="0090" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">グーゲロチン遺伝子クラスター、ＯＲＦ、及びそれによりコードされるタンパク質</u> <br class="style-scope patent-text">
  本開示は、ある遺伝子座内に位置するグーゲロチン遺伝子クラスターの核酸配列、そこに含有されるＯＲＦ、及びそれによりコードされるタンパク質を提供する。この情報は、例えば、他のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属の菌にあるようなグーゲロチン遺伝子クラスターのホモログをコードする関連の核酸分子及び対応するＯＲＦの単離を可能にする。本開示はさらに、グーゲロチン遺伝子クラスター又はその一部分によりコードされるタンパク質（例えば、限定されるものではないが、ＧｏｕＡ、ＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、ＧｏｕＭ、及び／又はＧｏｕＮなど）の変異体、及びかかる変異体をコードする核酸分子の生産を可能にする。
</span> <u class="style-scope patent-text">Gougerotin gene cluster, ORF, and proteins encoded thereby The</u> present disclosure provides the nucleic acid sequence of the gougerotin gene cluster located within a locus, the ORF contained therein, and the protein encoded thereby. This information allows for the isolation of related nucleic acid molecules and corresponding ORFs that encode homologues of the gougerotin gene cluster, such as those found in other bacteria of the genus Streptomyces. The present disclosure further includes proteins encoded by the Gugelotin gene cluster or portions thereof (eg, but not limited to GouA, GouB, GouC, GouD, GouE, GouF, GouG, GouH, GouI, GouJ, GouK, GouL , GouM, and / or GouN), and nucleic acid molecules encoding such variants.</span>
    </p>
    <p num="0091" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）株から同定された配列番号：４３（ヌクレオチド残基１−２１９３３）内に含まれるグーゲロチン遺伝子クラスターはＯＲＦ４２４８〜４２７１と称される２４のＯＲＦを含む。ＯＲＦ４２５１、４２５２、４２５３、４２５５、４２５６、４２５７、４２５８、４２５９、４２６１、４２６２、４２６３、４２６４、４２６５、及び４２７１はそれぞれ１３の遺伝子ｇｏｕＡ、ｇｏｕＢ、ｇｏｕＣ、ｇｏｕＤ、ｇｏｕＥ、ｇｏｕＦ、ｇｏｕＧ、ｇｏｕＨ、ｇｏｕＩ、ｇｏｕＪ、ｇｏｕＫ、ｇｏｕＬ、ｇｏｕＭ、及びｇｏｕＮである。配列番号：８９−１００（ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）株から同定された）はそれぞれオルソロガスな遺伝子ｇｏｕＢ、ｇｏｕＣ、ｇｏｕＤ、ｇｏｕＥ、ｇｏｕＦ、ｇｏｕＧ、ｇｏｕＨ、ｇｏｕＩ、ｇｏｕＪ、ｇｏｕＫ、ｇｏｕＬ、ｇｏｕＭを提供することに注意。（これらの遺伝子の潜在的な機能及びグーゲロチン合成におけるその可能な役割は表２に提供する。）<br class="style-scope patent-text">
  開示された遺伝子座（配列番号：４３）及びそこに含有されるＯＲＦの配列が提供されると、インビトロ核酸増幅（例えば、限定されるものではないが、ＰＣＲなど）を、上記表１に掲げたグーゲロチン生合成タンパク質の１以上をコードする核酸配列を製造するための簡単な方法として利用することができる。このようにしてタンパク質をコードする核酸分子を製造するための代表的な技術を以下に提供する。
</span>The gougerotin gene cluster contained within SEQ ID NO: 43 (nucleotide residues 1-21933) identified from the Streptomyces microflavus strain contains 24 ORFs designated ORF 4248-4271. ORF 4251, 4252, 4253, 4255, 4256, 4257, 4258, 4259, 4261, 4262, 4263, 4264, 4265, and 4271 are the 13 genes goA, goB, gouC, gouD, gouE, goF, gouG, goH, goI , GouJ, gouK, gouL, gouM, and gouN. SEQ ID NOs: 89-100 (identified from the Streptomyces puniceus strain) are orthologous genes guB, guC, guD, guE, guF, guG, guH, guI, guJ, guL Please note that provide. (The potential functions of these genes and their possible role in gougerotin synthesis are provided in Table 2.) <br class="style-scope patent-text"> Given the disclosed locus (SEQ ID NO: 43) and the sequence of the ORF contained therein, in vitro nucleic acid amplification (eg, but not limited to PCR, etc.) is listed in Table 1 above. It can be used as a simple method for producing a nucleic acid sequence encoding one or more of gougerotin biosynthetic proteins. Representative techniques for producing nucleic acid molecules encoding proteins in this way are provided below.</span>
    </p>
    <p num="0092" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  当業者に周知のいろいろな方法のいずれかによりＲＮＡ又はＤＮＡを細胞から抽出する。Ｓａｍｂｒｏｏｋ  ｅｔ  ａｌ．（Ｍｏｌｅｃｕｌａｒ  Ｃｌｏｎｉｎｇ：  Ａ  Ｌａｂｏｒａｔｏｒｙ  Ｍａｎｕａｌ、Ｃｏｌｄ  Ｓｐｒｉｎｇ  Ｈａｒｂｏｒ  Ｌａｂｏｒａｔｏｒｙ  Ｐｒｅｓｓ、Ｎｅｗ  Ｙｏｒｋ、１９８９）及びＡｕｓｕｂｅｌ  ｅｔ  ａｌ．（Ｃｕｒｒｅｎｔ  Ｐｒｏｔｏｃｏｌｓ  ｉｎ  Ｍｏｌｅｃｕｌａｒ  Ｂｉｏｌｏｇｙ、Ｇｒｅｅｎｅ  Ｐｕｂｌ．  Ａｓｓｏｃ．  ａｎｄ  Ｗｉｌｅｙ−Ｉｎｔｅｒｓｃｉｅｎｃｅｓ、１９９２）はＲＮＡ又はＤＮＡの単離のための方法の代表的な説明を提供する。グーゲロチン生合成酵素は、少なくとも、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）で発現される。従って、幾つかの例において、ＲＮＡ又はＤＮＡはストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）細胞から抽出され得る。抽出されたＲＮＡは、例えば、ｃＤＮＡを生成するために逆転写（ＲＴ）−ＰＣＲ増幅を実施するための鋳型として使用し得る。ＲＴ−ＰＣＲの代表的な方法及び条件はＫａｗａｓａｋｉ  ｅｔ  ａｌ．（ＰＣＲ  Ｐｒｏｔｏｃｏｌｓ、Ａ  Ｇｕｉｄｅ  ｔｏ  Ｍｅｔｈｏｄｓ  ａｎｄ  Ａｐｐｌｉｃａｔｉｏｎｓ、Ｉｎｎｉｓ  ｅｔ  ａｌ．（ｅｄｓ．）  ２１−２７  Ａｃａｄｅｍｉｃ  Ｐｒｅｓｓ、Ｉｎｃ．、Ｓａｎ  Ｄｉｅｇｏ、Ｃａｌｉｆ．、１９９０）に記載されている。
</span>
&nbsp;&nbsp;RNA or DNA is extracted from the cells by any of a variety of methods well known to those skilled in the art. Sambrook et al. (Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, 1989) and Ausubel et al. (Current Protocols in Molecular Biology, Greene Publ. Assoc. And Wiley-Intersciences, 1992) provides a representative description of methods for RNA or DNA isolation. Gougerotin biosynthetic enzymes are expressed at least in Streptomyces microflavus. Thus, in some examples, RNA or DNA can be extracted from Streptomyces microflavus cells. The extracted RNA can be used, for example, as a template for performing reverse transcription (RT) -PCR amplification to generate cDNA. Representative methods and conditions for RT-PCR are described in Kawasaki et al. (PCR Protocols, A Guide to Methods and Applications, Innis et al. (Eds.) 21-27 Academic Press, Inc., San Diego, Calif., 1990).
</span>
    </p>
    <p num="0093" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  増幅プライマーの選択は増幅しようとするＤＮＡの部分（複数でもよい）に従って行い得る。プライマーは、１つの実施形態においてＤＮＡのあるセグメント（例えば、特定のＯＲＦ又は隣接するＯＲＦの組）を、又は別の実施形態においては全ＤＮＡ分子を増幅するように選択され得る。異なる長さ及び組成のプライマー及びアンプリコンに適合させるために増幅条件の変更が必要になり得る。かかる問題は当業界で周知であり、例えば、Ｉｎｎｉｓ  ｅｔ  ａｌ．（ＰＣＲ  Ｐｒｏｔｏｃｏｌｓ、Ａ  Ｇｕｉｄｅ  ｔｏ  Ｍｅｔｈｏｄｓ  ａｎｄ  Ａｐｐｌｉｃａｔｉｏｎｓ、Ａｃａｄｅｍｉｃ  Ｐｒｅｓｓ、Ｉｎｃ．、Ｓａｎ  Ｄｉｅｇｏ、Ｃａｌｉｆ．、１９９０）で論じられている。例として、選択されたグーゲロチン生合成タンパク質をコードする核酸分子（例えば、ｇｏｕＡ〜ｇｏｕＮのいずれか又は組合せ）は、プロトタイプのストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ｇｏｕＡ、ｇｏｕＢ、ｇｏｕＣ、ｇｏｕＤ、ｇｏｕＥ、ｇｏｕＦ、ｇｏｕＧ、ｇｏｕＨ、ｇｏｕＩ、ｇｏｕＪ、ｇｏｕＫ、ｇｏｕＬ、ｇｏｕＭ、及び／又はｇｏｕＮ配列の５’−及び３’−末端に対するプライマーを用いて増幅することができる。多くの異なるプライマーが提供された核酸配列から誘導され得ることが理解されよう。増幅された配列の確認を容易にし、グーゲロチンと増幅された配列との間の天然の変化に関する情報を提供するために、いずれかの増幅手順で得られた増幅産物の再度の配列決定が推奨される。グーゲロチン配列のいずれかから誘導されたオリゴヌクレオチドを、例えば、対応するグーゲロチン（又はグーゲロチン関連）アンプリコンの配列決定に使用することができる。
</span>
&nbsp;&nbsp;Selection of amplification primers can be made according to the portion (s) of DNA to be amplified. Primers can be selected to amplify a segment of DNA (eg, a particular ORF or a set of adjacent ORFs) in one embodiment, or in another embodiment, an entire DNA molecule. Changes in amplification conditions may be required to accommodate primers and amplicons of different lengths and compositions. Such problems are well known in the art and are described, for example, in Innis et al. (PCR Protocols, A Guide to Methods and Applications, Academic Press, Inc., San Diego, Calif., 1990). By way of example, a nucleic acid molecule (eg, any or a combination of gouA to gouN) encoding a selected gougerotin biosynthetic protein is a prototype Streptomyces microflavus gouA, gouB, gouC, gouD, gouE, It can be amplified using primers for the 5'- and 3'-ends of the gouF, gouG, gouH, gouI, gouJ, gouK, gouL, gouM, and / or gouN sequences. It will be appreciated that many different primers can be derived from the provided nucleic acid sequences. In order to facilitate identification of the amplified sequence and provide information on the natural changes between gougerotin and the amplified sequence, re-sequencing of the amplification product obtained from either amplification procedure is recommended. The Oligonucleotides derived from any of the gougerotin sequences can be used, for example, to sequence the corresponding gougerotin (or gougerotin related) amplicon.
</span>
    </p>
    <p num="0094" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、グーゲロチン遺伝子クラスター、又はグーゲロチンＯＲＦ（例えば、配列番号：１、３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、及び４１の１以上）のオルソログをコードする配列をクローニングするために、慣用のハイブリダイゼーションとＰＣＲ増幅の両方の方法を使用し得る。これらの技術の両方に共通するのは、上流及び下流のフランキング領域を伴うか又は伴わないグーゲロチン遺伝子クラスター又はグーゲロチンＯＲＦ核酸配列から誘導されるプローブ又はプライマーのハイブリダイゼーションである。また、ハイブリダイゼーションはノーザンブロット、サザンブロット、又はＰＣＲの状況で起こり得る。
</span>
&nbsp;&nbsp;Further, a gougerotin gene cluster or a gougerotin ORF (for example, SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35 Both conventional hybridization and PCR amplification methods can be used to clone sequences encoding orthologs of one, more than 37, 39, and 41). Common to both of these techniques is the hybridization of probes or primers derived from a gougerotin gene cluster or gougerotin ORF nucleic acid sequence with or without upstream and downstream flanking regions. Hybridization can also occur in the context of Northern blots, Southern blots, or PCR.
</span>
    </p>
    <p num="0095" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  問題の細菌種から調製されたＤＮＡライブラリーに対して直接ＰＣＲ増幅を行ってもよいし、又は標準的な方法を用いて細菌細胞から抽出されたＲＮＡを用いてＲＴ−ＰＣＲを行ってもよい。ＰＣＲプライマーは上流及び下流のフランキング領域を伴うか又は伴わないグーゲロチン遺伝子クラスター又はグーゲロチンＯＲＦ核酸配列の少なくとも１０の連続したヌクレオチドを含む。当業者には了解されるように、グーゲロチン遺伝子クラスター又はグーゲロチンＯＲＦ核酸配列と増幅される標的の核酸との間の配列差異は増幅効率を下げる結果となり得る。これを補償するために、より長いＰＣＲプライマー又はより低いアニーリング温度を増幅サイクル中使用し得る。より低いアニーリング温度を使用する場合は、増幅特異性を高めるためにネステッドプライマー対を使用する連続的な増幅ラウンドが有用であり得る。
</span>
&nbsp;&nbsp;PCR amplification may be performed directly on a DNA library prepared from the bacterial species in question, or RT-PCR may be performed using RNA extracted from bacterial cells using standard methods . A PCR primer comprises at least 10 consecutive nucleotides of a gougerotin gene cluster or gougerotin ORF nucleic acid sequence with or without upstream and downstream flanking regions. As will be appreciated by those skilled in the art, sequence differences between the gougerotin gene cluster or the gougerotin ORF nucleic acid sequence and the target nucleic acid to be amplified can result in reduced amplification efficiency. To compensate for this, longer PCR primers or lower annealing temperatures can be used during the amplification cycle. If lower annealing temperatures are used, successive rounds of amplification using nested primer pairs to increase amplification specificity may be useful.
</span>
    </p>
    <p num="0096" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  開示されたグーゲロチン生合成タンパク質のオルソログは、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属の多くの他の一員、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）種の他の菌株、及び他のグーゲロチン産生性有機体に存在し得る。開示されたグーゲロチン遺伝子クラスター及びそのＯＲＦ４２５１−４２５３、４２５５−４２５９、４２６１−４２６５、及び４２７１、並びにフランキング及び介在性のＯＲＦ４２４８−４２５０及び４２６６−４２７０の核酸配列が提供されたことにより、タンパク質をコードするＤＮＡ（例えば、ＯＲＦ）及びこれらの他の有機体においてグーゲロチン生合成酵素オルソログをコードする遺伝子クラスターの標準的な方法によるクローニングが今や可能になった。開示されたグーゲロチン生合成酵素及びタンパク質のオルソログは、例えばシトシンシンターゼ（ＯＲＦ４２５８；ｇｏｕＧ；配列番号：１５及び１６）又はＣＧＡシンターゼ（ＯＲＦ４２６１；ｇｏｕＩ；配列番号：２１及び２２）のように、本明細書に開示された生物活性又は機能を有する。
</span>
&nbsp;&nbsp;Orthologs of the disclosed gougerotin biosynthetic proteins are present in many other members of the genus Streptomyces, other strains of the Streptomyces microflavus species, and other gougerotin producing organisms Can do. Providing the disclosed gougelotin gene cluster and its ORFs 4251-4253, 4255-4259, 4261-4265, and 4271, and the flanking and intervening ORFs 4248-4250 and 4266-4270, for coding proteins It has now become possible to clone gene clusters encoding Guguerotin biosynthetic enzyme orthologs in standard methods (eg, ORFs) and other organisms. Orthologs of the disclosed gougerotin biosynthetic enzymes and proteins are described herein, for example, as cytosine synthase (ORF4258; gouG; SEQ ID NOs: 15 and 16) or CGA synthase (ORF4261; gouI; SEQ ID NOs: 21 and 22). Have the biological activity or function disclosed in.
</span>
    </p>
    <p num="0097" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  オルソログは一般に、開示されたグーゲロチン生合成タンパク質（例えば、配列番号：１、３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、及び４１の１以上）をコードする核酸配列に対して少なくとも６５％の配列同一性を共有する。具体的な実施形態において、オルソロガスなグーゲロチン遺伝子クラスター又はグーゲロチンＯＲＦは場合により開示されたストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）又はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）ヌクレオチド又はアミノ酸配列と少なくとも７０％、少なくとも７５％、少なくとも８０％、少なくとも８５％、少なくとも９０％、少なくとも９１％、少なくとも９２％、少なくとも９３％、少なくとも９４％、少なくとも９５％、少なくとも９６％、少なくとも９７％、少なくとも９８％、又は少なくとも９９％の配列同一性を共有し得る。
</span>
&nbsp;&nbsp;Orthologs are generally disclosed by the disclosed gougerotin biosynthetic proteins (eg, SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33). , 35, 37, 39, and 41) share at least 65% sequence identity to the nucleic acid sequence encoding. In a specific embodiment, the orthologous gougerotin gene cluster or gougerotin ORF is optionally at least 70% with the disclosed Streptomyces microflavus or Streptomyces pniciusus nucleotide or amino acid sequence, 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99 % Sequence identity.
</span>
    </p>
    <p num="0098" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  慣用のハイブリダイゼーション技術の場合、ハイブリダイゼーションプローブは放射性ラベルのような検出可能なラベルとコンジュゲートするのが好ましく、プローブは長さが少なくとも１０のヌクレオチドであるのが好ましい。当業界で周知のように、ハイブリダイゼーションプローブの長さを増大すると高まった特異性を提供する傾向がある。グーゲロチン遺伝子クラスター又はグーゲロチンＯＲＦ核酸配列から誘導されたラベルされたプローブを細菌性ＤＮＡライブラリーとハイブリッドさせ、当業界で公知の方法を用いてハイブリダイゼーションシグナルを検出し得る。ハイブリダイズするコロニー又はプラーク（使用したライブラリーの種類による）を精製し、そのコロニー又はプラークに含有されるクローニングされた配列を単離し、特性決定することができる。
</span>
&nbsp;&nbsp;In conventional hybridization techniques, the hybridization probe is preferably conjugated to a detectable label, such as a radioactive label, and the probe is preferably at least 10 nucleotides in length. As is well known in the art, increasing the length of a hybridization probe tends to provide increased specificity. Labeled probes derived from a gougerotin gene cluster or a gougerotin ORF nucleic acid sequence can be hybridized with a bacterial DNA library and hybridization signals detected using methods known in the art. The hybridizing colony or plaque (depending on the type of library used) can be purified and the cloned sequence contained in the colony or plaque can be isolated and characterized.
</span>
    </p>
    <p num="0099" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  特定の例において、ゲノムライブラリーの構築は、市販されているいろいろなコスミド又はフォスミド系（例えば、Ｓｔｒａｔａｇｅｎｅ、Ｅｐｉｃｅｎｔｒｅ）を用いて迅速に達成することができる。有利なことに、これらの系はクローニングされたＤＮＡの不安定性を最小にする。かかる例においては、ゲノムライブラリーのスクリーニングの後、コスミド又はフォスミドを単離し、一群のオーバーラップするクローンにグループ分けし、分析してクラスターの同一性を確立する。コスミド末端配列決定を使用して、天然産物構造及びその推定される生合成起源から予測される期待経路特性に基づく特定のクローンの適切さに関する予備的な情報を得ることができる。
</span>
&nbsp;&nbsp;In certain instances, the construction of a genomic library can be rapidly accomplished using various commercially available cosmid or fosmid systems (eg, Stratagene, Epicenter). Advantageously, these systems minimize the instability of the cloned DNA. In such an example, after screening of the genomic library, cosmids or fosmids are isolated, grouped into a group of overlapping clones, and analyzed to establish cluster identity. Cosmid terminal sequencing can be used to obtain preliminary information about the suitability of a particular clone based on the expected pathway characteristics predicted from the natural product structure and its putative biosynthetic origin.
</span>
    </p>
    <p num="0100" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  或いは、グーゲロチン遺伝子クラスター（＋／−上流又は下流のフランキング領域）のオルソログ又はグーゲロチンＯＲＦ核酸配列は発現ライブラリーの免疫スクリーニングによって得ることができる。本明細書に開示された遺伝子座（配列番号：４３）の提供により、対応するタンパク質を異種の発現系（例えば、大腸菌（Ｅ．ｃｏｌｉ））で発現させ精製することができ、ＧｏｕＡ、ＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、ＧｏｕＭ、及び／又はＧｏｕＮのようなグーゲロチン生合成酵素又はタンパク質に対して特異的な抗体（モノクローナル又はポリクローナル）を産生させるのに使用することができる。抗体はまた、本明細書に提示したグーゲロチンアミノ酸配列（配列番号：２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、及び４２及び／又は配列番号：７７−８８）から誘導された合成ペプチドに対して産生させてもよい。抗体を産生させる方法は当業界で周知であり、Ｈａｒｌｏｗ  ａｎｄ  Ｌａｎｅ、Ａｎｔｉｂｏｄｉｅｓ、Ａ  Ｌａｂｏｒａｔｏｒｙ  Ｍａｎｕａｌ、Ｃｏｌｄ  Ｓｐｒｉｎｇｓ  Ｈａｒｂｏｒ、１９８８に概説されている。かかる抗体は、細菌から生産された発現ライブラリーをスクリーニングするのに使用することができる。例えば、このスクリーニングはグーゲロチンオルソログを同定する。選択されたＤＮＡは配列決定及び酵素活性アッセイにより確認することができる。
</span>
&nbsp;&nbsp;Alternatively, orthologues or gougerotin ORF nucleic acid sequences of the gougerotin gene cluster (+/− upstream or downstream flanking regions) can be obtained by immunoscreening the expression library. By providing the locus disclosed herein (SEQ ID NO: 43), the corresponding protein can be expressed and purified in a heterologous expression system (eg, E. coli), GouA, GouB, Produce antibodies (monoclonal or polyclonal) specific for gougerotin biosynthetic enzymes or proteins such as GouC, GouD, GouE, GouF, GouG, GouH, GouI, GouJ, GouK, GouL, GouM, and / or GouN Can be used for The antibody may also be a gougelotin amino acid sequence as presented herein (SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32. , 34, 36, 38, 40, and 42 and / or SEQ ID NOs: 77-88). Methods for producing antibodies are well known in the art and are reviewed in Harlow and Lane, Antibodies, A Laboratory Manual, Cold Springs Harbor, 1988. Such antibodies can be used to screen expression libraries produced from bacteria. For example, this screen identifies a gougerotin ortholog. The selected DNA can be confirmed by sequencing and enzyme activity assays.
</span>
    </p>
    <p num="0101" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン遺伝子クラスターから誘導されたオリゴヌクレオチド（配列番号：４３）又は遺伝子クラスターのＯＲＦをコードする核酸配列（配列番号：１、３、５、７、９、１１、１３、１５、１７、１９、２１、２３、２５、２７、２９、３１、３３、３５、３７、３９、及び４１）、又はこれらの核酸配列の断片は本開示の範囲内に含まれる。かかるオリゴヌクレオチドは、例えば、プローブ又はプライマーとして使用できる。１つの実施形態において、オリゴヌクレオチドはグーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）又はグーゲロチンＯＲＦ核酸配列の少なくとも１０の連続したヌクレオチドの配列を含み得る。これらのオリゴヌクレオチドをインビトロ増幅法（例えばＰＣＲ）に使用する場合、オリゴヌクレオチドを長くすると増幅の特異性を高め得る。すなわち、その他の実施形態において、これらの配列の少なくとも１５、２０、２５、３０、３５、４０、４５、５０、又はそれ以上の連続したヌクレオチドを含むオリゴヌクレオチドプライマーを使用し得る。別の例において、グーゲロチン生合成酵素をコードする核酸分子（例えば、配列番号：１５又は２１など）の３０の連続したヌクレオチドを含むプライマーは、別のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）種（又は他のグーゲロチン産生性種）に由来するＤＮＡライブラリー内に存在するグーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）又はグーゲロチンホモログのような標的配列にアニールし、１５のみのヌクレオチドの対応するプライマーより高い特異性を有する。より大きい特異性を得るために、グーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）又はグーゲロチンＯＲＦヌクレオチド配列の少なくとも１７、２０、２３、２５、３０、３５、４０、４５、５０又はそれ以上の連続したヌクレオチドを含むプローブ及びプライマーを選択することができる。特定の例において、プローブ又はプライマーは、開示されたグーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）又はグーゲロチンＯＲＦ配列の少なくとも１００、２５０、５００、６００又は１０００の連続した核酸であることができる。
</span>
&nbsp;&nbsp;Nucleotide sequences (SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21 encoding oligonucleotides (SEQ ID NO: 43) or gene cluster ORFs derived from the gougerotin gene cluster 23, 25, 27, 29, 31, 33, 35, 37, 39, and 41), or fragments of these nucleic acid sequences are included within the scope of this disclosure. Such oligonucleotides can be used, for example, as probes or primers. In one embodiment, the oligonucleotide may comprise a sequence of at least 10 contiguous nucleotides of a Gugurotin gene cluster (+/− upstream and downstream flanking regions) or a Gugurotin ORF nucleic acid sequence. When these oligonucleotides are used in in vitro amplification methods (eg, PCR), longer oligonucleotides can increase the specificity of the amplification. That is, in other embodiments, oligonucleotide primers comprising at least 15, 20, 25, 30, 35, 40, 45, 50, or more consecutive nucleotides of these sequences may be used. In another example, a primer comprising 30 consecutive nucleotides of a nucleic acid molecule encoding a gougerotin biosynthetic enzyme (eg, SEQ ID NO: 15 or 21, etc.) is added to another Streptomyces species (or other gougerotin). Annealing to a target sequence such as a gougerotin gene cluster (+/− upstream and downstream flanking regions) or a gougerotin homolog present in a DNA library derived from a productive species, corresponding to only 15 nucleotides Has higher specificity than the primer. To obtain greater specificity, at least 17, 20, 23, 25, 30, 35, 40, 45, 50 or more of the gougerotin gene cluster (+/− upstream and downstream flanking regions) or gougerotin ORF nucleotide sequences Probes and primers containing the above consecutive nucleotides can be selected. In a particular example, the probe or primer is at least 100, 250, 500, 600 or 1000 contiguous nucleic acids of the disclosed gougerotin gene cluster (+/− upstream and downstream flanking regions) or gougerotin ORF sequences. Can do.
</span>
    </p>
    <p num="0102" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  オリゴヌクレオチド（例えば、プライマー又はプローブ）は、開示されたグーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）又はグーゲロチンＯＲＦ核酸配列のいずれかの領域から得ることができる。例として、グーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）又はグーゲロチンＯＲＦ配列は配列の長さに基づいて約１／２、１／３又は１／４ずつに分けることができ、単離された核酸分子（例えば、オリゴヌクレオチド）は分子の１／２ずつに分けた第１又は第２、１／３ずつに分けた３つのうちのいずれか、又は１／４ずつに分けた４つのうちのいずれか誘導することができる。対象の核酸配列はまたより小さい領域、例えば、約１／８ずつ、１／１６ずつ、１／２０ずつ、１／５０ずつなどに分割することもでき、同様の効果がある。或いは、保存されたドメインをコードする領域毎に分割することができる。
</span>
&nbsp;&nbsp;Oligonucleotides (eg, primers or probes) can be obtained from any region of the disclosed gougerotin gene cluster (+/− upstream and downstream flanking regions) or gougerotin ORF nucleic acid sequences. As an example, the gougerotin gene cluster (+/− upstream and downstream flanking regions) or gougerotin ORF sequences can be divided into about 1/2, 1/3 or 1/4 based on the length of the sequence, The separated nucleic acid molecules (for example, oligonucleotides) are divided into ½ each of the first or second, divided into ず つ each of the three, or divided into ¼ each 4 One of the two can be guided. The nucleic acid sequence of interest can also be divided into smaller regions, for example, approximately 1/8, 1/16, 1/20, 1/50, etc., with similar effects. Or it can divide | segment into every area | region which codes the preserve | saved domain.
</span>
    </p>
    <p num="0103" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書にグーゲロチン生合成タンパク質及び対応する核酸配列が提供されたことにより、これらの配列の変異体の創成が可能になる。変異体グーゲロチン生合成酵素には、開示されたプロトタイプの酵素とはアミノ酸配列が異なるがそれでも表１に掲げたプロトタイプのタンパク質の生物学的活性／機能を保持するタンパク質を包含される。変異体酵素はまた、グーゲロチンの生合成前駆体であってそれら酵素の活性／機能を産生する生合成前駆体又はグーゲロチンの新規なアナログが除かれていてもよい。
</span>
&nbsp;&nbsp;Provided herein are gougerotin biosynthetic proteins and corresponding nucleic acid sequences, allowing the creation of variants of these sequences. Variant gougerotin biosynthetic enzymes include proteins that differ in amino acid sequence from the disclosed prototype enzymes but still retain the biological activity / function of the prototype proteins listed in Table 1. The mutant enzyme may also be a biosynthetic precursor of gougerotin and a biosynthetic precursor that produces the activity / function of those enzymes or a new analog of gougerotin.
</span>
    </p>
    <p num="0104" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、変異体グーゲロチン生合成タンパク質には、開示されたグーゲロチン生合成タンパク質配列（例えば、配列番号：２、４、６、８、１０、１２、１４、１６、１８、２０、２２、２４、２６、２８、３０、３２、３４、３６、３８、４０、及び４２及び／又は配列番号：７７−８８）とはアミノ酸配列が異なるがかかる酵素配列と少なくとも６５％のアミノ酸配列同一性を共有するタンパク質が包含される。その他の実施形態において、他の変異体は少なくとも７０％、少なくとも７５％、少なくとも８０％、少なくとも８５％、少なくとも９０％、少なくとも９１％、少なくとも９２％、少なくとも９３％、少なくとも９４％、少なくとも９５％、少なくとも９６％、少なくとも９７％、少なくとも９８％、又は少なくとも９９％のアミノ酸配列同一性を共有する。標準的な手法（例えば、部位特異的突然変異誘発又はＰＣＲ）を使用する開示されたグーゲロチン遺伝子クラスター（＋／−上流及び下流のフランキング領域）及びグーゲロチンＯＲＦヌクレオチド配列の操作はを使用してかかる変異体を生成することができる。最も簡単な改変は類似の生化学的性質を有するアミノ酸の１以上のアミノ酸への置換を含む。これらのいわゆる保存的置換は得られるタンパク質の活性に対する影響が最小でなり得る。
</span>
&nbsp;&nbsp;In one embodiment, the mutant gougerotin biosynthetic protein includes a disclosed gougerotin biosynthetic protein sequence (eg, SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22). , 24, 26, 28, 30, 32, 34, 36, 38, 40, and 42 and / or SEQ ID NO: 77-88) but at least 65% amino acid sequence identity with such enzyme sequences Proteins that share are included. In other embodiments, the other variants are at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95% Share at least 96%, at least 97%, at least 98%, or at least 99% amino acid sequence identity. Manipulating the disclosed gougerotin gene clusters (+/− upstream and downstream flanking regions) and standard gougerotin ORF nucleotide sequences using standard techniques (eg, site-directed mutagenesis or PCR) takes Mutants can be generated. The simplest modification involves the substitution of one or more amino acids with similar biochemical properties. These so-called conservative substitutions can have minimal impact on the activity of the resulting protein.
</span>
    </p>
    <p num="0105" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">グーゲロチンの生合成生産</u> <br class="style-scope patent-text">
  グーゲロチンを創成するための生合成方法はその効率的な生産に有用であり、グーゲロチン及びそのアナログの生産に同様に使用することができる。従って、グーゲロチン生合成遺伝子クラスター又はそれに由来するＯＲＦの大腸菌（Ｅ．ｃｏｌｉ）又は他のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属の菌のような異種の宿主におけるクローニング及び発現は、遺伝子クラスター内に含まれるグーゲロチン、グーゲロチン前駆体、グーゲロチン中間体、又は酵素若しくはタンパク質の生産を増大するのに使用することができる。さらに、遺伝子組換え及びドメイン交換構築体は、伝統的な合成方法を用いて作成するのが困難なグーゲロチン構造の創成を可能にする。
</span> <u class="style-scope patent-text">Biosynthetic production of</u> gougerotin The biosynthetic method for creating gougerotin is useful for its efficient production and can be used for the production of gougerotin and its analogs as well. Accordingly, cloning and expression in heterologous hosts, such as the Guguerotin biosynthetic gene cluster or ORFs derived from it from E. coli or other Streptomyces fungi, is included in the gene cluster. It can be used to increase the production of gougerotin precursors, gougerotin intermediates, or enzymes or proteins. Furthermore, genetic recombination and domain exchange constructs allow the creation of gougerotin structures that are difficult to create using traditional synthetic methods.</span>
    </p>
    <p num="0106" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、組換え発現系は原核生物宿主から選択される。細菌細胞はアメリカ合衆国培養細胞系統保存機関（ＡＴＣＣ；  Ｍａｎａｓｓａｓ、Ｖａ．）のような当業者に公知の公共の供給源を含めて数多くの供給源から入手可能である。組換えタンパク質発現に使用される細胞の商業的供給源はまたかかる細胞の利用のための指示を提供する。
</span>
&nbsp;&nbsp;In one embodiment, the recombinant expression system is selected from a prokaryotic host. Bacterial cells are available from a number of sources, including public sources known to those skilled in the art, such as the United States Cultured Cell Line Conservation Organization (ATCC; Manassas, Va.). Commercial sources of cells used for recombinant protein expression also provide instructions for the use of such cells.
</span>
    </p>
    <p num="0107" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン遺伝子クラスターの発現のための１つの代表的な異種宿主系はストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）種である。特定の例において、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属の菌は非常に大きいサイズの天然産物生合成遺伝子クラスターを発現するための人工の宿主として使用されている（例えば、Ｓｔｕｔｚｍａｎ−Ｅｎｇｗａｌｌ  ａｎｄ  Ｈｕｔｃｈｉｎｓｏｎ  Ｐｒｏｃ．  Ｎａｔｌ．  Ａｃａｄ．  Ｓｃｉ．  ＵＳＡ  ８６：  ３１３５−３１３９、１９８９；  Ｍｏｔａｍｅｄｉ  ａｎｄ  Ｈｕｔｃｈｉｎｓｏｎ  Ｐｒｏｃ．  Ｎａｔｌ．  Ａｃａｄ．  Ｓｃｉ．  ＵＳＡ  ８４：  ４４４５−４４４９、１９８７；  Ｇｒｉｍ  ｅｔ  ａｌ．  Ｇｅｎｅ  １５１：  １−１０  １９９４；  Ｋａｏ  ｅｔ  ａｌ．  Ｓｃｉｅｎｃｅ  ２６５：  ５０９−５１２、１９９４：  ａｎｄ  Ｈｏｐｗｏｏｄ  ｅｔ  ａｌ．  Ｍｅｔｈ．  Ｅｎｚｙｍｏｌ．  １５３：  １１６−１６６、１９８７参照）。ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）属の菌は有用な異種の宿主系であり、すなわち容易に増殖され、生合成遺伝子クラスターの発現及び／又は組込のためのプラスミド及びコスミドは十分に特性が決定されており、機能経路を生成するのに必要とされる改変し補助する酵素の<br class="style-scope patent-text">
ａｎｄ  ｔｈｅｙ  ｈｏｕｓｅ  多くを保有するからである（Ｄｏｎａｄｉｏ  ｅｔ  ａｌ．  Ｊ．  Ｂｉｏｔｅｃｈｎｏｌ．  ９９：１８７−１９８、２００２）。断片化する菌糸体を有する宿主細胞は低い粘度を保つ利点を示し得、宿主細胞の（大量のグーゲロチンを発現する能力に加えて）さらに望ましい特性には迅速な増殖及び簡単な基質による増殖が含まれる。
</span>One representative heterologous host system for expression of the gougerotin gene cluster is the Streptomyces species. In certain instances, the bacteria of the genus Streptomyces have been used as artificial hosts to express very large sized natural product biosynthetic gene clusters (eg, Stutzman-Engwall and Hutchinson Proc. Natl). Sci.USA 86: 3135-3139, 1989; Motamedi and Hutchinson Proc.Natl.Acad.Sci.USA 84: 4445-4449, 1987; Grim et al. Gene 151: 1-10 19: 1-10. Science 265: 509-512, 1994: and Hopwood et al. Meth. Enzymol. 153: 116-166, 198 7). Streptomyces spp. Are useful heterologous host systems, i.e., easily propagated, plasmids and cosmids for the expression and / or integration of biosynthetic gene clusters are well characterized. And possesses many and the enzyme houses that are needed to generate functional pathways and aid the house (Donado et al. J. Biotechnol. 99: 187-198, 2002). Host cells with fragmented mycelium can show the advantage of low viscosity, and more desirable properties (in addition to the ability to express large amounts of gougerotin) include rapid growth and simple substrate growth It is.</span>
    </p>
    <p num="0108" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン遺伝子クラスター（又は１以上のそのＯＲＦ）の発現のための別の代表的な異種宿主系は大腸菌（Ｅ．ｃｏｌｉ）である。大腸菌（Ｅ．ｃｏｌｉ）は、成長が速く、遺伝子操作が容易であるので魅力的な人工の発現系である。大腸菌（Ｅ．ｃｏｌｉ）に基づく発現系の近年の進歩により、単一の宿主有機体で同時に複数の遺伝子を発現させる努力が大いに軽減された。今や、大腸菌（Ｅ．ｃｏｌｉ）で複雑な生合成系から複数のＯＲＦを同時に発現させることができる。
</span>
&nbsp;&nbsp;Another representative heterologous host system for expression of the gougerotin gene cluster (or one or more of its ORFs) is E. coli. E. coli is an attractive artificial expression system because it is fast growing and easy to manipulate. Recent advances in E. coli-based expression systems have greatly reduced the effort to simultaneously express multiple genes in a single host organism. Now, multiple ORFs can be expressed simultaneously from complex biosynthetic systems in E. coli.
</span>
    </p>
    <p num="0109" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  しかし、発現系の選択は発現させるポリペプチドに望まれる特徴に依存する。任意の形質導入可能なクローニングベクターを現在開示されている核酸構築体のためのクローニングベクターとして使用することができる。大きいクラスターを発現させたい場合、複数のヌクレオチド配列を宿主細胞中にクローニングするためにファージミド、コスミド、フォスミド、Ｐ１、ＹＡＣ、ＢＡＣ、ＰＡＣ、ＨＡＣ又は同様なクローニングベクターを使用するのが好ましい。これらのベクターは、それぞれＭ１３ファージ及びラムダ  ファージと比較してＤＮＡのより大きい断片を  挿入する能力及び安定に増殖させる能力のために有利である。
</span>
&nbsp;&nbsp;However, the choice of expression system depends on the characteristics desired for the polypeptide to be expressed. Any transducible cloning vector can be used as a cloning vector for the currently disclosed nucleic acid constructs. If it is desired to express a large cluster, it is preferred to use a phagemid, cosmid, fosmid, P1, YAC, BAC, PAC, HAC or similar cloning vector to clone multiple nucleotide sequences into the host cell. These vectors are advantageous because of their ability to insert larger fragments of DNA and the ability to grow stably compared to M13 phage and lambda phage, respectively.
</span>
    </p>
    <p num="0110" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  １つの実施形態において、開示されているＯＲＦ及び／又はその変異体の１以上を、当業者に公知の方法を用いて１以上の発現ベクターに挿入することができる。ベクターを使用して、グーゲロチン生合成遺伝子又はグーゲロチン遺伝子クラスターを宿主細胞内に導入する。堅い細胞壁を有する原核生物の宿主細胞又は他の宿主細胞は、当業界で公知のいずれかの方法、例えば、リン酸カルシウム沈殿、又はエレクトロポレーションを用いて形質転換することができる。代表的な原核生物形質転換技術は、例えばＤｏｗｅｒ（Ｇｅｎｅｔｉｃ  Ｅｎｇｉｎｅｅｒｉｎｇ、Ｐｒｉｎｃｉｐｌｅｓ  ａｎｄ  Ｍｅｔｈｏｄｓ  １２：２７５−２９６、Ｐｌｅｎｕｍ  Ｐｕｂｌｉｓｈｉｎｇ  Ｃｏｒｐ．、１９９０）及びＨａｎａｈａｎ  ｅｔ  ａｌ．（Ｍｅｔｈ．  Ｅｎｚｙｍｏｌ．  ２０４：６３、１９９１）に記載されている。ベクターは所望のＯＲＦに機能可能なように連結された１以上の調節配列を含んでいる。しかし、発現カセットの選択は選択される宿主系及び発現されるポリペプチド又は天然産物に望まれる特徴に依存し得る。通例、発現カセットは、選択された宿主系で機能し、構成的又は誘導可能であることができるプロモーターを含んでいる。１つの実施形態において、発現カセットは、プロモーター、リボソーム結合部位、必要であれば開始コドン、及び場合により所望のＤＮＡ分子に加えてリーダーペプチドをコードする領域、並びに停止コドンを含んでいる。さらに、３’末端領域（翻訳及び／又は転写ターミネーター）をカセット内に含ませることができる。ＤＮＡ分子内に組み入れられたＯＲＦは、転写及び翻訳が宿主細胞内で起こるようにプロモーターにより単独に制御され得る。プロモーターをコードする領域は当業者に周知であり利用可能である。プロモーターの例として、細菌性プロモーター（例えば、ガラクトース、ラクトース及びマルトースのような糖代謝酵素に由来するものなど）、トリプトファンのような生合成酵素に由来するプロモーター配列、ｔｈｅ  ベータ−ラクタマーゼプロモーター系、バクテリオファージラムダＰＬ及びＴＦ並びにウィルス性プロモーターを挙げることができる。
</span>
&nbsp;&nbsp;In one embodiment, one or more of the disclosed ORFs and / or variants thereof can be inserted into one or more expression vectors using methods known to those skilled in the art. A vector is used to introduce a gougerotin biosynthesis gene or gougerotin gene cluster into a host cell. Prokaryotic host cells or other host cells with a rigid cell wall can be transformed using any method known in the art, for example, calcium phosphate precipitation, or electroporation. Representative prokaryotic transformation techniques are described, for example, by Dower (Genetic Engineering, Principles and Methods 12: 275-296, Plenum Publishing Corp., 1990) and Hanahan et al. (Meth. Enzymol. 204: 63, 1991). The vector contains one or more regulatory sequences operably linked to the desired ORF. However, the choice of expression cassette may depend on the host system chosen and the characteristics desired for the expressed polypeptide or natural product. Typically, the expression cassette contains a promoter that can function in the chosen host system and be constitutive or inducible. In one embodiment, the expression cassette includes a promoter, a ribosome binding site, a start codon if necessary, and optionally a region encoding the leader peptide in addition to the desired DNA molecule, and a stop codon. In addition, a 3 'terminal region (translation and / or transcription terminator) can be included in the cassette. An ORF incorporated within a DNA molecule can be independently controlled by a promoter so that transcription and translation occur in the host cell. The region encoding the promoter is well known and available to those skilled in the art. Examples of promoters include bacterial promoters (eg, those derived from sugar metabolizing enzymes such as galactose, lactose and maltose), promoter sequences derived from biosynthetic enzymes such as tryptophan, the beta-lactamase promoter system, bacterio Mention may be made of phage lambda PL and TF and viral promoters.
</span>
    </p>
    <p num="0111" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  発現カセット内の追加の調節配列の存在は宿主細胞の成長に呼応した１以上のＯＲＦの発現の調節を可能にするために望ましい可能性がある。これらの調節配列は当業界で周知である。調節配列の例には、化学物質又は物理的刺激に応答して遺伝子発現をオン・オフする配列、並びにエンハンサー配列がある。調節配列に加えて、形質転換された細胞の選抜を助けるために選択可能なマーカーを含ませることができる。例えば、抗生物質抵抗性又は感受性をプラスミドに与える遺伝子を選択可能なマーカーとして使用し得る。
</span>
&nbsp;&nbsp;The presence of additional regulatory sequences within the expression cassette may be desirable to allow regulation of the expression of one or more ORFs in response to host cell growth. These regulatory sequences are well known in the art. Examples of regulatory sequences include sequences that turn gene expression on and off in response to chemicals or physical stimuli, as well as enhancer sequences. In addition to regulatory sequences, selectable markers can be included to help select for transformed cells. For example, genes that confer antibiotic resistance or sensitivity to plasmids can be used as selectable markers.
</span>
    </p>
    <p num="0112" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  対象のグーゲロチン遺伝子クラスター又は１以上のグーゲロチンＯＲＦは、個々のカセットとして別々の調節要素と共に、又は単一の調節要素（例えば、プロモーター）の制御下で１以上の組換えベクター中にクローニングすることができると考えられる。１つの実施形態において、ＯＲＦは、混成合成経路を得ることができるように他のオープンリーディングフレームの容易な欠失及び挿入を可能にするために２以上の制限部位を含む。かかる制限部位の設計及び使用は当業界で周知であり、ＰＣＲ又は部位特異的突然変異誘発のような上記技術を用いて行うことができる。形質転換された細胞により発現されたタンパク質は当業者に周知の標準的な方法に従って回収することができる。例えば、タンパク質は単離を容易にするために便利なタグと共に発現させることができる。さらに、得られたポリペプチドは、ポリペプチドに結合するリガンドを用いることによりアフィニティークロマトグラフィーによって精製することができる。
</span>
&nbsp;&nbsp;A subject gougerotin gene cluster or one or more gougerotin ORFs can be cloned into separate cassettes as individual cassettes or into one or more recombinant vectors under the control of a single regulator (eg, promoter). It is considered possible. In one embodiment, the ORF contains two or more restriction sites to allow easy deletion and insertion of other open reading frames so that a hybrid synthetic pathway can be obtained. The design and use of such restriction sites is well known in the art and can be performed using such techniques as PCR or site-directed mutagenesis. Proteins expressed by the transformed cells can be recovered according to standard methods well known to those skilled in the art. For example, the protein can be expressed with a convenient tag to facilitate isolation. Furthermore, the resulting polypeptide can be purified by affinity chromatography using a ligand that binds to the polypeptide.
</span>
    </p>
    <p num="0113" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、グーゲロチンの産生について既に記載した発酵条件を利用することにより、対象とする様々なグーゲロチンＯＲＦ、遺伝子クラスター、又はグーゲロチンタンパク質を生産することができると考えられる。生産後、化合物は、例えば、高圧液体クロマトグラフィー（ＨＰＬＣ）をはじめとする当業者に周知の方法により精製及び／又は分析することができる。
</span>
&nbsp;&nbsp;Furthermore, by using the fermentation conditions already described for the production of gougerotin, it is considered that various target gougerotin ORFs, gene clusters, or gougerotin proteins can be produced. After production, the compound can be purified and / or analyzed by methods well known to those skilled in the art including, for example, high pressure liquid chromatography (HPLC).
</span>
    </p>
    <p num="0114" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明はまた、（ｉ）ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）種の菌株をスクリーニングし、（ｉｉ）配列番号４３に対して、又は配列番号：４３のヌクレオチド配列のタンパク質ＧｏｕＡ、ＧｏｕＢ、ＧｏｕＣ、ＧｏｕＤ、ＧｏｕＥ、ＧｏｕＦ、ＧｏｕＧ、ＧｏｕＨ、ＧｏｕＩ、ＧｏｕＪ、ＧｏｕＫ、ＧｏｕＬ、及び／又はＧｏｕＭをコードする領域に対して、少なくとも約６５％の配列同一性、少なくとも約６６％の配列同一性、少なくとも約６７％の配列同一性、少なくとも約６８％の配列同一性、少なくとも約６９％の配列同一性、少なくとも約７０％の配列同一性、少なくとも約８０％の配列同一性、少なくとも約９０％の配列同一性、少なくとも約９５％の配列同一性、少なくとも約９６％の配列同一性、少なくとも約９７％の配列同一性、少なくとも約９８％の配列同一性、又は少なくとも約９９％の配列同一性を有するヌクレオチド配列を有する菌株を選択し、（ｉｉｉ）選択された菌株に殺ダニ性の発酵産物を産生させることによって、殺ダニ性及び／又は殺真菌性の細菌産物を同定及び／又は製造する方法も包含する。幾つかの他の実施形態において、選択するステップは、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも７０％の配列同一性を有するアミノ酸配列をコードするヌクレオチド配列を有する菌株を選択することを含む。幾つかの実施形態においては、次のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）種の菌株をスクリーニングする。Ｓ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）、Ｓ．グリセウス（Ｓ．ｇｒｉｓｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）、又はＳ．グラミネアルス（Ｓ．ｇｒａｍｉｎｅａｒｕｓ）。幾つかの実施形態において、スクリーニングされるストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）種は親のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）株の突然変異体である。１つの態様において、かかる突然変異体は、実施例１６に記載される方法を含めて本出願で説明されているようにして、又は当業界で公知の他の方法によって生成させる。幾つかの実施形態において、スクリーニングステップの前に、親のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）株の突然変異体を発生させるステップがある。突然変異体を発生させる方法は本明細書に記載されている。幾つかの実施形態において、選択するステップは、菌株の発酵ブロスを調製し、少なくとも約６０％のハダニ効力も有する菌株を選択することも含む。かかる選択するステップは配列同一性に基づいて選択するステップの前又は後に実施することができる。発酵産物を調製し殺ダニ活性を試験する方法は本明細書に記載されている。１つの実施形態において、産生させるステップ（ステップ（ｉｉｉ））の発酵産物は少なくとも約１ｇ／Ｌ、少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、少なくとも約７ｇ／Ｌ、少なくとも約８ｇ／Ｌ、少なくとも約９ｇ／Ｌ、又は少なくとも約１０ｇ／Ｌのグーゲロチン濃度を有する。グーゲロチン濃度を測定する方法は当業者に公知である。
</span>
&nbsp;&nbsp;The present invention also includes (i) screening strains of the Streptomyces species, (ii) proteins GouA, GouB, GouC, GouD, GouE with a nucleotide sequence of SEQ ID NO: 43 or against SEQ ID NO: 43. , At least about 65% sequence identity, at least about 66% sequence identity, at least about 67% to the region encoding GouF, GouG, GouH, GouI, GouJ, GouK, GouL, and / or GouM. Sequence identity, at least about 68% sequence identity, at least about 69% sequence identity, at least about 70% sequence identity, at least about 80% sequence identity, at least about 90% sequence identity, at least About 95% sequence identity, at least about 96% sequence identity, at least Selecting a strain having a nucleotide sequence having 97% sequence identity, at least about 98% sequence identity, or at least about 99% sequence identity, and (iii) acaricidal fermentation product to the selected strain Also included are methods for identifying and / or producing acaricidal and / or fungicidal bacterial products by producing. In some other embodiments, the selecting step comprises SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: At least one amino acid sequence selected from the group consisting of SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42. Selecting a strain having a nucleotide sequence encoding an amino acid sequence having 70% sequence identity. In some embodiments, strains of the following Streptomyces species are screened. S. S. microflavus, S. S. griseus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. S. alboviridis, S. alboviridis S. puniceus, or S. Gramineales. In some embodiments, the Streptomyces species to be screened is a mutant of the parent Streptomyces strain. In one embodiment, such mutants are generated as described in this application, including the methods described in Example 16, or by other methods known in the art. In some embodiments, prior to the screening step, there is a step of generating a mutant of the parent Streptomyces strain. Methods for generating mutants are described herein. In some embodiments, selecting includes preparing a fermentation broth of the strain and selecting a strain that also has a tick efficacy of at least about 60%. Such a selection step can be performed before or after the selection step based on sequence identity. Methods for preparing fermented products and testing for acaricidal activity are described herein. In one embodiment, the fermentation product of the producing step (step (iii)) is at least about 1 g / L, at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, at least It has a gougerotin concentration of about 6 g / L, at least about 7 g / L, at least about 8 g / L, at least about 9 g / L, or at least about 10 g / L. Methods for measuring gougerotin concentrations are known to those skilled in the art.
</span>
    </p>
    <p num="0115" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">寄託情報</u> <br class="style-scope patent-text">
  本発明のストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）株のサンプルは、２０１１年８月１９日、ｔｈｅ  Ｎａｔｉｏｎａｌ  Ｃｅｎｔｅｒ  ｆｏｒ  Ａｇｒｉｃｕｌｔｕｒａｌ  Ｕｔｉｌｉｚａｔｉｏｎ  Ｒｅｓｅａｒｃｈ、Ａｇｒｉｃｕｌｔｕｒａｌ  Ｒｅｓｅａｒｃｈ  Ｓｅｒｖｉｃｅ、米国農務省、１８１５  Ｎｏｒｔｈ  Ｕｎｉｖｅｒｓｉｔｙ  Ｓｔｒｅｅｔ、Ｐｅｏｒｉａ、ＩＬ  ６１６０４に所在のｔｈｅ  Ａｇｒｉｃｕｌｔｕｒａｌ  Ｒｅｓｅａｒｃｈ  Ｓｅｒｖｉｃｅ  Ｃｕｌｔｕｒｅ  Ｃｏｌｌｅｃｔｉｏｎにブダペスト条約下で寄託され、ＮＲＲＬ  Ｂ−５０５５０という受託番号が付いている。
</span> <u class="style-scope patent-text">Deposit Information</u> A sample of the Streptomyces microflavus strain of the present invention is August 19, 2011, The National Center for Agricultural Research, Agricultural Research, Agricultural Research Research, Agricultural Research. Deposited at the Agricultural Research Service Culture Collection at 61604 under the Budapest Treaty and under the deposit number NRRL B-50550.</span>
    </p>
    <p num="0116" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株の突然変異体（本明細書ではストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｍ株と称され、ＡＱ６１２１．００２ともいう）のサンプルは、２０１３年９月２７日、ｔｈｅ  Ｎａｔｉｏｎａｌ  Ｃｅｎｔｅｒ  ｆｏｒ  Ａｇｒｉｃｕｌｔｕｒａｌ  Ｕｔｉｌｉｚａｔｉｏｎ  Ｒｅｓｅａｒｃｈ、Ａｇｒｉｃｕｌｔｕｒａｌ  Ｒｅｓｅａｒｃｈ  Ｓｅｒｖｉｃｅ、米国農務省、１８１５  Ｎｏｒｔｈ  Ｕｎｉｖｅｒｓｉｔｙ  Ｓｔｒｅｅｔ、Ｐｅｏｒｉａ、ＩＬ  ６１６０４に所在のｔｈｅ  Ａｇｒｉｃｕｌｔｕｒａｌ  Ｒｅｓｅａｒｃｈ  Ｓｅｒｖｉｃｅ  Ｃｕｌｔｕｒｅ  Ｃｏｌｌｅｃｔｉｏｎにブダペスト条約下で寄託されている。この株はまた、２０１３年１０月８日、１０８０１  Ｕｎｉｖｅｒｓｉｔｙ  Ｂｏｕｌｅｖａｒｄ  Ｍａｎａｓｓａｓ、ＶＡ  ２０１１０  ＵＳＡに所在のアメリカ合衆国培養細胞系統保存機関にもブダペスト条約下で寄託されている。さらにまたこの株は、２０１３年１０月９日、１０１５  Ａｒｌｉｎｇｔｏｎ  Ｓｔｒｅｅｔ  Ｗｉｎｎｉｐｅｇ、Ｍａｎｉｔｏｂａ  Ｃａｎａｄａ  Ｒ３Ｅ  ３Ｒ２に所在のカナダの国際寄託機関（ｔｈｅ  Ｉｎｔｅｒｎａｔｉｏｎａｌ  Ｄｅｓｐｏｓｉｔａｒｙ  Ａｕｔｈｏｒｉｔｙ  ｏｆ  Ｃａｎａｄａ）にも受託番号０９１０１３−０２（仮）で寄託されている。
</span>
&nbsp;&nbsp;A sample of a mutant of the Streptomyces microflavus NRRL B-50550 strain (referred to herein as the Streptomyces microflavus M strain, also referred to as AQ6121.002) is 2013. September 27, at the National Center for Agricultural Utility Research, Agricultural Research Service, U.S. Department of Agriculture, 1815 North University Street, Peoria, IL 61604 ection is deposited under the Budapest Treaty. This strain has also been deposited under the Budapest Treaty with the United States Cultured Cell Line Conservation Agency located on October 8, 2013, at 10801 University Boulevard Manassas, VA 20110 USA. Furthermore, this strain was also deposited with the Canadian International Depository of Canada (No. 101) at the 1015 Arlington Street Winnipeg, the Canadian International Depository of Canada (No. 101) at the International Depository of Canada 9 (No. 101). Has been.
</span>
    </p>
    <p num="0117" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本明細書でストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株（ＡＱ７４３９ともいう）と称するストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）株のサンプルは、２０１３年１０月８日、１０８０１  Ｕｎｉｖｅｒｓｉｔｙ  Ｂｏｕｌｅｖａｒｄ  Ｍａｎａｓｓａｓ、ＶＡ  ２０１１０  ＵＳＡに所在のアメリカ合衆国培養細胞系統保存機関にブダペスト条約下で寄託されている。またこの株は、２０１３年１０月９日、１０１５  Ａｒｌｉｎｇｔｏｎ  Ｓｔｒｅｅｔ  Ｗｉｎｎｉｐｅｇ、Ｍａｎｉｔｏｂａ  Ｃａｎａｄａ  Ｒ３Ｅ  ３Ｒ２に所在のカナダの国際寄託機関（ｔｈｅ  Ｉｎｔｅｒｎａｔｉｏｎａｌ  Ｄｅｓｐｏｓｉｔａｒｙ  Ａｕｔｈｏｒｉｔｙ  ｏｆ  Ｃａｎａｄａ）にも受託番号０９１０１３−０１（仮）で寄託されている。
</span>
&nbsp;&nbsp;A sample of Streptomyces puniceus strain, referred to herein as Streptomyces puniceus strain A (also referred to as AQ7439), is October 8, 2013, 10801 Univ. Deposited under the Budapest Treaty with the United States Cultured Cell Line Conservation Organization located in the USA. This strain was also deposited on October 9, 2013 at 1015 Arlington Street Winnipeg, the Canadian International Depository of Canada (No. 101) at deposit number 0 (No. 101) at the International Depository Authority of Canada, located in Manitoba Canada R3E 3R2. ing.
</span>
    </p>
    <p num="0118" class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  以下、本発明の純粋な例示として、限定されない目的で実施例を挙げる。
</span>
&nbsp;&nbsp;In the following, examples are given as purely illustrative examples of the present invention for non-limiting purposes.
</span>
    </p>
    <embodiments-example class="style-scope patent-text">
      <p num="0119" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１．  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の選抜</u> <br class="style-scope patent-text">
  菌株の内部コレクションから菌株を採り、初期スクリーニング試験を行って、全般的な殺ダニ活性をスクリーニングするために一般的に使用されるモデル生物であるナミハダニ（「ＴＳＳＭ」）に対する潜在的な候補菌株の有効性を決定した。まず、寒天プレートで急速に成長する変異体のような実験室又は人工培養に適した性質で微生物を選択した。選択した菌株の培養ストックを、実施例２に記載する培地１及び培地２のような、それぞれの菌株に適した培地で増殖させた。得られた発酵産物（全ブロス）を、水及び０．０３％の界面活性剤ＢＲＥＡＫ−ＴＨＲＵ  ＦＩＲＳＴ  Ｃｈｏｉｃｅ（登録商標）ポリエーテル−ポリメチルシロキサン−コポリマーを用いて２５％溶液に希釈した。その後、８ｍＬの希釈した発酵産物を（２つの植物体の）ライマメ葉の上面及び下面に流れ出すまで施用した（ライマメ植物は１〜１．５週齢であった）。かかる処理の後、同日５０−１００のＴＳＳＭを植物に寄生させ、５日間温室内に放置した。５日目植物をダニ及び卵の存在に関して１〜４のスケールで評価した。殺ダニ剤ＡＶＩＤ（登録商標）（アバメクチン、Ｓｙｎｇｅｎｔａ）を陽性対照として使用した。ダニ及び卵に関して、１は１００％の死亡率を示し、１．５は９０％〜９５％の死亡率を示し、２．０は７５％〜９０％の死亡率を表し、２．５は４０％〜５５％の死亡率を表し、３．０は２０％〜３５％の死亡率を表し、４．０は０％〜１０％の死亡率を表す。ＮＲＲＬ  Ｂ−５０５５０の他にも、他のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株及び幾つかのＢａｃｉｌｌｕｓ菌株がダニに対して活性であることが判明した。
</span> <u class="style-scope patent-text">Example 1.</u> A model organism commonly used for screening strains from an internal collection <u class="style-scope patent-text">of selected</u> strains of <u class="style-scope patent-text">Streptomyces microflavus NRRL B-50550</u> and conducting initial screening tests to screen general acaricidal activity The efficacy of potential candidate strains against the urticae (“TSSM”) was determined. First, microorganisms were selected with properties suitable for laboratory or artificial culture such as mutants that grow rapidly on agar plates. Culture stocks of selected strains were grown in media suitable for each strain, such as media 1 and media 2 described in Example 2. The resulting fermentation product (total broth) was diluted to a 25% solution with water and 0.03% surfactant BRAKE-THRU FIRST Choice® polyether-polymethylsiloxane copolymer. Thereafter, 8 mL of the diluted fermentation product was applied until it flowed to the upper and lower surfaces of the lima bean leaves (of 2 plants) (the lima bean plants were 1 to 1.5 weeks old). After this treatment, 50-100 TSSMs were infested with plants on the same day and left in the greenhouse for 5 days. Day 5 plants were evaluated on a scale of 1-4 for the presence of ticks and eggs. The acaricide AVID® (Abamectin, Syngenta) was used as a positive control. For ticks and eggs, 1 indicates 100% mortality, 1.5 indicates 90% -95% mortality, 2.0 indicates 75% -90% mortality, 2.5 indicates 40% % Represents a mortality rate of from 55%, 3.0 represents a mortality rate of 20% to 35%, 4.0 represents a mortality rate of 0% to 10%. In addition to NRRL B-50550, other Streptomyces strains and several Bacillus strains were found to be active against ticks.</span>
      </p>
      <p num="0120" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに選択するため、他の活性の中で、スクリーニングした菌株のＵＶ安定性及び層透過活性を試験した。これは、殺ダニ剤は野外散布で有効であるためにはＵＶ光に対して安定で、層透過活性を保有するべきだからである。
</span>
&nbsp;&nbsp;For further selection, among other activities, the screened strains were tested for UV stability and permeation activity. This is because an acaricide should be stable to UV light and possess layer-penetrating activity in order to be effective in field spraying.
</span>
      </p>
      <p num="0121" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＵＶ安定性の評価のため、発酵産物の上記２５％希釈液をライマメ植物の上面に噴霧した。かかる処理の後、同日５０−１００のＴＳＳＭを植物に寄生させ、２４時間ＵＶ光に曝し、５日間温室内に放置した。ダニは、葉に付けてダニに対する無感覚の境界線として役立たせたワセリンリングを用いて葉の向軸の（上の）表面に閉じ込めた。５日目植物を上記のようにダニ及び卵の存在に関して１〜４のスケールで評価した。殺ダニ剤ＡＶＩＤ（登録商標）（アバメクチン、Ｓｙｎｇｅｎｔａ）及びＯＢＥＲＯＮ（登録商標）（スピロメシフェン、Ｂａｙｅｒ  ＣｒｏｐＳｃｉｅｎｃｅ  ＡＧ）を対照として用いた。結果を図１に示す。ＮＲＲＬ  Ｂ−５０５５０株の発酵産物は試験した全ての菌株の中で最良のＵＶ安定性を示した。
</span>
&nbsp;&nbsp;For the assessment of UV stability, the above 25% dilution of the fermentation product was sprayed on top of the lima bean plants. After such treatment, 50-100 TSSMs were infested on the same day, exposed to UV light for 24 hours and left in the greenhouse for 5 days. The mites were confined to the (up) surface of the leaf's axial axis using petrolatum rings that were attached to the leaves and served as insensitive borders for the mites. Day 5 plants were evaluated on a scale of 1-4 for the presence of ticks and eggs as described above. The acaricides AVID® (Abamectin, Syngenta) and OBERON® (Spiromesifen, Bayer CropScience AG) were used as controls. The results are shown in FIG. The fermentation product of strain NRRL B-50550 showed the best UV stability among all the strains tested.
</span>
      </p>
      <p num="0122" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  層透過活性の評価のため、菌株を上記のように培養し、得られた全ブロスを水及び０．３５％の界面活性剤を用いて希釈し、（２つの植物体の）ライマメ葉の下面に流れ出すまで施用した。処理の１日後、処理した葉の上面に５０−１００のＴＳＳＭを寄生させ、これらは葉の上面に付け、上記のようにワセリンリング／物理的障壁を用いて閉じ込めた。６日目植物をダニ及び卵存在に関して１〜４の上記スケールで評価した。殺ダニ剤ＡＶＩＤ（登録商標）（アバメクチン、Ｓｙｎｇｅｎｔａ）及びＯＢＥＲＯＮ（登録商標）（スピロメシフェン、Ｂａｙｅｒ  ＣｒｏｐＳｃｉｅｎｃｅ  ＡＧ）を対照として使用した。結果を図２に示す。ＮＲＲＬ  Ｂ−５０５５０株の発酵産物は試験した菌株の中で最良の層透過活性を示した。
</span>
&nbsp;&nbsp;For evaluation of the permeabilization activity, the strain was cultured as described above, the whole broth obtained was diluted with water and 0.35% surfactant, and the bottom surface of the lima bean leaves (of two plants) It was applied until it began to flow. One day after treatment, 50-100 TSSM was parasitized on the top of the treated leaves, which were attached to the top of the leaves and confined using a petrolatum ring / physical barrier as described above. Day 6 plants were evaluated on the above scale of 1-4 for mites and egg presence. The acaricides AVID® (Abamectin, Syngenta) and OBERON® (Spiromesifen, Bayer CropScience AG) were used as controls. The results are shown in FIG. The fermentation product of NRRL B-50550 strain showed the best permeation activity among the strains tested.
</span>
      </p>
      <p num="0123" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例２．  ハダニに対する活性</u> <br class="style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０のナミハダニ（「ＴＳＳＭ」）に対する有効性をより厳密に決定するためにさらに試験を行った。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の培養ストックを１Ｌの振盪フラスコ内の培地１又は培地２において２８℃で５日間増殖させた。培地１は２．０％デンプン、１．０％  デキストロース、０．５％酵母エキス、０．５％カゼイン加水分解物及び０．１％ＣａＣＯ<sub class="style-scope patent-text">３</sub>からなっていた。培地２は２％ＰｒｏＦｌｏ綿実粕、２％麦芽エキス、０．６％ＫＨ<sub class="style-scope patent-text">２</sub>ＰＯ<sub class="style-scope patent-text">４</sub>及び０．４８％Ｋ<sub class="style-scope patent-text">２</sub>ＨＰＯ<sub class="style-scope patent-text">４</sub>からなっていた。得られた発酵産物を、水及び０．０３％界面活性剤ＢＲＥＡＫ−ＴＨＲＵ  ＦＩＲＳＴ  ＣＨＯＩＣＥ（登録商標）（ポリエーテル−ポリメチルシロキサン−コポリマー）を用いて２５％溶液に希釈し、６ｍＬを（２つの植物体の）ライマメ葉の上面及び下面に流れ出すまで施用した。かかる処理の後、同日植物に５０−１００のＴＳＳＭを寄生させ、温室内に５日間放置した。６日目植物をダニ及び卵の存在に関して１〜４のスケールで評価した。殺ダニ剤ＡＶＩＤ（登録商標）（アバメクチン、Ｓｙｎｇｅｎｔａ）を陽性対照として使用した。ダニ及び卵に関して、１は１００％の死亡率を示し、１．５は９０％〜９５％の死亡率を示し、２．０は７５％〜９０％の死亡率を表し、２．５は４０％〜５５％の死亡率を表し、３．０は２０％〜３５％の死亡率を表し、４．０は０％〜１０％の死亡率を表す。結果を下記表３に示す。ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０の両方の発酵産物で９０％以上のダニ死亡率が得られた。<br class="style-scope patent-text">
<tables num="3" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000008" he="48" wi="163" file="2015534950.tif" img-format="tif" img-content="drawing" width="652" height="192" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 2</u> Further tests were conducted in order to more precisely determine the effectiveness against <u class="style-scope patent-text">active</u> Streptomyces Mikurofurabusu (Streptomyces microflavus) NRRL B-50550 spider mites ( "TSSM") <u class="style-scope patent-text">against spider mites.</u> A culture stock of Streptomyces microflavus NRRL B-50550 was grown for 5 days at 28 ° C. in medium 1 or medium 2 in a 1 L shake flask. Medium 1 consisted of 2.0% starch, 1.0% dextrose, 0.5% yeast extract, 0.5% casein hydrolyzate and 0.1% CaCO <sub class="style-scope patent-text">3</sub> . Medium 2 consisted of 2% ProFlo cottonseed meal, 2% malt extract, 0.6% KH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> and 0.48% K <sub class="style-scope patent-text">2</sub> HPO <sub class="style-scope patent-text">4</sub> . The resulting fermented product is diluted to a 25% solution with water and 0.03% surfactant BRAK-THRU FIRST CHOICE® (polyether-polymethylsiloxane-copolymer) and 6 mL (two It was applied until it flowed to the upper and lower surfaces of the lima bean leaves. After such treatment, 50-100 TSSM was infested on the same day and left in the greenhouse for 5 days. Day 6 plants were evaluated on a scale of 1-4 for the presence of ticks and eggs. The acaricide AVID® (Abamectin, Syngenta) was used as a positive control. For ticks and eggs, 1 indicates 100% mortality, 1.5 indicates 90% -95% mortality, 2.0 indicates 75% -90% mortality, 2.5 indicates 40% It represents a mortality rate of between% and 55%, 3.0 represents a mortality rate of 20% to 35%, and 4.0 represents a mortality rate of 0% to 10%. The results are shown in Table 3 below. More than 90% tick mortality was obtained with both fermentation products of Streptomyces microflavus NRRL B-50550. <br class="style-scope patent-text"> <tables num="3" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000008" he="48" wi="163" file="2015534950.tif" img-format="tif" img-content="drawing" width="652" height="192" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0124" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  アーモンドでのパシフィックスパイダーマイト（Ｐａｃｉｆｉｃ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ブドウでのパシフィックスパイダーマイト（Ｐａｃｉｆｉｃ  ｓｐｉｄｅｒ  ｍｉｔｅ）、及びイチゴでのナミハダニに関する圃場試験で、上記の温室での結果が確認された。アーモンドにおけるパシフィックスパイダーマイト（Ｐａｃｉｆｉｃ  ｓｐｉｄｅｒ  ｍｉｔｅ）に対する圃場試験の結果を下記表４−６に示す。殺ダニ剤ＡＧＲＩ−ＭＥＫ（登録商標）（アバメクチン、Ｓｙｎｇｅｎｔａ）を陽性対照として使用した。培地１を含有する振盪フラスコにＮＲＲＬ  Ｂ−５０５５０の凍結培養菌を接種し、２８−３０℃で１−２日増殖させた。得られた発酵産物を用いて培地（６．０％デンプン、３．０％デキストロース、１．５％酵母エキス及び１．５％カゼイン加水分解物並びに０．３％炭酸カルシウム）を含有する２０Ｌのバイオリアクターに播種した。この培地を２８℃で７日間発酵させた。得られた全ブロスを用いてアジュバントＢＲＥＡＫ−ＴＨＲＵ  ＦＩＲＳＲ  ＣＨＯＩＣＥ（登録商標）（ポリエーテル−ポリメチルシロキサン−コポリマー）０．０３％と混合した凍結乾燥粉末（「ＦＤＰ」）を作成し、その後試験に使用した。<br class="style-scope patent-text">
<tables num="4" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000009" he="62" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="248" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
<tables num="5" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000010" he="62" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="248" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables>
<tables num="6" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000011" he="61" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="244" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables>
Field tests on Pacific spider mites in almonds, Pacific spider mites in grapes, and spider mites in strawberries confirmed the above greenhouse results. Table 4-6 below shows the results of the field test for Pacific spider mite in Almond. The acaricide AGRI-MEK® (Abamectin, Syngenta) was used as a positive control. A shake flask containing Medium 1 was inoculated with a frozen culture of NRRL B-50550 and grown at 28-30 ° C. for 1-2 days. 20 L of medium containing the medium (6.0% starch, 3.0% dextrose, 1.5% yeast extract and 1.5% casein hydrolyzate and 0.3% calcium carbonate) using the obtained fermentation product Seeded in bioreactor. This medium was fermented at 28 ° C. for 7 days. The resulting whole broth was used to make a lyophilized powder ("FDP") mixed with 0.03% adjuvant BRAKE-THRU FIRSR CHOICE® (polyether-polymethylsiloxane-copolymer) for subsequent testing. used. <br class="style-scope patent-text"> <tables num="4" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000009" he="62" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="248" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> <tables num="5" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000010" he="62" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="248" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> <tables num="6" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000011" he="61" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="244" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0125" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例３．  柑橘類ダニに対する圃場活性</u> <br class="style-scope patent-text">
  バレンシアオレンジにおけるミカンサビダニ（ｃｉｔｒｕｓ  ｒｕｓｔ  ｍｉｔｅ）（フィロコプツルタ・オレイボラ（Ｐｈｙｌｌｏｃｏｐｔｒｕｔａ  ｏｌｅｉｖｏｒａ））に対するＮＲＲＬ  Ｂ−５０５５０の有効性を決定するために圃場試験を実施した。培地１（実施例２参照）を含有する振盪フラスコにＮＲＲＬ  Ｂ−５０５５０の凍結させた培養株を接種し、２０−３０℃で１−２日増殖させた。これを繰り返した。得られた発酵産物を用いて、培地（６．０％デンプン、３．０％デキストロース、１．５％酵母エキス、２．０％大豆酸加水分解物、０．６％グリシン、及び０．２％炭酸カルシウム）を含有する２０Ｌのバイオリアクターに播種した。この培地を２８℃で８日間発酵させた。得られた全ブロスを用いて、以下の試験に使用した凍結乾燥粉末（「ＦＤＰ」）を作成した。凍結乾燥粉末を水中に希釈し、下記表７に示す割合で１００ｇａｌ／エーカー施用した。殺ダニ剤ＥＮＶＩＤＯＲ（登録商標）（スピロジクロフェン、Ｂａｙｅｒ  ＣｒｏｐＳｃｉｅｎｃｅ，  Ｇｅｒｍａｎｙ）を陽性対照として使用した。処理１−３においては、ＢＲＥＡＫ−ＴＨＲＵ  ＦＩＲＳＴ  ＣＨＯＩＣＥ（登録商標）アジュバント（ポリエーテル−ポリメチルシロキサン−コポリマー、上記参照）を０．６６％ｖ／ｖ添加した。０．６２５ｌｂ／Ａの割合で施用した発酵産物は１６−ｆｌ  ｏｚ／Ａの割合で施用したＥＮＶＩＤＯＲ（登録商標）スピロジクロフェンより良好な殺ダニ活性を示した。<br class="style-scope patent-text">
<tables num="7" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000012" he="64" wi="169" file="2015534950.tif" img-format="tif" img-content="drawing" width="676" height="256" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 3 FIG. Field Activity on Citrus Mites</u> Field trials were conducted to determine the efficacy of NRRL B-50550 against citrus rust mite (Phyllocoptruta oleivara) in Valencia orange. A shake flask containing Medium 1 (see Example 2) was inoculated with a frozen culture of NRRL B-50550 and grown at 20-30 ° C. for 1-2 days. This was repeated. Using the obtained fermentation product, medium (6.0% starch, 3.0% dextrose, 1.5% yeast extract, 2.0% soy acid hydrolyzate, 0.6% glycine, and 0.2% 20L bioreactor containing (% calcium carbonate). This medium was fermented at 28 ° C. for 8 days. The resulting broth was used to make a lyophilized powder (“FDP”) used in the following tests. The lyophilized powder was diluted in water and applied at 100 gal / acre at the rate shown in Table 7 below. The acaricide ENVIDOR® (spirodiclofen, Bayer CropScience, Germany) was used as a positive control. In Treatment 1-3, 0.66% v / v of BRAKE-THRU FIRST CHOICE® adjuvant (polyether-polymethylsiloxane-copolymer, see above) was added. The fermented product applied at a rate of 0.625 lb / A exhibited better acaricidal activity than ENVIDOR® spirodiclofen applied at a rate of 16-fl oz / A. <br class="style-scope patent-text"> <tables num="7" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000012" he="64" wi="169" file="2015534950.tif" img-format="tif" img-content="drawing" width="676" height="256" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0126" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例４．  他のダニに対する活性</u> <br class="style-scope patent-text">
  研究により、ＮＲＲＬ  Ｂ−５０５５０がフシダニ科（ｅｒｉｏｐｈｙｉｄ）（ｒｕｓｓｅｔ）ダニ及び広範なチャノホコリダニ（ｂｒｏａｄ  ｍｉｔｅｓ）を含めて様々な他のダニに対して活性であることが示された。実施例２に記載した圃場試験のものと同様な発酵ブロスを調製した。得られた発酵ブロスを水及び０．３５％界面活性剤を用いて様々な濃度に希釈し、希釈したブロスの１０ｍＬを（２つの植物体の）ライマメ葉の上面及び下面に流れ出すまで施用した。処理の日に植物に寄生させ、処理の６日後上に記載したスケールで褐色斑点ダニの存在を評価した。４のスコアは防除がないことを示し、評価の時点で少なくとも１００の褐色斑点ダニが存在していたことを示す。殺ダニ剤ＡＶＩＤ（登録商標）（アバメクチン）を陽性対照として使用した。<br class="style-scope patent-text">
<tables num="8" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000013" he="58" wi="169" file="2015534950.tif" img-format="tif" img-content="drawing" width="676" height="232" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 4 Activity</u> studies <u class="style-scope patent-text">against other ticks have shown</u> that NRRL B-50550 is active against a variety of other ticks, including erophyid (russet) ticks and a wide range of broad mites. A fermentation broth similar to that of the field test described in Example 2 was prepared. The resulting fermentation broth was diluted to various concentrations with water and 0.35% surfactant, and 10 mL of the diluted broth was applied until it flowed to the upper and lower surfaces of the lima bean leaves (of two plants). Plants were infested on the day of treatment and the presence of brown spotted mites was evaluated on the scale described above after 6 days of treatment. A score of 4 indicates no control and at least 100 brown spotted ticks were present at the time of evaluation. The acaricide AVID® (abamectin) was used as a positive control. <br class="style-scope patent-text"> <tables num="8" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000013" he="58" wi="169" file="2015534950.tif" img-format="tif" img-content="drawing" width="676" height="232" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0127" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例５．  残効性</u> <br class="style-scope patent-text">
  他の研究により、ＮＲＲＬ  Ｂ−５０５５０が残効性を有することが明らかになった。実施例２の培地１を含有する振盪フラスコに、（ＮＲＲＬ  Ｂ−５０５５０の凍結させた培養株を植え付けておいた）ＮＲＲＬ  Ｂ−５０５５０のルリアブロスに基づく培養物を接種し、１−２日２８℃で増殖させた。得られた発酵産物を用いて培地（８．０％デキストロース、１．５％酵母エキス、１．５％カゼイン加水分解物及び０．１％炭酸カルシウム）を含有する２０Ｌのバイオリアクターに播種した。この培地を２８℃で７−８日間発酵させた。得られた発酵産物を水及び０．３５％界面活性剤を用いて３．１３％溶液に希釈し、８ｍＬの希釈ブロスを（２つの植物体の）ライマメ葉の上面及び下面に流れ出すまで施用した。かかる処理の６日後植物に５０−１００のＴＳＳＭを寄生させ、処理の１２日後ダニ及び卵の存在を前記スケールで評価した。殺ダニ剤ＡＶＩＤ（登録商標）（アバメクチン）を陽性対照として使用した。結果を下記表９に示す。<br class="style-scope patent-text">
<tables num="9" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000014" he="41" wi="166" file="2015534950.tif" img-format="tif" img-content="drawing" width="664" height="164" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 5 FIG. After</u> Effects Other studies have shown that NRRL B-50550 has after effects. A shake flask containing Medium 1 of Example 2 was inoculated with a culture based on Luria broth of NRRL B-50550 (which had been inoculated with a frozen culture of NRRL B-50550), 1-2 days at 28 ° C. Was grown on. The obtained fermentation product was used to inoculate a 20 L bioreactor containing a medium (8.0% dextrose, 1.5% yeast extract, 1.5% casein hydrolyzate and 0.1% calcium carbonate). This medium was fermented at 28 ° C. for 7-8 days. The resulting fermented product was diluted with water and 0.35% surfactant to a 3.13% solution and 8 mL of diluted broth was applied until it flowed to the top and bottom surfaces of the lima bean leaves (of two plants). . Six days after such treatment, the plants were infested with 50-100 TSSM and after 12 days of treatment the presence of ticks and eggs was assessed on the scale. The acaricide AVID® (abamectin) was used as a positive control. The results are shown in Table 9 below. <br class="style-scope patent-text"> <tables num="9" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000014" he="41" wi="166" file="2015534950.tif" img-format="tif" img-content="drawing" width="664" height="164" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0128" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  処理された植物に最初に曝露されたダニに対する効果に加えて、処理された葉に後の時点で移動してくるかもしれないダニに対する効果も評価した。全ての植物は、実施例１３に記載するのと同様にして生成させた６．２５％又は１．５６％の全ブロスでゼロ日に処理した。その後、処理後１週間の間隔でダニを植物群に加えた。この処理には比較のために他の殺ダニ剤も含めた。ダニは処理後５週間各週加えた。活性は５週間にわたって維持され、活性低下の速さはＯＢＥＲＯＮ（登録商標）（スピロメシフェン）製品と同様であり、ＡＶＩＤ（登録商標）製品より少し大きかった。この研究では、ライマメ植物の初生葉を処理したとき、後に出て来る葉は保護されなかったことも示された。
</span>
&nbsp;&nbsp;In addition to the effect on ticks initially exposed to the treated plants, the effect on ticks that may migrate to the treated leaves at a later time point was also evaluated. All plants were treated on day zero with 6.25% or 1.56% total broth produced as described in Example 13. Thereafter, ticks were added to the plant group at intervals of 1 week after treatment. This treatment included other acaricides for comparison. Mites were added each week for 5 weeks after treatment. The activity was maintained over 5 weeks, and the rate of decrease in activity was similar to the OBERON® (Spiromesifen) product and was slightly greater than the AVID® product. The study also showed that when the primary leaves of Lima bean plants were treated, the leaves that emerged later were not protected.
</span>
      </p>
      <p num="0129" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例６．  層透過活性</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｂ−５０５５０が層透過活性を有するか否かを決定するための研究を行った。実施例５に記載したようにして全ブロスを調製した。得られた全ブロスを水及び０．３５％界面活性剤を用いて希釈し、１０ｍＬの希釈したブロスを（２つの植物体の）ライマメ葉の下の表面に流れ出すまで施用した。処理の１日後処理した葉の上の表面に５０−１００のＴＳＳＭを寄生させた。ＴＳＳＭは葉の上の表面に付け、葉の上の表面においたワセリンリング／物理的障壁を用いて閉じ込めた。処理の５日後植物をダニ及び卵の存在に関して前記スケールで評価した。結果を下記表１０に示す。<br class="style-scope patent-text">
<tables num="10" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000015" he="59" wi="163" file="2015534950.tif" img-format="tif" img-content="drawing" width="652" height="236" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 6</u> A study was conducted to determine whether the <u class="style-scope patent-text">layer permeability activity</u> NRRL B-50550 has layer permeability activity. All broths were prepared as described in Example 5. The total broth obtained was diluted with water and 0.35% surfactant and 10 mL of diluted broth was applied until it flowed to the surface under the lima bean leaves (of two plants). One day after treatment, 50-100 TSSM were infested on the surface of the treated leaves. TSSM was applied to the surface above the leaves and confined using a petrolatum ring / physical barrier placed on the surface above the leaves. After 5 days of treatment, plants were evaluated on the scale for the presence of ticks and eggs. The results are shown in Table 10 below. <br class="style-scope patent-text"> <tables num="10" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000015" he="59" wi="163" file="2015534950.tif" img-format="tif" img-content="drawing" width="652" height="236" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0130" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例７．  殺卵活性</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｂ−５０５５０の殺卵活性を以下のようにして試験した。全ブロスは実施例５に記載したように調製した。２つのライマメ植物に、処理の４８時間前成虫の雌のダニに葉の表面に産卵させることによってＴＳＳＭの卵を予め寄生させた。その後植物を全ブロスの８ｍＬの様々な希釈液で処理した。処理の５日後植物を査定した。各処理及び対照において存在する生きている卵と死んだ卵の数を以下の表１１に示す。<br class="style-scope patent-text">
<tables num="11" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000016" he="59" wi="168" file="2015534950.tif" img-format="tif" img-content="drawing" width="672" height="236" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 7 Ovicidal activity</u> NRRL B-50550 was tested for ovicidal activity as follows. All broths were prepared as described in Example 5. Two Lima bean plants were pre-infested with TSSM eggs by allowing adult female ticks to lay eggs on the leaf surface for 48 hours prior to treatment. The plants were then treated with 8 ml of various dilutions of total broth. Plants were assessed after 5 days of treatment. The number of live and dead eggs present in each treatment and control is shown in Table 11 below. <br class="style-scope patent-text"> <tables num="11" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000016" he="59" wi="168" file="2015534950.tif" img-format="tif" img-content="drawing" width="672" height="236" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0131" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例８．  潅注活性</u> <br class="style-scope patent-text">
  砂で成長させたライマメを用いてＮＲＲＬ  Ｂ−５０５５０の潅注活性を検討した。全ブロスは実施例３に記載したようにして調製した。全ブロスの各々１０ｍＬの１２．５％希釈液を二回砂に散布した。ポットの底面からの全ブロスの浸出を防ぐために慎重に植物に水をやった。散布は植え付けの４日後及び５日後に行った。処理２の３日後下の葉に運動性のＴＳＳＭを寄生させた。下の葉に寄生させた９日後上の三つ葉に寄生した。評価は寄生後４、５、８及び１１日に下の葉で行った。上の葉の評価は寄生の２日後に行った。実施例２に記載したスコアシステムに基づく結果を下の表１２に示す。<br class="style-scope patent-text">
<tables num="12" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000017" he="90" wi="170" file="2015534950.tif" img-format="tif" img-content="drawing" width="680" height="360" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 8 FIG. The irrigation activity of</u> NRRL B-50550 was examined using lime beans grown in <u class="style-scope patent-text">irrigated active</u> sand. All broths were prepared as described in Example 3. Each broth was sprayed twice with 10 mL of a 12.5% dilution. The plants were carefully watered to prevent leaching of all broth from the bottom of the pot. Spraying was performed 4 and 5 days after planting. After 3 days of treatment 2, motile TSSM was infested in the lower leaves. 9 days after infesting the lower leaf, it infested the upper trefoil. Evaluation was performed on the lower leaves at 4, 5, 8 and 11 days after infestation. Evaluation of the upper leaf was performed 2 days after the infestation. The results based on the scoring system described in Example 2 are shown in Table 12 below. <br class="style-scope patent-text"> <tables num="12" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000017" he="90" wi="170" file="2015534950.tif" img-format="tif" img-content="drawing" width="680" height="360" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0132" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例９．  真菌の植物病原体に対する活性</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｂ−５０５５０の様々な植物真菌性病原体に対する活性を試験した。コムギ赤さび病及びキュウリうどんこ病の両方に対して活性であることが判明した。培地１を含有する振盪フラスコにＮＲＲＬ  Ｂ−５０５５０の凍結させた培養菌を接種し、１−２日２０−３０℃で増殖させた。得られた発酵産物を用いて同様な培地を含有する２０Ｌのバイオリアクターに播種し、１−２日２８℃で増殖させた。次に、得られた発酵産物を用いて、培地（７．０％デンプン、３．０％デキストロース、１．５％酵母エキス、２．０％大豆酸加水分解物、０．８％グリシン、及び０．２％炭酸カルシウム）を含有する２００Ｌの発酵槽に播種した。この培地を２６℃で８日間発酵させた。６日齢のコムギ実生を、下記表１３に示す０．０３％アジュバント（ＢＲＥＡＫ−ＴＨＲＵ  ＦＩＲＳＴ  ＣＨＯＩＣＥ（登録商標）ポリエーテル−ポリメチルシロキサン−コポリマー）を有する蒸留水中に様々な希釈度で調製したＮＲＲＬ−５０５５０の全ブロスで、両方の葉の表面を全ブロスで覆い乾燥させることにより、処理した。かかる処理の１日後実生にコムギ赤さび病懸濁液を接種した。処理の約１週後０−１００％の防除スケールで植物を評価した。ここで０％は防除なし、１００％は完全な防除である。<br class="style-scope patent-text">
<tables num="13" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000018" he="118" wi="140" file="2015534950.tif" img-format="tif" img-content="drawing" width="560" height="472" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 9 Activity against fungal plant pathogens The activity of</u> NRRL B-50550 <u class="style-scope patent-text">against</u> various plant fungal pathogens was tested. It was found to be active against both wheat red rust and cucumber powdery mildew. A shake flask containing Medium 1 was inoculated with a frozen culture of NRRL B-50550 and grown at 20-30 ° C. for 1-2 days. The obtained fermentation product was used to inoculate a 20 L bioreactor containing a similar medium and grown at 28 ° C. for 1-2 days. Next, using the obtained fermentation product, medium (7.0% starch, 3.0% dextrose, 1.5% yeast extract, 2.0% soybean acid hydrolyzate, 0.8% glycine, and Seeded in a 200 L fermentor containing 0.2% calcium carbonate). This medium was fermented at 26 ° C. for 8 days. Six day old wheat seedlings were prepared at various dilutions in distilled water with 0.03% adjuvant (BRAKE-THRU FIRST CHOICE® polyether-polymethylsiloxane-copolymer) as shown in Table 13 below. Treated with -50550 whole broth by covering both leaf surfaces with whole broth and drying. One day after such treatment, seedlings were inoculated with wheat red rust suspension. Plants were evaluated on a 0-100% control scale approximately one week after treatment. Here 0% is no control and 100% is complete control. <br class="style-scope patent-text"> <tables num="13" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000018" he="118" wi="140" file="2015534950.tif" img-format="tif" img-content="drawing" width="560" height="472" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0133" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、ＮＲＲＬ  Ｂ−５０５５０は、全ブロスを下の葉表面に施用し、病原体を上の葉表面に付けたとき、キュウリうどんこ病に対して活性を示した。
</span>
&nbsp;&nbsp;Furthermore, NRRL B-50550 showed activity against cucumber powdery mildew when whole broth was applied to the lower leaf surface and the pathogen was applied to the upper leaf surface.
</span>
      </p>
      <p num="0134" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  また、ＮＲＲＬ  Ｂ−５０５５０は治療試験においてもキュウリうどんこ病に対して活性を示した。植物がマイクロプロットを覆って濃いキャノピーを形成し、天然のうどんこ病が隣接するｐｌｏｔｓｒｅｅｄに現れ始めた時点でキュウリマイクロプロットにキュウリうどんこ病を接種した。感染の６日後、接種による病害の目に見える形跡はなかった。ＮＲＲＬ  Ｂ−５０５５０の凍結乾燥粉末は実施例１３に記載するのと同様にして調製された発酵ブロスから得られた。その後凍結乾燥粉末を不活性な成分（湿潤剤、安定剤、担体、流動助剤及び分散剤）と共に処方して水和剤を作成した。処方生成物７５重量％の凍結乾燥粉末を含んでいた。水和剤を水に希釈しし、下の表１４に示す割合で１００ｇａｌ／エーカーで施用した。（注意：１エーカー当たり１００ガロンは１マイクロプロット当たり２００ｍＬの噴霧容量に換算される。）評価は上記と同じスケールで行った。<br class="style-scope patent-text">
<tables num="14" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000019" he="58" wi="140" file="2015534950.tif" img-format="tif" img-content="drawing" width="560" height="232" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
In addition, NRRL B-50550 showed activity against cucumber powdery mildew in treatment tests. Cucumber microplots were inoculated with cucumber powdery mildew when the plants covered the microplot to form a thick canopy and natural powdery mildew began to appear in the adjacent plotsed. There was no visible evidence of disease from the inoculation 6 days after infection. The lyophilized powder of NRRL B-50550 was obtained from a fermentation broth prepared as described in Example 13. The lyophilized powder was then formulated with inert ingredients (wetting agent, stabilizer, carrier, flow aid and dispersant) to make a wettable powder. The formulated product contained 75% by weight of lyophilized powder. The wettable powder was diluted in water and applied at 100 gal / acre at the rates shown in Table 14 below. (Note: 100 gallons per acre is converted to a spray volume of 200 mL per microplot.) The evaluation was made on the same scale as above. <br class="style-scope patent-text"> <tables num="14" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000019" he="58" wi="140" file="2015534950.tif" img-format="tif" img-content="drawing" width="560" height="232" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0135" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１０．  コーンルートワーム活性</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｂ−５０５５０のコーンルートワームに対する有効性を決定するために試験を行った。ＮＲＲＬ  Ｂ−５０５５０全ブロスは実施例２に記載した培地１又は培地２中で調製した。ＮＲＲＬ  Ｂ−５０５５０全ブロスを希釈し、マイクロタイタープレートで実施したダイエット−ベースアッセイ（ｄｉｅｔ−ｂａｓｅｄ  ａｓｓａｙ）においてウエスタンスポッテドキューカンバービートル（ｗｅｓｔｅｒｎ  ｓｐｏｔｔｅｄ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・ウンデシンプンクタタ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ））の幼虫に与えた。活性を評価し、実施例２に記載した１〜４のスケールで等級付けした。殺シロアリ剤／殺虫剤ＴＥＲＭＩＤＯＲ（登録商標）ＳＣ（５−アミノ−１−（２，６−ジクロロ−４（トリフルオロメチル）フェニル）−４−（（１，Ｒ，Ｓ）−（トリフルオロメチル）スルフィニル）−１−Ｈ−ピラゾール−３−カルボニトリル、一般にフィプロニルとして公知、ＢＡＳＦ）を陽性対照として使用した。結果を表１５に示す。ＮＲＲＬ  Ｂ−５０５５０は、活性成分フィプロニルを含有する殺虫剤ＴＥＲＭＩＤＯＲ（登録商標）ＳＣと同じ殺虫活性を示した。<br class="style-scope patent-text">
<tables num="15" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000020" he="104" wi="157" file="2015534950.tif" img-format="tif" img-content="drawing" width="628" height="416" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 10 A</u> test was conducted to determine the effectiveness of corn rootworm <u class="style-scope patent-text">activity</u> NRRL B-50550 against corn rootworm. NRRL B-50550 whole broth was prepared in medium 1 or medium 2 described in Example 2. NRRL B-50550 whole broth was diluted in a Western-spotted cucumber beetle (Diablotica undescunt unduncunta uncantata (Diabrotica unduncunta uncuntata) Given to larvae. Activity was evaluated and graded on a scale of 1-4 as described in Example 2. Termicide / Insecticide TERMIDOR® SC (5-Amino-1- (2,6-dichloro-4 (trifluoromethyl) phenyl) -4-((1, R, S)-(trifluoromethyl ) Sulfinyl) -1-H-pyrazole-3-carbonitrile, commonly known as fipronil, BASF) was used as a positive control. The results are shown in Table 15. NRRL B-50550 showed the same insecticidal activity as the insecticide TERMIDOR® SC containing the active ingredient fipronil. <br class="style-scope patent-text"> <tables num="15" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000020" he="104" wi="157" file="2015534950.tif" img-format="tif" img-content="drawing" width="628" height="416" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0136" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１１．  薬量／応答実験室アッセイ</u> <br class="style-scope patent-text">
  いろいろな薬量のＮＲＲＬ  Ｂ−５０５５０に対するＴＳＳＭの応答を決定するために研究を行った。全ブロスは実施例５に記載したように調製した。得られた全ブロスを水及び０．３５％界面活性剤を用いて下記表１３に示すパーセントに希釈した。水及び０．３５％界面活性剤を対照処理として使用した。２つの別個のトライアルで、１つの薬量当たり４つの複製を用いて、全ブロス溶液及び対照処理をライマメ葉の下の表面に流れ出すまで施用した。かかる処理の１日後植物に５０−１００のＴＳＳＭを寄生させ、処理の５日後ダニ及び卵の存在を前記したスケールで評価した。結果を下記表１６に示す。<br class="style-scope patent-text">
<tables num="16" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000021" he="46" wi="156" file="2015534950.tif" img-format="tif" img-content="drawing" width="624" height="184" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 11</u> Dose <u class="style-scope patent-text">/ Response Laboratory Assay A</u> study was conducted to determine the response of TSSM to various doses of NRRL B-50550. All broths were prepared as described in Example 5. The resulting total broth was diluted with water and 0.35% surfactant to the percentages shown in Table 13 below. Water and 0.35% surfactant were used as control treatments. In two separate trials, using 4 replicates per dose, the whole broth solution and the control treatment were applied until it flowed to the lower surface of the lima bean leaves. One day after such treatment, plants were parasitized with 50-100 TSSM, and five days after treatment, the presence of ticks and eggs was evaluated on the scale described above. The results are shown in Table 16 below. <br class="style-scope patent-text"> <tables num="16" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000021" he="46" wi="156" file="2015534950.tif" img-format="tif" img-content="drawing" width="624" height="184" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0137" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  試験した最低の濃度（０．２０％全ブロス）で、処理のエラーバーに基づいて対照処理と比較して有意な死亡率が観察された。ＮＲＲＬ  Ｂ−５０５５０の施用に関連する効果の部分は、ダニが植物を離れて去って行くようにさせることであることが観察された。すなわち、致死量以下の薬量でも、ＮＲＲＬ  Ｂ−５０５５０は植物上のダニ集団を低減させ得る。
</span>
&nbsp;&nbsp;At the lowest concentration tested (0.20% total broth), significant mortality was observed compared to control treatments based on treatment error bars. It has been observed that part of the effect associated with the application of NRRL B-50550 is to let the mites leave the plant away. That is, NRRL B-50550 can reduce tick populations on plants even at sub-lethal doses.
</span>
      </p>
      <p num="0138" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１２．  アバメクチン−抵抗性ハダニに対する活性</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｂ−５０５５０のアバメクチン−抵抗性ナミハダニ（テトラニカス・ウルチカエ（Ｔｅｔｒａｎｙｃｈｕｓ  ｕｒｔｉｃａｅ）ＮＬ株）に対する活性を野生型のナミハダニ（テトラニカス・ウルチカエ（Ｔｅｔｒａｎｙｃｈｕｓ  ｕｒｔｉｃａｅ）ＲＷ株）と比較して決定するために研究を行った。フレンチビーン（サヤエンドウ）植物を、実施例９の最終段落に記載したように調製したＮＲＲＬ  Ｂ−５０５５０の発酵産物の水和剤によって、下記表１７に示す希釈後の割合で処理した。処理の１日前に植物に５０−１００の株ＮＬ又はＲＷを寄生させ、処理の７日及び１４日後にダニの存在を評価した。結果を下記表１７に示す。<br class="style-scope patent-text">
<tables num="17" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000022" he="90" wi="168" file="2015534950.tif" img-format="tif" img-content="drawing" width="672" height="360" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 12 Activity against Abamectin-resistant spider mite</u> NRRL B-50550 has <u class="style-scope patent-text">an activity against</u> Abamectin-resistant spider mite (Tetranychus urticae NL strain) compared with wild-type Nite spider mite (Tetranychus urticae) RW strain A study was conducted to determine. French bean plants were treated with the NRRL B-50550 fermentation product wettable powder prepared as described in the last paragraph of Example 9 in the proportions after dilution shown in Table 17 below. Plants were infested with 50-100 strains NL or RW one day before treatment and the presence of ticks was assessed after 7 and 14 days of treatment. The results are shown in Table 17 below. <br class="style-scope patent-text"> <tables num="17" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000022" he="90" wi="168" file="2015534950.tif" img-format="tif" img-content="drawing" width="672" height="360" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0139" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１３．  増大したレベルのグーゲロチンを含有する発酵産物−グリシンの使用</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｂ−５０５５０のグーゲロチン産生及び殺ダニ活性を最適化するために発酵を行った。１０．０ｇ／Ｌデンプン、１５．０ｇ／Ｌグルコース、１０．０ｇ／Ｌ酵母エキス、１０．０ｇ／Ｌカゼイン加水分解物（又は１０．０ｇ／Ｌ大豆ペプトン）及び２．０ｇ／ＬＣａＣＯ<sub class="style-scope patent-text">３</sub>からなる培地を用いて、実施例１に記載したように、２Ｌ振盪フラスコ中２０−３０℃で初期種培養物を調製した。約１−２日後、振盪フラスコ内で菌糸増殖が豊富になったとき、中味を新たな培地（上記と同じ、０．１％消泡剤を含む）に移し、４００Ｌの発酵槽において２０−３０℃で増殖させた。約２０−３０時間後、豊富な菌糸増殖が見られるとき、中味を３０００Ｌの発酵槽に移し、８０．０ｇ／Ｌ（８．０％）マルトデキストリン、３０．０ｇ／Ｌ（３．０％）グルコース、１５．０ｇ／Ｌ（１．５％）酵母エキス、２０．０ｇ／Ｌ（２．０％）大豆酸加水分解物、１０．０ｇ／Ｌ（１．０％）グリシン及び２．０ｇ／Ｌ（０．２％）炭酸カルシウム並びに２．０ｍｌ／Ｌ消泡剤からなる培地中で１６０−２００時間２０−３０℃で増殖させた。<br class="style-scope patent-text">
<tables num="18" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000023" he="46" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="184" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 13 Fermentation product containing increased levels of gougerotin</u> - <u class="style-scope patent-text">use of glycine</u> Fermentation was performed to optimize gougerotin production and acaricidal activity of NRRL B-50550. Consists of 10.0 g / L starch, 15.0 g / L glucose, 10.0 g / L yeast extract, 10.0 g / L casein hydrolyzate (or 10.0 g / L soy peptone) and 2.0 g / LCaCO <sub class="style-scope patent-text">3</sub> An initial seed culture was prepared at 20-30 ° C. in a 2 L shake flask as described in Example 1 using media. After about 1-2 days, when the mycelial growth was abundant in the shake flask, the contents were transferred to a fresh medium (same as above, containing 0.1% antifoam) and 20-30 in a 400 L fermentor. Grow at ℃. When abundant mycelial growth is seen after about 20-30 hours, the contents are transferred to a 3000 L fermentor, 80.0 g / L (8.0%) maltodextrin, 30.0 g / L (3.0%) Glucose, 15.0 g / L (1.5%) yeast extract, 20.0 g / L (2.0%) soy acid hydrolyzate, 10.0 g / L (1.0%) glycine and 2.0 g / The cells were grown at 20-30 ° C. for 160-200 hours in a medium consisting of L (0.2%) calcium carbonate and 2.0 ml / L antifoam. <br class="style-scope patent-text"> <tables num="18" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000023" he="46" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="184" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0140" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  第１の３０００Ｌ発酵を一例として用いて、発酵槽におけるグーゲロチンの収量は次のようにして計算される。３３９７ｋｇ×１．７ｍｇ／ｇ発酵ブロス＝５７７４．９０ｇグーゲロチン＝５．７８ｋｇ。発酵槽の初期の量は３４９６ｋｇ（３２５６ｋｇ培地＋２４０ｋｇシード）であり、これが標的の容量３０００Ｌより大きい最終容量となった。標的容量３０００Ｌは生産培地中の全ての成分の量を計算するための基礎となるので、規格化された容量測定生産性は５７７４．９ｇ／３０００Ｌ＝１．９ｇ／Ｌである。このグーゲロチン濃度は、上記と同じ培地を用い、最終発酵ステップ及び培地は（アミノ酸として）グリシンを含有させて行う２０Ｌ発酵で達成される１．８ｇ／Ｌと同様であった。
</span>
&nbsp;&nbsp;Using the first 3000L fermentation as an example, the yield of gougerotin in the fermentor is calculated as follows. 3397 kg × 1.7 mg / g fermentation broth = 5774.90 g gougerotin = 5.78 kg. The initial amount of fermentor was 3496 kg (3256 kg medium + 240 kg seed), which resulted in a final volume greater than the target volume of 3000 L. Since the target volume of 3000 L is the basis for calculating the amount of all components in the production medium, the normalized volumetric productivity is 5764.9 g / 3000 L = 1.9 g / L. This gougerotin concentration was similar to 1.8 g / L achieved in a 20 L fermentation using the same medium as above, with the final fermentation step and medium containing glycine (as amino acid).
</span>
      </p>
      <p num="0141" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本出願を通じて、グーゲロチンレベルは後に実施例１６及び１９で記載する分析ＨＰＬＣクロマトグラフィーを用いて検出される。
</span>
&nbsp;&nbsp;Throughout this application, gougerotin levels are detected using analytical HPLC chromatography as described later in Examples 16 and 19.
</span>
      </p>
      <p num="0142" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１４．  増大したレベルのグーゲロチンを含有する発酵産物−グルタミン酸の使用</u> <br class="style-scope patent-text">
  ＮＲＲＬ  Ｎｏ．  Ｂ−５０５５０のグーゲロチン産生及び殺ダニ活性を最適化するために発酵を行った。実施例１に記載したように、１０．０ｇ／Ｌデンプン、１５．０ｇ／Ｌグルコース、１０．０ｇ／Ｌ酵母エキス、１０．０ｇ／Ｌカゼイン加水分解物（又は１０．０ｇ／Ｌ大豆ペプトン）及び２．０ｇ／ＬＣａＣＯ<sub class="style-scope patent-text">３</sub>からなる培地を用い、１Ｌ振盪フラスコにおいて２０−３０℃で初期種培養物を調製した。約１−２日後、振盪フラスコ内で豊富な菌糸増殖があるとき、中味を新たな培地（上記と同じ、０．１％消泡剤を含む）に移し、１Ｌ振盪フラスコ内で２０−３０℃で増殖させた。約２０−３０時間後、豊富な菌糸増殖が見られるとき、中味を２０Ｌ発酵槽に移し、１６０−２００時間２０−３０℃で６０．０ｇ／Ｌ（８．０％）デンプン、３０．０ｇ／Ｌ（３．０％）デキストロース、１５．０ｇ／Ｌ（１．５％）酵母エキス、２０．０ｇ／Ｌ（２．０％）大豆酸加水分解物、１２．０ｇ／Ｌ（１．０％）Ｌ−グルタミン酸及び２．０ｇ／Ｌ（０．２％）炭酸カルシウム並びに２．０ｍＬ／Ｌ消泡剤からなる培地中で増殖させた。
</span> <u class="style-scope patent-text">Example 14 Fermentation products containing increased levels of gougerotin-Use of glutamic acid</u> NRRL No. Fermentation was performed to optimize B-50550's gougerotin production and acaricidal activity. As described in Example 1, 10.0 g / L starch, 15.0 g / L glucose, 10.0 g / L yeast extract, 10.0 g / L casein hydrolyzate (or 10.0 g / L soy peptone) And an initial seed culture at 20-30 ° C. in a 1 L shake flask using a medium consisting of 2.0 g / LCaCO <sub class="style-scope patent-text">3</sub> . After about 1-2 days, when there is abundant mycelium growth in the shake flask, the contents are transferred to fresh medium (same as above, containing 0.1% antifoam) and 20-30 ° C. in a 1 L shake flask. Was grown on. After about 20-30 hours, when abundant mycelium growth is seen, the contents are transferred to a 20 L fermentor and 160-200 hours at 20-30 ° C. 60.0 g / L (8.0%) starch, 30.0 g / L (3.0%) dextrose, 15.0 g / L (1.5%) yeast extract, 20.0 g / L (2.0%) soybean acid hydrolyzate, 12.0 g / L (1.0% ) Grown in medium consisting of L-glutamic acid and 2.0 g / L (0.2%) calcium carbonate and 2.0 mL / L antifoam.</span>
      </p>
      <p num="0143" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  この発酵においてアミノ酸としてＬ−グルタミン酸を用いるこのグーゲロチン濃度は１．１ｇ／Ｌであった。
</span>
&nbsp;&nbsp;This gougerotin concentration using L-glutamic acid as an amino acid in this fermentation was 1.1 g / L.
</span>
      </p>
      <p num="0144" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１５．  増大したレベルのグーゲロチンを含有する発酵産物−ヌクレオチドの使用</u> <br class="style-scope patent-text">
  理論に縛られるつもりはないが、本出願人は、図６の仮想の合成経路により示されるように、シトシンの利用可能性がグーゲロチンの産生に極めて重要であると仮定する。すなわち、培地中に供給されるシトシンのレベルを増大すると、得られるグーゲロチンの量も増大するはずである。本出願人は、シトシン、チミン及び／又はウラシルを加えた培地中でのストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｂ−５０５５０によるグーゲロチン産生を試験した。具体的には、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｂ−５０５５０を、２Ｌ振盪フラスコにおいて、２０．０ｇ／Ｌマルトデキストリン、１０．０ｇ／Ｌグルコース、５．０ｇ／Ｌ酵母エキス、６．０ｇ／Ｌ大豆タンパク質酸加水分解物、２．０ｇ／Ｌグリシン、１．０ｇ／ＬＣａＣＯ<sub class="style-scope patent-text">３</sub>及びシトシン、ウラシル及び／又はチミン（各々０又は０．５０ｇ／Ｌの濃度）からなる培地中で６日間２０−３０℃で増殖させた。結果を下の表１９に示す。<br class="style-scope patent-text">
<tables num="19" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000024" he="89" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="356" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 15. While</u> not intending to be bound by the theory <u class="style-scope patent-text">of use of fermented product-nucleotides that contain increased levels of gougerotin, the Applicant believes that</u> the availability of cytosine is the production of gougerotin, as shown by the hypothetical synthetic pathway of FIG. Is extremely important. That is, increasing the level of cytosine supplied in the medium should increase the amount of gougerotin obtained. Applicants tested gougerotin production by Streptomyces microflavus B-50550 in medium supplemented with cytosine, thymine and / or uracil. Specifically, Streptomyces microflavus B-50550 in a 2 L shake flask, 20.0 g / L maltodextrin, 10.0 g / L glucose, 5.0 g / L yeast extract, 6.0 g / L soy protein acid hydrolyzate, 2.0 g / L glycine, 1.0 g / LCaCO <sub class="style-scope patent-text">3</sub> and cytosine, uracil and / or thymine (concentration of 0 or 0.50 g / L, respectively) for 6 days 20 Grow at -30 ° C. The results are shown in Table 19 below. <br class="style-scope patent-text"> <tables num="19" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000024" he="89" wi="165" file="2015534950.tif" img-format="tif" img-content="drawing" width="660" height="356" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0145" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１６．  グーゲロチンを過剰生産する突然変異体</u> <br class="style-scope patent-text">
  グーゲロチンの産生及び生物活性を増大する目的で、個々の抗生物質（ゲンタマイシン、リファンピシン、ストレプトマイシン、パロモマイシン又はトブラマイシン）に抵抗性の突然変異体のライブラリーを生成させる抗生物質−抵抗性突然変異体スクリーニングプログラムにより、親の菌株ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｎｏ．Ｂ−５０５５０から突然変異体を創成した。Ｏｋａｍｏｔｏ−Ｈｏｓｏｙａ、Ｙ．、ｅｔ  ａｌ．、Ｔｈｅ  Ｊｏｕｒｎａｌ  ｏｆ  Ａｎｔｉｂｉｏｔｉｃｓ  ４３（１２）  Ｄｅｃ  ２０００参照。Ｎ−メチル−Ｎ’−ニトロ−Ｎ−ニトロソグアニジン（「ＮＴＧ」）を用いて親の菌株を突然変異誘発に付した後、得られた抗生物質抵抗性突然変異体を選択しスクリーニングした。さらなる研究のためにグーゲロチンを過剰生産する菌株を選抜した突然変異体ライブラリーの創成及びスクリーニングの詳細な説明を以下に記載する。
</span> <u class="style-scope patent-text">Example 16</u> Antibiotics that generate libraries of mutants that are resistant to individual antibiotics (gentamicin, rifampicin, streptomycin, paromomycin or tobramycin) for the purpose of increasing the production and biological activity of <u class="style-scope patent-text">mutant gougerotins that overproduce gougerotin</u> Resistant mutant screening program allows the parental strain Streptomyces microflavus NRRL No. A mutant was created from B-50550. Okamoto-Hosoya, Y. et al. Et al. , The Journal of Antibiotics 43 (12) Dec 2000. After subjecting the parental strain to mutagenesis using N-methyl-N′-nitro-N-nitrosoguanidine (“NTG”), the resulting antibiotic-resistant mutants were selected and screened. A detailed description of the creation and screening of mutant libraries that select for strains that overproduce gougerotin for further study is set forth below.</span>
      </p>
      <p num="0146" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｂ−５０５５０の胞子懸濁液を、およそ１４日増殖させたか又は胞子形成させたＢ−５０５５０を含有する大豆粉マルトース（ＳＦＭ）寒天プレートから調製し、−８０℃で２０％グリセロール中に保存した。適切なバッファーに溶解させたＮＴＧを、５０％死滅を得るのに適した量（０．５ｍｇ／ｍＬ、ｐＨ８．５、１時間３７℃でゆっくり振盪した）で胞子懸濁液に加えた。その後、ＮＴＧで処理した胞子懸濁液を、以下の濃度の抗生物質を補充したＧＹＭ（グルコース４ｇ／Ｌ、酵母エキス４ｇ／Ｌ、麦芽エキス１０ｇ／Ｌ、及び寒天１２ｇ／Ｌ）に蒔いた。下記表２０参照。<br class="style-scope patent-text">
<tables num="20" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000025" he="54" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="216" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
A spore suspension of Streptomyces microflavus B-50550 was prepared from soy flour maltose (SFM) agar plates containing B-50550 grown or sporulated for approximately 14 days, -80 Stored in 20% glycerol at 0C. NTG dissolved in the appropriate buffer was added to the spore suspension in an amount appropriate to obtain 50% kill (0.5 mg / mL, pH 8.5, shaken slowly at 37 ° C. for 1 hour). Thereafter, the spore suspension treated with NTG was seeded in GYM (glucose 4 g / L, yeast extract 4 g / L, malt extract 10 g / L, and agar 12 g / L) supplemented with the following concentrations of antibiotics. See Table 20 below. <br class="style-scope patent-text"> <tables num="20" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000025" he="54" wi="158" file="2015534950.tif" img-format="tif" img-content="drawing" width="632" height="216" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0147" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
Ｋｉｅｓｅｒ、Ｔ．、ｅｔ  ａｌ．、Ｐｒａｃｔｉｃａｌ  Ｓｔｒｅｐｔｏｍｙｃｅｓ  Ｇｅｎｅｔｉｃｓ、Ｃｈ．  ５  Ｊｏｈｎ  Ｉｎｅｓ  Ｃｅｎｔｒｅ  Ｎｏｒｗｉｃｈ  Ｒｅｓｅａｒｃｈ  Ｐａｒｋ、Ｅｎｇｌａｎｄ  （２０００）、ｐｐ．  ９９−１０７参照。以下に記載するようにおよそ３５０の個々の抗生物質抵抗性コロニーを単離し、精製し、スクリーニングした。
</span>
Kieser, T .; Et al. Practical Streptomyces Genetics, Ch. 5 John Ins Center Norwich Research Park, England (2000), pp. 199 99-107. Approximately 350 individual antibiotic resistant colonies were isolated, purified and screened as described below.
</span>
      </p>
      <p num="0148" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ＧＹＭ抗生物質プレートから取り出した各々の単離菌をＳＦＭ寒天プレートに再度蒔いた。抗生物質抵抗性細菌を含有する寒天プラグを用いて、２．５ｍＬのシード培地を含有する２４−ウェルブロックに接種した。これらの接種したブロック中の細菌を３日間増殖させ、得られた培養ブロスを用いて生産培地を含有する２４−ウェルブロックに接種した。生産ブロック中の細菌を７日間２８℃で増殖させた。シードブロックの各ウェルはトリプシンａｓｅ  Ｓｏｙ  Ｂｒｏｔｈ（ＴＳＢ）（ＤＩ  Ｈ<sub class="style-scope patent-text">２</sub>Ｏ  １リットル当たり：１７ｇのＢａｃｔｏ  Ｔｒｙｐｔｏｎｅ（カゼインの膵液消化物）、３ｇのＢａｃｔｏ  Ｓｏｙｔｏｎｅ（大豆粕の膵液消化物）、２．５ｇのデキストロース、５ｇのＮａＣｌ、２．５ｇのリン酸二カリウム）を含有し、生産ブロックの各ウェルは実施例２の培地２（Ｐｒｏｆｌｏ  ２０ｇ／Ｌ、麦芽エキス２０ｇ／Ｌ、一塩基性ＫＨ<sub class="style-scope patent-text">２</sub>ＰＯ<sub class="style-scope patent-text">４</sub>６ｇ／Ｌ、二塩基性Ｋ<sub class="style-scope patent-text">２</sub>ＨＰＯ<sub class="style-scope patent-text">４</sub>４．８ｇ／Ｌ）を含有していた。
</span>Each isolate removed from the GYM antibiotic plate was plated again on an SFM agar plate. Agar plugs containing antibiotic resistant bacteria were used to inoculate 24-well blocks containing 2.5 mL seed medium. The bacteria in these inoculated blocks were grown for 3 days and the resulting culture broth was used to inoculate 24-well blocks containing production medium. Bacteria in the production block were grown for 7 days at 28 ° C. Each well of the seed block contains trypsin as Soy Broth (TSB) (per liter of DI H <sub class="style-scope patent-text">2</sub> O: 17 g Bacto Tryptone (casein pancreatic juice digest), 3 g Bacto Soytone (soybean meal pancreatic juice digest), 2.5 g Of dextrose, 5 g NaCl, 2.5 g dipotassium phosphate) and each well of the production block was medium 2 from Example 2 (Proflo 20 g / L, malt extract 20 g / L, monobasic KH <sub class="style-scope patent-text">2</sub> PO <sub class="style-scope patent-text">4</sub> 6 g / L, dibasic K <sub class="style-scope patent-text">2</sub> HPO <sub class="style-scope patent-text">4</sub> 4.8 g / L).</span>
      </p>
      <p num="0149" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  生産ブロックの各々のウェルの全ブロスを、以下のように分析用ＨＰＬＣクロマトグラフィーを用いてグーゲロチン産生に関して試験した。２．４ｍＬの水を生産ブロックの各々のウェルに加えた。ブロックをボルテックスし、遠心分離した。０．８ｍＬの上清を、ウェル当たり４ｍＬの水を含有する抽出ブロックに移した。生産ブロックの各々のウェル内の細胞ペレットに３．２ｍＬの水を加え、ブロックを再度ボルテックスし、遠心分離した。この３．２ｍＬの洗浄水はその後各々の抽出ブロックの適当なウェルに加えた。次に、分析用ＨＰＬＣクロマトグラフィーを用いて抽出ブロック中の水性エキスのグーゲロチン含有率をアッセイした。具体的には、Ｄｉａｍｏｎｄ  Ｈｙｄｒｉｄガードカラムを備えたＣｏｇｅｎｔ  Ｄｉａｍｏｎｄハイブリッドカラム（１００Ａ、４μｍ、１５０×４．６ｍｍ）にサンプルを注入した。カラムを３０分アセトニトリル／ＮＨ<sub class="style-scope patent-text">４</sub>ＯＡＣ勾配（以下参照）で溶出した。流量は１ｍＬ／ｍｉｎであった。グーゲロチンは２５４ｎｍで検出した。グーゲロチンは１９分の概略保持時間で単一のピークとして溶出する。最高の過剰生産突然変異体は、２４ウェルブロック及び２５０ｍＬフラスコの両方で再度増殖させてグーゲロチンレベルを確認することによって確認した。確認されたら幾つかの単離株を少なくとももう一回突然変異誘発及び抗生物質抵抗性スクリーニングのラウンドに付した。各々の次の抗生物質−スクリーニングと併せた突然変異誘発のラウンドは、誘導された単離株が前のラウンドで抵抗性を示さなかった残存する抗生物質を用いて行った。スクリーニングの単一のラウンド後にグーゲロチン産生の小さい（１．２×）上昇が見られ、次のラウンドでは同じ元の低レベル過剰生産株から生じた単離株でより大きい上昇となった。この元の低レベル過剰生産株はこれらの研究で基本培地を用いて小規模に培養したとき約０．３ｍｇ／ｇのグーゲロチンを産生した。図３参照。
</span>All broths in each well of the production block were tested for gougerotin production using analytical HPLC chromatography as follows. 2.4 mL of water was added to each well of the production block. The block was vortexed and centrifuged. 0.8 mL of the supernatant was transferred to an extraction block containing 4 mL of water per well. 3.2 mL of water was added to the cell pellet in each well of the production block, and the block was vortexed again and centrifuged. This 3.2 mL of wash water was then added to the appropriate well of each extraction block. The aqueous extract in the extraction block was then assayed for gougerotin content using analytical HPLC chromatography. Specifically, the sample was injected into a Coagent Diamond hybrid column (100A, 4 μm, 150 × 4.6 mm) equipped with a Diamond Hydrod guard column. The column was eluted with an acetonitrile / NH <sub class="style-scope patent-text">4</sub> OAC gradient (see below) for 30 minutes. The flow rate was 1 mL / min. Gougerotin was detected at 254 nm. Gougerotin elutes as a single peak with an approximate retention time of 19 minutes. The highest overproduction mutant was confirmed by re-growing both in a 24 well block and a 250 mL flask to check for gougerotin levels. Once confirmed, several isolates were subjected to at least one more round of mutagenesis and antibiotic resistance screening. A round of mutagenesis in conjunction with each subsequent antibiotic-screen was performed with the remaining antibiotic that the induced isolate did not show resistance in the previous round. There was a small (1.2 ×) increase in gougerotin production after a single round of screening, with a larger increase in isolates resulting from the same original low level overproducing strain in the next round. This original low-level overproducing strain produced about 0.3 mg / g gougerotin when cultured on a small scale using basal media in these studies. See FIG.</span>
      </p>
      <p num="0150" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  より高くグーゲロチンを産生しＳＦＭ寒天プレートで胞子形成する能力を有する選択された突然変異体を１Ｌのバッフル付き振盪フラスコで増殖させ、その後培地２を含有する５ＬのＳａｒｔｏｒｉｕｓ  Ｂ＋バイオリアクター及び／又は２０Ｌのバイオリアクターにスケールアップした。図４参照。
</span>
&nbsp;&nbsp;Selected mutants with higher ability to produce gougerotin and sporulate on SFM agar plates are grown in 1 L baffled shake flasks, followed by 5 L Sartorius B + bioreactor containing medium 2 and / or 20 L Scaled up to bioreactor. See FIG.
</span>
      </p>
      <p num="0151" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  図３及び４でラウンド３単離株４とされている菌株を、実施例１３に記載する方法に従うスケールアップのために選択した。この菌株は３．８ｍｇ／ｇのグーゲロチンを含有する発酵ブロスを生じた。
</span>
&nbsp;&nbsp;The strain designated as Round 3 isolate 4 in FIGS. 3 and 4 was selected for scale-up according to the method described in Example 13. This strain yielded a fermentation broth containing 3.8 mg / g gougerotin.
</span>
      </p>
      <p num="0152" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１７．  変換率：全ブロス／凍結乾燥粉末</u> <br class="style-scope patent-text">
  表２１に、実施例１３に記載したように調製したＢ−５０５５０の全ブロスの幾つかのロットに対する全ブロス／凍結乾燥粉末の変換率を示す。これらの計算では、全ブロスが凍結乾燥粉末及び１ｇ／ｍＬの全ブロスの密度に完全に変換されると仮定している。（注意：何も後処理しないうちの発酵ブロスの密度は約１ｇ／ｍｌである。）「平均％」はあるロットの全ブロスから得られた凍結乾燥粉末の重量平均パーセントである。<br class="style-scope patent-text">
<tables num="21" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000026" he="38" wi="170" file="2015534950.tif" img-format="tif" img-content="drawing" width="680" height="152" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 17. Conversion rate: Total broth / lyophilized powder</u> Table 21 shows the conversion rate of total broth / lyophilized powder for several lots of B-50550 total broth prepared as described in Example 13. These calculations assume that the entire broth is completely converted to a lyophilized powder and a density of 1 g / mL total broth. (Note: The density of the fermentation broth without any post-treatment is about 1 g / ml.) “Average%” is the weight average percentage of lyophilized powder obtained from all broths in a lot. <br class="style-scope patent-text"> <tables num="21" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000026" he="38" wi="170" file="2015534950.tif" img-format="tif" img-content="drawing" width="680" height="152" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0153" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１８．  他のストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株−発酵及びダニ防除方法</u> <br class="style-scope patent-text">
  実施例１３に記載したのと同様な条件を用いてストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）の幾つかの菌株を培養した。全ての菌株は、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株のＧｏｕＡ−Ｍ又はＧｏｕＢ−Ｍタンパク質（例えば．、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、及び配列番号：３０）に対して少なくとも約９０％の配列同一性を有するアミノ酸配列をコードするグーゲロチン生合成遺伝子クラスターをもっていた。菌株の呼称及び実施例１３に記載した方法に準じて（しかし、より小さい規模で）調製した発酵ブロスのグーゲロチン濃度を下記表２２に示す。（濃度ｇ／Ｌに関し、後処理前の発酵ブロスの密度を約１ｇ／ｍｌとしている。）<br class="style-scope patent-text">
<tables num="22" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000027" he="39" wi="159" file="2015534950.tif" img-format="tif" img-content="drawing" width="636" height="156" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
 <u class="style-scope patent-text">Example 18 Other Streptomyces strains-fermentation and tick control methods</u> Several strains of Streptomyces were cultured using conditions similar to those described in Example 13. All strains are GouA-M or GouB-M proteins of Streptomyces microflavus NRRL B-50550 strain (eg, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, and SEQ ID NO: 30) And had a gougerotin biosynthetic gene cluster encoding an amino acid sequence having at least about 90% sequence identity. Table 22 below shows the gougerotin concentration of the fermentation broth prepared according to the name of the strain and the method described in Example 13 (but on a smaller scale). (Regarding the concentration g / L, the density of the fermentation broth before post-treatment is about 1 g / ml.) <br class="style-scope patent-text"> <tables num="22" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000027" he="39" wi="159" file="2015534950.tif" img-format="tif" img-content="drawing" width="636" height="156" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0154" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
グリシンを加えたか又は加えない発酵培地で上記菌株を増殖させた別の実験を行った。グリシンの添加により、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株ではグーゲロチン産生が倍増したが、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）Ｂ株又はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ｂ株のグーゲロチン産生には殆ど効果がなかった。
</span>
Another experiment was conducted in which the strain was grown in a fermentation medium with or without glycine. The addition of glycine doubled gougerotin production in the Streptomyces puniceus A strain, but the Streptomyces microflavus B strain or the Streptomyces pnepus Had little effect.
</span>
      </p>
      <p num="0155" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  水及び界面活性剤で希釈した上記全ブロス（約１．０ｍｇ／ｇのグーゲロチンを有する）を用い、前記実施例２に記載したナミハダニ（ＴＳＳＭ）実験室アッセイを用いて、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株の発酵ブロスをスクリーニングした。ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株及びストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株に対する結果を下記表２３に示す。<br class="style-scope patent-text">
<tables num="23" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000028" he="67" wi="144" file="2015534950.tif" img-format="tif" img-content="drawing" width="576" height="268" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
Using the above broth diluted with water and surfactant (with approximately 1.0 mg / g gougerotin), using the urticae (TSSM) laboratory assay described in Example 2 above, Streptomyces puniseius ( Streptomyces puniceus) strain A fermentation broth was screened. The results for Streptomyces puniceus A strain and Streptomyces microflavus NRRL B-50550 strain are shown in Table 23 below. <br class="style-scope patent-text"> <tables num="23" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000028" he="67" wi="144" file="2015534950.tif" img-format="tif" img-content="drawing" width="576" height="268" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0156" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">実施例１９．  グーゲロチン遺伝子クラスターの機能を確認するためにＮＲＲＬ  Ｂ−５０５５０のグーゲロチン遺伝子クラスターをノックアウトする</u> <br class="style-scope patent-text">
  推定上の遺伝子クラスターがグーゲロチンの発現を担っていることを確認するために研究を行った。ブラストサイジンのシトシニンシンターゼと類似のアミノトランスフェラーゼ遺伝子（ＯＲＦ４２５８）、シトシルグルクロン酸シンターゼ遺伝子（ＯＲＦ４２６１）、及びＵＤＰ−グルクロン酸の産生に関与するかもしれないデヒドロゲナーゼ／ヒドロキシイソブチレート（ＯＲＦ４２５３）、プラスコード領域の上流の３００ヌクレオチドを含有する３つの構築体をＮＲＲＬ  Ｂ−５０５５０ゲノムＤＮＡから生成した。理論に縛られることは望まないが、本出願人は、アミノトランスフェラーゼ遺伝子（ＯＲＦ４２５８）及びシトシルグルクロン酸シンターゼ遺伝子（ＯＲＦ４２６１）はグーゲロチン生合成の経路の比較的早期に必要とされると仮定する。ＯＲＦ４２５８とＯＲＦ４２６１はゲノム内で互いに近接しており、また遺伝子クラスターの中央に位置しているので、デヒドロゲナーゼ遺伝子（ＯＲＦ４２５３）はＵＤＰ−グルクロン酸の産生に関与するかもしれない。本出願人は、この酵素も経路内で早期に必要とされると仮定する。
</span> <u class="style-scope patent-text">Example 19. To confirm the function of the gougerotin gene cluster</u> , a study was conducted to confirm that <u class="style-scope patent-text">the putative gene cluster knocking out the gougerotin gene cluster of NRRL B-50550</u> is responsible for the expression of gougerotin. An aminotransferase gene (ORF4258) similar to the cytosine synthase of blasticidin, a cytosyl glucuronic acid synthase gene (ORF 4261), and a dehydrogenase / hydroxyisobutyrate (ORF 4253) that may be involved in the production of UDP-glucuronic acid, Three constructs containing 300 nucleotides upstream of the plus coding region were generated from NRRL B-50550 genomic DNA. While not wishing to be bound by theory, Applicants postulate that the aminotransferase gene (ORF4258) and the cytosyl glucuronic acid synthase gene (ORF4261) are required relatively early in the pathway for gougerotin biosynthesis. Since ORF4258 and ORF4261 are close to each other in the genome and are located in the middle of the gene cluster, the dehydrogenase gene (ORF4253) may be involved in the production of UDP-glucuronic acid. Applicants assume that this enzyme is also required early in the pathway.</span>
      </p>
      <p num="0157" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  使用した細菌菌株及びベクターを表２４に示す。ＤＮＡ断片をプラスミドベクター中でサブクローニングするための制限酵素部位を含有するプライマーは配列番号：４４−７５として提供される。<br class="style-scope patent-text">
<tables num="24" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000029" he="53" wi="166" file="2015534950.tif" img-format="tif" img-content="drawing" width="664" height="212" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
The bacterial strains and vectors used are shown in Table 24. Primers containing restriction enzyme sites for subcloning DNA fragments in plasmid vectors are provided as SEQ ID NOs: 44-75. <br class="style-scope patent-text"> <tables num="24" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000029" he="53" wi="166" file="2015534950.tif" img-format="tif" img-content="drawing" width="664" height="212" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0158" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン遺伝子クラスター配列が正しいことを確認するために、ＰＣＲ及び配列確認のための７対のプライマーを設計した（配列番号：４４−５７）。ＰＣＲ産物のＤＮＡ抽出はＱｉａｇｅｎゲノムＤＮＡ抽出キットプロトコルに従った。ゲノムＤＮＡ及びいろいろなプライマー対のための熱サイクルパラメーターは、９５℃で１５分、次に３５サイクルの９５℃で１分、５８℃で１分及び７２℃で１分、その後７２℃で１０分であり、４℃で貯蔵した。ＰＣＲ産物をアガロースゲルの電気泳動で分離し（図９参照）、また配列確認のために送った。ＰＣＲ産物の大きさ及び配列結果により、グーゲロチン遺伝子クラスター配列が正しいことが確認され、そのようにプライマーを設計してノックアウト実験を行った。
</span>
&nbsp;&nbsp;In order to confirm that the gougerotin gene cluster sequence was correct, 7 pairs of primers for PCR and sequence confirmation were designed (SEQ ID NO: 44-57). DNA extraction of PCR products followed the Qiagen genomic DNA extraction kit protocol. Thermal cycling parameters for genomic DNA and various primer pairs are 15 minutes at 95 ° C, then 35 cycles of 95 ° C for 1 minute, 58 ° C for 1 minute and 72 ° C for 1 minute, then 72 ° C for 10 minutes. And stored at 4 ° C. PCR products were separated by agarose gel electrophoresis (see FIG. 9) and sent for sequence confirmation. The size of the PCR product and the sequence result confirmed that the gougerotin gene cluster sequence was correct, and the primer was designed in that way and a knockout experiment was performed.
</span>
      </p>
      <p num="0159" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">クロスオーバーのためのカセット構築</u> <br class="style-scope patent-text">
  特定の遺伝子をノックアウトするために、特異的な制限酵素部位を含有する上流及び下流のプライマーを設計した（配列番号：６０−７５参照）。遺伝子上流では、フォワードプライマーはＥｃｏＲＩ部位（ＧＡＡＴＴＣ）を、リバースプライマーはＫｐｎＩ部位（ＧＧＴＡＣＣ）を用いた。遺伝子下流では、フォワードプライマーはＸｂａＩ部位（ＴＣＴＡＧＡ）を、リバースプライマーはＨｉｎｄＩＩＩ（ＡＡＧＣＴＴ）部位を用いた。中央では、カナマイシン抵抗性遺伝子を選択マーカーとして加えた。構築体は全てｐＵＣ１１８ベクター（図１０）にクローニングした。上流及び下流にカナマイシン抵抗性及びノックアウト遺伝子を含有するカセットを、上流及び下流の配列を配列決定することによって確認した。カセットをＨｉｎｄＩＩＩ及びＥｃｏＲＩで消化し、カナマイシンを選択マーカーとして有するｐＫＣ１１３９シャトルベクター（図１１）にクローニングした。ｐＫＣ１１３９：：Ｃ<sub class="style-scope patent-text">ｕｐ</sub>ＫＩ<sub class="style-scope patent-text">ｄｏｗｎ</sub>；ｐＫＣ１１３９：Ｃ<sub class="style-scope patent-text">ｕｐ</sub>ＫＷ<sub class="style-scope patent-text">ｄｏｗｎ</sub>；ｐＫＣ１１３９：Ｉ<sub class="style-scope patent-text">ｕｐ</sub>ＫＩ<sub class="style-scope patent-text">ｄｏｗｎ</sub>、ｐＫＣ１１３９Ｗ<sub class="style-scope patent-text">ｕｐ</sub>ＫＷ<sub class="style-scope patent-text">ｄｏｗｎ</sub>。制限酵素分析、ＰＣＲ、及び配列確認の後、クラスターを大腸菌（Ｅ．ｃｏｌｉ）ＥＴ１２５６７（ｐＵＺ８００２）にエレクトロポレーションした。形質転換体をアプラマイシン及びカナマイシンの存在下での選抜により選択し、ＰＣＲで上流及び下流のプライマーを確認した。
</span> <u class="style-scope patent-text">Cassette Construction for Crossover</u> Upstream and downstream primers containing specific restriction enzyme sites were designed to knock out specific genes (see SEQ ID NOs: 60-75). In the upstream of the gene, the EcoRI site (GAATTC) was used as the forward primer, and the KpnI site (GGTACC) was used as the reverse primer. In the downstream of the gene, the forward primer used an XbaI site (TCTAGA), and the reverse primer used a HindIII (AAGCTT) site. In the middle, the kanamycin resistance gene was added as a selectable marker. All constructs were cloned into the pUC118 vector (Figure 10). Cassettes containing kanamycin resistance and knockout genes upstream and downstream were confirmed by sequencing the upstream and downstream sequences. The cassette was digested with HindIII and EcoRI and cloned into the pKC1139 shuttle vector (FIG. 11) with kanamycin as a selectable marker. <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text"> <sub class="style-scope patent-text">pKC1139 :: C up KI down; pKC1139</sub> </sub> </sub> </sub> : C up KW down; pKC1139: I up KI down, pKC1139W up KW down. After restriction enzyme analysis, PCR, and sequence confirmation, the clusters were electroporated into E. coli ET12567 (pUZ8002). Transformants were selected by selection in the presence of apramycin and kanamycin, and upstream and downstream primers were confirmed by PCR.</span>
      </p>
      <p num="0160" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  遺伝子の崩壊を保証するために、単一クロスオーバー相同組換えを行うように実験を設計した。約１ｋｂのＨｉｎｄＩＩＩ／ＥｃｏＲＩ断片をゲノムＤＮＡから増幅し、ｐＫＣ１１３９のＨｉｎｄＩＩＩ／ＥｃｏＲＩ部位に挿入してｐＫＣ１１３９：Ｃ、ｐＫＣ１１３９：Ｇ、及びｐＫＣ１１３９：Ｉを得た。
</span>
&nbsp;&nbsp;Experiments were designed to perform single crossover homologous recombination to ensure gene disruption. An approximately 1 kb HindIII / EcoRI fragment was amplified from genomic DNA and inserted into the HindIII / EcoRI site of pKC1139 to obtain pKC1139: C, pKC1139: G, and pKC1139: I.
</span>
      </p>
      <p num="0161" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
接合<br class="style-scope patent-text">
  この実験のドナーはｐＫＣ１１３９シャトルベクター上にノックアウトカセットを含有する大腸菌（Ｅ．ｃｏｌｉ）の菌株（ＥＴ１２５６７／ｐＵＺ８００２）であった。以下に説明する細菌性接合によるプラスミド伝達のための改変プロトコルに従って、カセットがＮＲＲＬ  Ｂ−５０５５０中にうまく導入された。
</span>Conjugation The donor for this experiment was an E. coli strain (ET12567 / pUZ8002) containing a knockout cassette on the pKC1139 shuttle vector. The cassette was successfully introduced into NRRL B-50550 according to a modified protocol for plasmid transfer by bacterial conjugation as described below.</span>
      </p>
      <p num="0162" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  プラスミドｐＵＺ８００２  ｗ／  ｐｋｃ１１３９：：Ｉ<sub class="style-scope patent-text">ｕｐ</sub>ＫＩ<sub class="style-scope patent-text">ｄｏｗｎ</sub>を含有する大腸菌（Ｅｓｃｈｅｒｉｃｈｉａ  ｃｏｌｉ）（ＥＴ１２５６７株）をルリアブロス（ＬＢ）寒天プレート上に画線し、３０℃又は３７℃で一晩インキュベートして単一のコロニーを得た。２５μｇ／ｍＬのクロラムフェニコールＣｍ、２５μｇ／ｍＬのカナマイシン、及び１００μｇ／ｍＬのアプラマイシンを補充した１０ｍＬのＬＢ（ＬＢ<sub class="style-scope patent-text">Ｃｍ２５Ｋ−Ｋａｎ２５−Ａｐｒ１００</sub>）を含有する少なくとも２つの５０ｍＬチューブに単一のコロニーを接種した。コロニーを３７℃振盪培養器内で一晩（２０−２４時間）増殖させた。一晩培養下菌を５０ｍＬのＬＢ<sub class="style-scope patent-text">Ａｐｒ１００</sub>中で１：１００に希釈した後、３７℃振盪培養器でＯＤ<sub class="style-scope patent-text">６００</sub>が０．４−０．６になるまで（通例４−５時間を要する）増殖させた。その後、細胞をおよそ５０００ＲＣＦ、４℃で１５−２０ｍｉｎペレット化した。得られた上清はデカントし捨てた。ペレットをラックに入れて再懸濁させ、ＬＢで二回洗浄して残留する抗生物質を除去した。ペレット化した大腸菌（Ｅ．ｃｏｌｉ）細胞を洗浄している間に、充分なグリセロールストック胞子ｐｒｅｐチューブが解けて試験される各々の受容菌／状態のための細胞が得られた。ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）胞子は小さく、数えるのが極めて難しいので、視覚的に濃い調製物を使用した。また、細胞を洗浄する一方で、寒天プレートを選択し、ラミナーフローフードで乾燥させた。各々の接合では、５００μＬの胞子調製物を無菌の２．０ｍＬ微量遠心管内で５００μＬの２×ＹＴブロスと混合した後、５０℃でおよそ２０分ヒートショックにかけた（実験的に、１０分〜１時間の範囲のヒートショック時間は生存能力に検出可能な差異を生じなかった）。ＹＴブロスはルリアブロスより富化した培地である（ＬＢの二倍もの酵母エキスとＬＢより約６０％多くのペプトンを含有する）。次に、混合物を室温に冷却し、その後５００μＬのペレット化した大腸菌（Ｅ．ｃｏｌｉ）細胞を各チューブに加え、次いで十分に混合した。細胞を５０００ＲＣＦ、室温で５分遠心分離した。上清をデカントした。ペレット化した細胞を再懸濁し、寒天プレートに蒔いた。細胞を、４−１０の１２ｍｍガラスビーズ又はＬａｚｙ  Ｌスプレッダーを用いて拡げた。プレートを一晩３０℃で（１６−２０時間）インキュベートした。各々のプレートについて、５ｍｇのカナマイシン及び０．５ｍｇのナリジクス酸（ＮａＯＨストック由来）を１ｍＬの水中で調製した後、Ｌａｚｙ  Ｌスプレッダーを用いてプレートに加えて溶液を均一に分布させた。これには、数分の反復展延と空気乾燥が必要であった。その後、プレートを３０℃でさらにインキュベートした。４−６日のインキュベーション後、白色のカナマイシン抵抗性コロニーをＰＣＲ確認及びグーゲロチン産生アッセイ用に選択した。
</span>Escherichia coli (ET12567 strain) containing plasmid pUZ8002 w / pkc1139 :: I <sub class="style-scope patent-text">up</sub> KI <sub class="style-scope patent-text">down</sub> is streaked on Luria broth (LB) agar plates and incubated overnight at 30 ° C. or 37 ° C. A colony was obtained. Single colonies in at least two 50 mL tubes containing 10 <sub class="style-scope patent-text">μL</sub> LB (LB <sub class="style-scope patent-text">Cm25K-Kan25-Apr100</sub> ) supplemented with 25 μg / mL chloramphenicol Cm, 25 μg / mL kanamycin, and 100 μg / mL <sub class="style-scope patent-text">apramycin</sub> Was inoculated. Colonies were grown overnight (20-24 hours) in a 37 ° C. shaker incubator. The overnight cultures are diluted 1: 100 in 50 mL LB <sub class="style-scope patent-text">Apr100 and then grown</sub> in a 37 ° C. shaker incubator until OD <sub class="style-scope patent-text">600</sub> is 0.4-0.6 (typically 4-5 hours required). It was. Cells were then pelleted at approximately 5000 RCF at 4 ° C. for 15-20 min. The obtained supernatant was decanted and discarded. The pellet was resuspended in a rack and washed twice with LB to remove residual antibiotic. While washing the pelleted E. coli cells, enough glycerol stock spore prep tubes were opened to obtain cells for each recipient / condition to be tested. Since Streptomyces spores are small and extremely difficult to count, a visually dark preparation was used. While washing the cells, an agar plate was selected and dried with a laminar flow hood. For each conjugation, 500 μL of the spore preparation was mixed with 500 μL of 2 × YT broth in a sterile 2.0 mL microcentrifuge tube and then subjected to a heat shock at 50 ° C. for approximately 20 minutes (experimentally 10 minutes to 1 Heat shock time in the time range did not produce a detectable difference in viability). YT broth is a richer medium than Luria broth (contains twice as much yeast extract as LB and about 60% more peptone than LB). The mixture was then cooled to room temperature, after which 500 μL of pelleted E. coli cells were added to each tube and then mixed well. Cells were centrifuged at 5000 RCF at room temperature for 5 minutes. The supernatant was decanted. The pelleted cells were resuspended and plated on agar plates. Cells were expanded using 4-10 12 mm glass beads or Lazy L spreader. The plates were incubated overnight at 30 ° C. (16-20 hours). For each plate, 5 mg kanamycin and 0.5 mg nalidixic acid (from NaOH stock) were prepared in 1 mL water and then added to the plate using a Lazy L spreader to distribute the solution evenly. This required several minutes of repeated spreading and air drying. The plate was then further incubated at 30 ° C. After 4-6 days of incubation, white kanamycin resistant colonies were selected for PCR confirmation and gougerotin production assays.</span>
      </p>
      <p num="0163" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">ＰＣＲ確認</u> <br class="style-scope patent-text">
  ＰＣＲ確認用に選択された白色のカナマイシン抵抗性コロニーをカナマイシン抗生物質を含むトリプシン大豆ブロス（ＴＳＢ）培地で培養し、ＤＮＡ抽出のためにＡ  ＺＹＧＥＭキット（ＺｙＧＥＭ  Ｃｏｒｐｏｒａｔｉｏｎ  Ｌｔｄ．（ＮＺ）製）を、製造業者のプロトコルに従い、８８μＬの培養物、１０μＬの１０×グリーンバッファー、１μＬのｐｒｅｐＧＥＭ、及び１μＬのリゾチームを用いて、３７℃で１５ｍｉｎ、７５℃で１５ｍｉｎ及び９５℃で５ｍｉｎインキュベーションして使用した。その後、適当なプライマー及びサイクルパラメーター（９５℃で１５ｍｉｎ、その後３５サイクルの９５℃で１ｍｉｎ、５８℃で１ｍｉｎ、及び７２℃で１ｍｉｎ、次いで７２℃で１０ｍｉｎ）を用いてＰＣＲを行い、４℃で貯蔵した。ＰＣＲ産物は１％アガロースゲルの電気泳動により分離した（図１２）。
</span> <u class="style-scope patent-text">PCR Confirmation</u> White kanamycin resistant colonies selected for PCR confirmation were cultured in trypsin soy broth (TSB) medium containing kanamycin antibiotics and AZYEM kit (ZyGEM Corporation Ltd. (NZ)) for DNA extraction. Incubate with 88 μL culture, 10 μL 10 × green buffer, 1 μL prepGEM, and 1 μL lysozyme for 15 min at 37 ° C., 15 min at 75 ° C. and 5 min at 95 ° C. according to manufacturer's protocol did. The PCR was then performed using appropriate primers and cycle parameters (95 ° C for 15 min, then 35 cycles of 95 ° C for 1 min, 58 ° C for 1 min, 72 ° C for 1 min, then 72 ° C for 10 min) at 4 ° C. Stored. PCR products were separated by electrophoresis on a 1% agarose gel (FIG. 12).</span>
      </p>
      <p num="0164" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ｐＫＣ１１３９：ＩはｐＫＣ１１３９シャトルベクターに挿入されたｇｏｕＩ断片であり、その後単一の相同クロスオーバーにより染色体に組み込まれる。このアプローチの結果、遺伝子の２つの突然変異対立遺伝子が隣接して存在するベクターの組み込まれたコピーが得られた。ＰＣＲの結果はやはりｇｏｕＩ及びｇｏｕＧのバンドを示した（図１２）。二重クロスオーバーのｐＫＣ１１３９：ＩＫＩ  ＰＣＲはｇｏｕＩ  ＰＣＲ産物を示さなかった（図１２）。ｇｏｕＧ産物のｐＫＣ１１３９：ＣＫＷ、ＰＣＲはより小さい分子量のバンドを示したが、これは遺伝子の部分的な欠失に起因し得るであろう。
</span>
&nbsp;&nbsp;pKC1139: I is a goul fragment inserted into the pKC1139 shuttle vector, which is then integrated into the chromosome by a single homologous crossover. This approach resulted in an integrated copy of the vector in which the two mutant alleles of the gene were adjacent. The PCR results also showed gouI and gouG bands (FIG. 12). Double crossover pKC1139: IKI PCR showed no goul PCR product (FIG. 12). The gouG product pKC1139: CKW, PCR showed a smaller molecular weight band, which could be due to a partial deletion of the gene.
</span>
      </p>
      <p num="0165" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> <u class="style-scope patent-text">グーゲロチン産生</u> <br class="style-scope patent-text">
  分析用ＨＰＬＣクロマトグラフィーを用いてグーゲロチン産生を測定した。簡単にいうと、試験サンプル（１．０ｇ）を遠心分離管に移し、３ｍＬの水で抽出する。成分をボルテックス及び超音波処理により混合した後遠心分離を用いて分離する。上清をきれいなフラスコ中にデカントする。この手順をもう一回繰り返し、上清を前に分離した上清と一緒にする。水性エキスを最終容量１０ｍＬとし、分析用ＨＰＬＣクロマトグラフィーを用いてグーゲロチン含有率をアッセイする。
</span> <u class="style-scope patent-text">Gougerotin production</u> was measured using HPLC chromatography for <u class="style-scope patent-text">gougerotin production</u> analysis. Briefly, the test sample (1.0 g) is transferred to a centrifuge tube and extracted with 3 mL of water. The components are mixed by vortexing and sonication and then separated using centrifugation. Decant the supernatant into a clean flask. Repeat this procedure one more time, combining the supernatant with the previously separated supernatant. The aqueous extract is brought to a final volume of 10 mL and assayed for gougerotin content using analytical HPLC chromatography.</span>
      </p>
      <p num="0166" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  希釈したサンプルをろ過し、Ｄｉａｍｏｎｄ  Ｈｙｄｒｉｄガードカラムを備えたＣｏｇｅｎｔ  Ｄｉａｍｏｎｄハイブリッドカラム（１００Ａ、４μｍ、１５０×４．６ｍｍ）を用いてＨＰＬＣにより分析する。カラムを３０分アセトニトリル／ＮＨ<sub class="style-scope patent-text">４</sub>ＯＡＣ勾配（下記参照）で溶出する。流量は１ｍＬ／ｍｉｎである。所望の代謝物質の検出は２５４ｎｍで行う。グーゲロチンは１７−１９分の概略保持時間で単一のピークとして溶出する。野生型ＮＲＲＬ  Ｂ−５０５５０は０．５ｍｇ／ｇのグーゲロチンを産生することができるが、ｇｏｕＩ遺伝子が不活性化されると、グーゲロチン産生はなくなった（表２５参照）。ｇｏｕＩ及びｇｏｕＧの単一のクロスオーバー不活性化でもグーゲロチン産生がなくなった。また全体のグーゲロチン遺伝子クラスターの不活性化でもグーゲロチン産生がなくなった。<br class="style-scope patent-text">
<tables num="25" class="style-scope patent-text"> </tables></span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000030" he="69" wi="166" file="2015534950.tif" img-format="tif" img-content="drawing" width="664" height="276" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> 
The diluted sample is filtered and analyzed by HPLC using a Cogen Diamond hybrid column (100A, 4 μm, 150 × 4.6 mm) equipped with a Diamond Hydrod guard column. The column is eluted with an acetonitrile / NH <sub class="style-scope patent-text">4</sub> OAC gradient (see below) for 30 minutes. The flow rate is 1 mL / min. Detection of the desired metabolite is performed at 254 nm. Gougerotin elutes as a single peak with an approximate retention time of 17-19 minutes. Wild type NRRL B-50550 can produce 0.5 mg / g of gougerotin, but when the goul gene was inactivated, gougerotin production was lost (see Table 25). A single crossover inactivation of gouI and gouG also abolished gougerotin production. In addition, inactivation of the entire gougerotin gene cluster resulted in no gougerotin production. <br class="style-scope patent-text"> <tables num="25" class="style-scope patent-text"> <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png" class="style-scope patent-text"><img id="000030" he="69" wi="166" file="2015534950.tif" img-format="tif" img-content="drawing" width="664" height="276" alt="Figure 2015534950" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/73/4e/931e76ede1145b/2015534950-9.png"></a></div> </tables> 
      <p class="style-scope patent-text"></p>
      <p num="0167" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  他に定義されない限り、本明細書中の技術及び科学用語は全て、本発明が属する技術分野で通常の能力を有する者が一般に理解しているのと同じ意味を有する。本明細書に記載したものと類似又は等価なあらゆる方法と材料を本発明の実施又は試験に使用することができるが、好ましい方法と材料は本明細書に記載されている。引用した全ての刊行物、特許及び特許刊行物は、全ての目的で、参照によりその全体を本明細書に組み入れる<br class="style-scope patent-text">
  本明細書中で論じた刊行物は単に本出願の出願日以前の開示を提供するものである。本明細書の記載はいずれも、先発明という理由で、本発明がかかる刊行物より先になされたものでないと自認するものということを認めるものではない。
</span>Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are described herein. All cited publications, patents and patent publications are incorporated herein by reference in their entirety for all purposes. The publications discussed herein merely provide disclosure prior to the filing date of the present application. To do. Nothing herein is to be construed as an admission that the present invention has not been made prior to such publications, for reasons of prior invention.</span>
      </p>
      <p num="0168" class="style-scope patent-text">
        <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  本発明の特定の実施形態に関連して説明して来たが、さらに改変することができ、本出願は、一般に本発明の原理に従い、また本発明が属する技術分野で公知又は通例の慣習であるとして、また以上に記載され後述の特許請求の範囲に規定される必須の特徴に適用され得るとして、本発明のあらゆる変形、使用、又は適合を含めて、本開示からのかかる逸脱を包含することを意図していると理解されたい。
</span>
&nbsp;&nbsp;Although described in connection with specific embodiments of the present invention, further modifications can be made and the present application generally follows the principles of the present invention and is known or customary in the art to which the present invention belongs. Including such departures from this disclosure, including any variations, uses, or adaptations of the invention, as it may be applied to the essential features described above and as defined in the claims below. It should be understood that this is intended.
</span>
      </p>
    </embodiments-example>
  </description-of-embodiments>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(80)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM90314693" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  植物食性−殺ダニ性及び／又は殺真菌性のストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株の生物学的に純粋な培養物を含む組成物。
</span>
&nbsp;&nbsp;Phytophagocytic-acaricidal and / or fungicidal Streptomyces microflavus NRRL B-50550 strain or a phytophagic-acaricidal and / or fungicidal mutant organism derived therefrom A composition comprising a chemically pure culture.
</span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株が層透過活性を有する、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;The composition of claim 1, wherein the mutant strain has laminar permeability activity.
</span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株が殺卵活性を有する、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;The composition of claim 1, wherein the mutant strain has ovicidal activity.
</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株が残効性を有する、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;The composition of claim 1, wherein the mutant strain has a residual effect.
</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株が殺菌活性を有する、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;The composition according to claim 1, wherein the mutant strain has bactericidal activity.
</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株が白カビ（ｍｉｌｄｅｗ）に対する活性を有する、請求項５に記載の組成物。
</span>
&nbsp;&nbsp;6. The composition of claim 5, wherein the mutant strain has activity against mildew.
</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株が殺虫活性を有する、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;The composition of claim 1, wherein the mutant strain has insecticidal activity.
</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記突然変異株がコーンルートワームに対する活性を有する、請求項７に記載の組成物。
</span>
&nbsp;&nbsp;8. The composition of claim 7, wherein the mutant strain has activity against corn rootworm.
</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  培養物１ｍＬ当たり少なくとも約１×１０<sup class="style-scope patent-text">６</sup>ＣＦＵの菌株を含む、請求項１に記載の組成物。
</span>2. The composition of claim 1, comprising at least about 1 x 10 &lt; <sup class="style-scope patent-text">6</sup> &gt; CFU strain per mL of culture.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配合成分をさらに含む、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;The composition of claim 1 further comprising a formulation component.
</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記配合成分が湿潤剤である、請求項１０に記載の組成物。
</span>
&nbsp;&nbsp;The composition according to claim 10, wherein the compounding component is a wetting agent.
</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  少なくとも約５０％のハダニ効力（Ｓｐｉｄｅｒ  Ｍｉｔｅ  Ｐｏｔｅｎｃｙ）を有する、請求項１に記載の組成物。
</span>
&nbsp;&nbsp;2. The composition of claim 1 having a Spider Mite Potency of at least about 50%.
</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  少なくとも約６０％のハダニ効力を有する、請求項１２に記載の組成物。
</span>
&nbsp;&nbsp;13. The composition of claim 12, having a tick efficacy of at least about 60%.
</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  殺ダニ性及び／又は殺真菌性のストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株の発酵産物を含む組成物。
</span>
&nbsp;&nbsp;Contains fermentation products of acaricidal and / or fungicidal Streptomyces microflavus NRRL B-50550 strain or phytophagous-acaricidal and / or fungicidal mutant strains derived therefrom Composition.
</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵産物がさらに配合成分を含む、請求項１４に記載の組成物。
</span>
&nbsp;&nbsp;15. The composition of claim 14, wherein the fermentation product further comprises a formulation component.
</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記配合成分が湿潤剤である、請求項１５に記載の組成物。
</span>
&nbsp;&nbsp;The composition according to claim 15, wherein the compounding component is a wetting agent.
</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  少なくとも約５０％のハダニ効力を有する、請求項１４に記載の組成物。
</span>
&nbsp;&nbsp;15. A composition according to claim 14 having a tick efficacy of at least about 50%.
</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  植物を処理して植物病害又は害虫を防除する方法であって、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又はそれから誘導される突然変異株を植物、植物の部分及び／又は植物の生育場所に施用することを含む、前記方法。
</span>
&nbsp;&nbsp;A method for treating plants to control plant diseases or pests, comprising Streptomyces microflavus NRRL B-50550 strain or phytophagous-acaricidal and / or suddenly derived therefrom Said method comprising applying the mutant strain to a plant, a plant part and / or a plant growth site.
</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性及び／又は殺真菌性の突然変異株を、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株を含む組成物として施用する、請求項１８に記載の方法。
</span>
&nbsp;&nbsp;A Streptomyces microflavus NRRL B-50550 strain or a phytophagocytic-acaricidal and / or fungicidal mutant strain derived therefrom is used as a Streptomyces microflavus NRRL B50550. 19. The method of claim 18, wherein the method is applied as a composition comprising a strain or a phytophagous-acaricidal mutant derived therefrom.
</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記組成物が、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株の発酵産物である、請求項１９に記載の方法。
</span>
&nbsp;&nbsp;20. The method of claim 19, wherein the composition is a fermentation product of a Streptomyces microflavus NRRL B-50550 strain or a phytophagous-acaricidal mutant strain derived therefrom.
</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記方法が、前記組成物を植物の茎葉部分に施用することを含む、請求項１９に記載の方法。
</span>
&nbsp;&nbsp;20. The method of claim 19, wherein the method comprises applying the composition to a plant foliage.
</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  防除対象の害虫がダニ及びジアブロチカ（Ｄｉａｂｒｏｔｉｃａ）から選択される、請求項１９に記載の方法。
</span>
&nbsp;&nbsp;20. The method according to claim 19, wherein the pest to be controlled is selected from mites and Diabrotica.
</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ダニが、クローバーハダニ、ニセクローバーハダニ、ハシバミハダニ（ｈａｚｅｌｎｕｔ  ｓｐｉｄｅｒ  ｍｉｔｅ）、アスパラガスハダニ（ａｓｐａｒａｇｕｓ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ホモノハダニ、マメダニ（ｌｅｇｕｍｅ  ｍｉｔｅ）、カタバミダニ（ｏｘａｌｉｓ  ｍｉｔｅ）、ツゲダニ（ｂｏｘｗｏｏｄ  ｍｉｔｅ）、テキサスミカンハダニ（Ｔｅｘａｓ  ｃｉｔｒｕｓ  ｍｉｔｅ）、オリエンタルミカンハダニ（Ｏｒｉｅｎｔａｌ  ｒｅｄ  ｍｉｔｅ）、ミカンハダニ、リンゴハダニ、キイロハダニ（ｙｅｌｌｏｗ  ｓｐｉｄｅｒ  ｍｉｔｅ）、イチジクハダニ（ｆｉｇ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ルイスハダニ（Ｌｅｗｉｓ  ｓｐｉｄｅｒ  ｍｉｔｅ）、コウノシロハダニ（ｓｉｘ−ｓｐｏｔｔｅｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ウィラメットダニ（Ｗｉｌｌａｍｅｔｔｅ  ｍｉｔｅ）、ユマハダニ（Ｙｕｍａ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ウェブスピニングマイト（ｗｅｂ−ｓｐｉｎｎｉｎｇ  ｍｉｔｅ）、パイナップルダニ（ｐｉｎｅａｐｐｌｅ  ｍｉｔｅ）、シトラスグリーンマイト（ｃｉｔｒｕｓ  ｇｒｅｅｎ  ｍｉｔｅ）、アメリカサイカチハダニ（ｈｏｎｅｙ−ｌｏｃｕｓｔ  ｓｐｉｄｅｒ  ｍｉｔｅ）、チャアカハダニ（ｔｅａ  ｒｅｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、チビコブハダニ、アボカドブラウンマイト（ａｖｏｃａｄｏ  ｂｒｏｗｎ  ｍｉｔｅ）、トドマツノハダニ、アボカドレッドマイト（ａｖｏｃａｄｏ  ｒｅｄ  ｍｉｔｅ）、バンクスグラスマイト（Ｂａｎｋｓ  ｇｒａｓｓ  ｍｉｔｅ）、ニセナミハダニ、アシノワハダニ、ヤサイハダニ（ｖｅｇｅｔａｂｌｅ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ツミドスパイダーマイト（ｔｕｍｉｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、イチゴハダニ（ｓｔｒａｗｂｅｒｒｙ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ナミハダニ、マクダニエルマイト（ＭｃＤａｎｉｅｌ  ｍｉｔｅ）、パシフィックスパイダーマイト（Ｐａｃｉｆｉｃ  ｓｐｉｄｅｒ  ｍｉｔｅ）、オウトウハダニ、フォースポッテドスパイダーマイト（ｆｏｕｒ−ｓｐｏｔｔｅｄ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ショエネイスパイダーマイト（Ｓｃｈｏｅｎｅｉ  ｓｐｉｄｅｒ  ｍｉｔｅ）、チリヒメハダニ（Ｃｈｉｌｅａｎ  ｆａｌｓｅ  ｓｐｉｄｅｒ  ｍｉｔｅ）、ブドウヒメハダニ、チャノヒメハダニ、フラットスカーレットマイト（ｆｌａｔ  ｓｃａｒｌｅｔ  ｍｉｔｅ）、ホワイトテイルドマイト（ｗｈｉｔｅ−ｔａｉｌｅｄ  ｍｉｔｅ）、パイナップルホコリダニ（ｐｉｎｅａｐｐｌｅ  ｔａｒｓｏｎｅｍｉｄ  ｍｉｔｅ）、ウェストインディアシュガーケーンマイト（Ｗｅｓｔ  Ｉｎｄｉａｎ  ｓｕｇａｒ  ｃａｎｅ  ｍｉｔｅ）、バルブスケールマイト（ｂｕｌｂ  ｓｃａｌｅ  ｍｉｔｅ）、シクラメンホコリダニ、チャノホコリダニ、ムギダニ、レッドレッグドアースマイト（ｒｅｄ−ｌｅｇｇｅｄ  ｅａｒｔｈ  ｍｉｔｅ）、フィルバートビッグ−ブッドマイト（ｆｉｌｂｅｒｔ  ｂｉｇ−ｂｕｄ  ｍｉｔｅ）、ブドウハモグリダニ、ピーアブリスターリーフマイト（ｐｅａｒ  ｂｌｉｓｔｅｒ  ｌｅａｆ  ｍｉｔｅ）、アップルリーフエッジローラーマイト（ａｐｐｌｅ  ｌｅａｆ  ｅｄｇｅｒｏｌｌｅｒ  ｍｉｔｅ）、ピーチモザイクベクターマイト（ｐｅａｃｈ  ｍｏｓａｉｃ  ｖｅｃｔｏｒ  ｍｉｔｅ）、アルダービーズゴールマイト（ａｌｄｅｒ  ｂｅａｄ  ｇａｌｌ  ｍｉｔｅ）、ペリアンウォルナットリーフゴールマイト（Ｐｅｒｉａｎ  ｗａｌｎｕｔ  ｌｅａｆ  ｇａｌｌ  ｍｉｔｅ）、ペカンリーフエッジロールマイト（ｐｅｃａｎ  ｌｅａｆ  ｅｄｇｅｒｏｌｌ  ｍｉｔｅ）、イチジクモンサビダニ（ｆｉｇ  ｂｕｄ  ｍｉｔｅ）、オリーブモンサビダニ（ｏｌｉｖｅ  ｂｕｄ  ｍｉｔｅ）、シトラスブッドマイト（ｃｉｔｒｕｓ  ｂｕｄ  ｍｉｔｅ）、ライチエリネウムマイト（ｌｉｔｃｈｉ  ｅｒｉｎｅｕｍ  ｍｉｔｅ）、チューリップサビダニ、ココナッツフラワーアンドナッツマイト（ｃｏｃｏｎｕｔ  ｆｌｏｗｅｒ  ａｎｄ  ｎｕｔ  ｍｉｔｅ）、シュガーケーンブリスターマイト（ｓｕｇａｒ  ｃａｎｅ  ｂｌｉｓｔｅｒ  ｍｉｔｅ）、バッファローグラスマイト（ｂｕｆｆａｌｏ  ｇｒａｓｓ  ｍｉｔｅ）、バミューダグラスマイト（ｂｅｒｍｕｄａ  ｇｒａｓｓ  ｍｉｔｅ）、ニンジンモンサビダニ（ｃａｒｒｏｔ  ｂｕｄ  ｍｉｔｅ）、スウィートポテトリーフゴールマイト（ｓｗｅｅｔ  ｐｏｔａｔｏ  ｌｅａｆ  ｇａｌｌ  ｍｉｔｅ）、ポメグラナテリーフカールマイト（ｐｏｍｅｇｒａｎａｔｅ  ｌｅａｆ  ｃｕｒｌ  ｍｉｔｅ）、アシュスプラングルゴールマイト（ａｓｈ  ｓｐｒａｎｇｌｅ  ｇａｌｌ  ｍｉｔｅ）、メイプルブラッダーゴールマイト（ｍａｐｌｅ  ｂｌａｄｄｅｒ  ｇａｌｌ  ｍｉｔｅ）、アルダーエリネウムマイト（ａｌｄｅｒ  ｅｒｉｎｅｕｍ  ｍｉｔｅ）、レッドベリーマイト（ｒｅｄｂｅｒｒｙ  ｍｉｔｅ）、コットンブリスターマイト（ｃｏｔｔｏｎ  ｂｌｉｓｔｅｒ  ｍｉｔｅ）、ブルーベリーブッドマイト（ｂｌｕｅｂｅｒｒｙ  ｂｕｄ  ｍｉｔｅ）、チャノナガサビダニ、チャノサビダニ、グレオシトラスマイト（ｇｒｅｙ  ｃｉｔｒｕｓ  ｍｉｔｅ）、サツマイモサビダニ（ｓｗｅｅｔ  ｐｏｔａｔｏ  ｒｕｓｔ  ｍｉｔｅ）、セイヨウトチノキサビダニ（ｈｏｒｓｅ  ｃｈｅｓｔｎｕｔ  ｒｕｓｔ  ｍｉｔｅ）、ミカンサビダニ（ｃｉｔｒｕｓ  ｒｕｓｔ  ｍｉｔｅ）、リンゴサビダニ、ブドウサビダニ、ナシサビダニ、フラットニードルシースパインマイト（ｆｌａｔ  ｎｅｅｄｌｅ  ｓｈｅａｔｈ  ｐｉｎｅ  ｍｉｔｅ）、ワイルドローズブッドアンドフルーツマイト（ｗｉｌｄ  ｒｏｓｅ  ｂｕｄ  ａｎｄ  ｆｒｕｉｔ  ｍｉｔｅ）、ドライベリーマイト（ｄｒｙｂｅｒｒｙ  ｍｉｔｅ）、マンゴーサビダニ（ｍａｎｇｏ  ｒｕｓｔ  ｍｉｔｅ）、アザレアサビダニ（ａｚａｌｅａ  ｒｕｓｔ  ｍｉｔｅ）、モモサビダニ（ｐｌｕｍ  ｒｕｓｔ  ｍｉｔｅ）、モモサビダニ（ｐｅａｃｈ  ｓｉｌｖｅｒ  ｍｉｔｅ）、リンゴサビダニ、トマトサビダニ、ミカンサビダニ（ｐｉｎｋ  ｃｉｔｒｕｓ  ｒｕｓｔ  ｍｉｔｅ）、穀類サビダニ（ｃｅｒｅａｌ  ｒｕｓｔ  ｍｉｔｅ）、イネサビダニ（ｒｉｃｅ  ｒｕｓｔ  ｍｉｔｅ）及びこれらの組合せからなる群から選択される、請求項２２に記載の方法。
</span>
&nbsp;&nbsp;The mites are clover spider mite, false clover spider mite, hazelnut spider mite, asparagus spider mite, homono spider mite, legumite mite, tick mite (texa mite), x (Texas citrus mite), Oriental red mite, Oriental red mite, Apple spider mite, Yellow spider mite, fig spider mite (Lepid spider mite), Lewis spite mite (Lespite spider mite) , Willamette mite, Yuma spider mite, web-spinning mite, pineapple mite-citrus green mite (citrus green mite), Citrus green mite (citrus green mite) ), Tea red spider mite, chibicob spider mite, avocado brown mite, avocado brown mite, avocado red mite, tick mite, scab verge table spider mite, tumid spider mite, strawberry spider mite, sardine spider mite, McDaniel mite, Pacific spider mite, Pacific spider mite (Pacific spider mite), Pacific spider mite (Pacific spider mite), Pacific spider mite (Pacific spider mite) four-spotted spider mite, Schoenei spider mite, Chilean spider mite (Chilean false spider mite), grape spider mite, white scarlet mite (flat scarlet mito) aileed mite, pineapple tarsonemid mite, west indian sugar cane mite, bulb scale mite, dick mite, mite dust mite mite), filbert big-bud mitite, grape herb mite, pear blister leaf mite (apple blister leaf mite), apple leaf edge roller mite (apple leaf edgeroller mite), peach mosaic vector peach mosaic vector mite, alder bead gall mite, perian walnut leaf gall mite, pecan leaf roll mite peige leaf mite bilge digger bilge digger bilge digb , Olive bud mite, citrus bud mite, litchi erineum mite, tulip rustic mite, coconut flower and nutmite, coconut flower and nutmitter mit garmit sugar cane blister mite, buffalo grass mite, bermuda grass mite, carrot bud mite, sweet potato leaf fate Curlmite (pomgranate leaf curl mite), ash sprangle gallmite (maple blader gallmite), alder ereneummite (alder erreite mine bull mint) mite), cotton blister mitite (cotton blister mit), blueberry bud mitite (blueberry bud mite), chanogasabi mite, chanosabi mite (gray citrus mite), sweet potato mite (sweet mite pest) horse chestnut rust mite, citrus rust mite, apple rust mite, grape rust mite, pear rust mite, flat needle sea pine mite (flat needle sea pine mite), wild rose bud and fruit d Dryberry mite, mango rust mite, azalea rust mite, plum rust mite, mite rust mite, peach sill mite, 23. The method of claim 22, wherein the method is selected from the group consisting of: mite), cereal rust mite, rice rust mite, and combinations thereof.
</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ジアブロチカ（ｄｉａｂｒｏｔｉｃａ）が、バンデッドキューカンバビートル（ｂａｎｄｅｄ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・バルテアタ（Ｄｉａｂｒｏｔｉｃａ  ｂａｌｔｅａｔａ））、ノーザンコーンルートワーム（Ｎｏｒｔｈｅｒｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・バルベリ（Ｄｉａｂｒｏｔｉｃａ  ｂａｒｂｅｒｉ））、サウザンコーンルートワーム（Ｓｏｕｔｈｅｒｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・ウンデシンプンクタタ・ホワーディ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ  ｈｏｗａｒｄｉ））、ウェスタンキューカンバビートル（Ｗｅｓｔｅｒｎ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・ウンデシンプンクタタ・テネラ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ  ｔｅｎｅｌｌａ））、ウエスタンスポッテドキューカンバービートル（Ｗｅｓｔｅｒｎ  ｓｐｏｔｔｅｄ  ｃｕｃｕｍｂｅｒ  ｂｅｅｔｌｅ）（ジアブロチカ・ウンデシンプンクタタ・ウンデシンプンクタタ（Ｄｉａｂｒｏｔｉｃａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ  ｕｎｄｅｃｉｍｐｕｎｃｔａｔａ））、ウェスタンコーンルートワーム（Ｗｅｓｔｅｒｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・ビルギフェラ・ビルギフェラ（Ｄｉａｂｒｏｔｉｃａ  ｖｉｒｇｉｆｅｒａ  ｖｉｒｇｉｆｅｒａ））、メキシカンコーンルートワーム（Ｍｅｘｉｃａｎ  ｃｏｒｎ  ｒｏｏｔｗｏｒｍ）（ジアブロチカ・ビルギフェラ・ゼアエ（Ｄｉａｂｒｏｔｉｃａ  ｖｉｒｇｉｆｅｒａ  ｚｅａｅ））及びこれらの組合せからなる群から選択される、請求項２２に記載の方法。
</span>
&nbsp;&nbsp;The diabrotica is a banded cucumber beetle (Diabrotica balteata), a northern corn root worm (Northern corn roe ber (S) corn rootworm (Diabrotica undecimuncuntata howardi), Western Cucumber beetle (Diabrotica undecynpunta tera terot tera ter.) west undecompactata tenella)), Western spotted cucumber beetle (Diabrotica undecocunta unduncenta) Bilgifera (Diabrotica virgifera virgifera), Mexican corn rootworm (Diabrotica virgifera zeae) and this It is selected from the group consisting of a combination method of claim 22.
</span>
    </claim-text>
  </claim>
  <claim num="25" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵産物が凍結乾燥粉末又は噴霧乾燥粉末であり、且つ、その発酵産物を約０．６２５ポンド／エーカー〜約５ポンド／エーカーの施用量で施用する、請求項２０に記載の方法。
</span>
&nbsp;&nbsp;21. The method of claim 20, wherein the fermentation product is a freeze-dried powder or a spray-dried powder, and the fermentation product is applied at a rate of about 0.625 pounds / acre to about 5 pounds / acre.
</span>
    </claim-text>
  </claim>
  <claim num="26" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵産物が少なくとも約２重量％のグーゲロチンを含む、請求項２５に記載の方法。
</span>
&nbsp;&nbsp;26. The method of claim 25, wherein the fermentation product comprises at least about 2% by weight gougerotin.
</span>
    </claim-text>
  </claim>
  <claim num="27" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵産物が少なくとも約４重量％のグーゲロチンを含む、請求項２６に記載の方法。
</span>
&nbsp;&nbsp;27. The method of claim 26, wherein the fermentation product comprises at least about 4% by weight gougerotin.
</span>
    </claim-text>
  </claim>
  <claim num="28" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ダニがアバメクチン抵抗性のダニである、請求項２３に記載の方法。
</span>
&nbsp;&nbsp;24. The method of claim 23, wherein the tick is an abamectin resistant tick.
</span>
    </claim-text>
  </claim>
  <claim num="29" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記植物病害が菌類により引き起こされる、請求項１９に記載の方法。
</span>
&nbsp;&nbsp;20. The method of claim 19, wherein the plant disease is caused by a fungus.
</span>
    </claim-text>
  </claim>
  <claim num="30" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記植物病害が白カビ（ｍｉｌｄｅｗ）又はさび病（ｒｕｓｔ  ｄｉｓｅａｓｅ）である、請求項２９に記載の方法。
</span>
&nbsp;&nbsp;30. The method of claim 29, wherein the plant disease is mildew or rust disease.
</span>
    </claim-text>
  </claim>
  <claim num="31" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記白カビ（ｍｉｌｄｅｗ）がうどんこ病（ｐｏｗｄｅｒｙ  ｍｉｌｄｅｗ）又はベと病（ｄｏｗｎｙ  ｍｉｌｄｅｗ）である、請求項３０に記載の方法。
</span>
&nbsp;&nbsp;32. The method of claim 30, wherein the mildew is powdery mildew or downy mildew.
</span>
    </claim-text>
  </claim>
  <claim num="32" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記さび病が、プッシニア・トリシチナ（Ｐｕｃｃｉｎｉａ  ｔｒｉｔｉｃｉｎａ）により引き起こされるコムギ赤さび病、プッシニア・ホルデイ（Ｐｕｃｃｉｎｉａ  ｈｏｒｄｅｉ）により引き起こされるオオムギの小さび病、プッシニア・レコンジタ（Ｐｕｃｃｉｎｉａ  ｒｅｃｏｎｄｉｔａ）により引き起こされるライ麦の赤さび病、赤さび病（ｂｒｏｗｎ  ｌｅａｆ  ｒｕｓｔ）、冠さび病（ｃｒｏｗｎ  ｒｕｓｔ）及び黒さび病（ｓｔｅｍ  ｒｕｓｔ）からなる群から選択される、請求項３０に記載の方法。
</span>
&nbsp;&nbsp;The rust disease is caused by wheat red rust caused by Puccinia triticina, barley scab caused by Puccinia hordei, red rust caused by Puccinia recondita, wheat rust caused by Puccinia recondita 31. The method of claim 30, wherein the method is selected from the group consisting of brown leaf rust, crown rust, and stem rust.
</span>
    </claim-text>
  </claim>
  <claim num="33" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスであって、少なくとも約１ｇ／Ｌのグーゲロチンを含む、前記発酵ブロス。
</span>
&nbsp;&nbsp;A fermentation broth of a Gougerotin-producing Streptomyces strain comprising at least about 1 g / L of Gougerotin.
</span>
    </claim-text>
  </claim>
  <claim num="34" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記グーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株が、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約８０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む、請求項３３に記載の発酵ブロス。
</span>
&nbsp;&nbsp;The gougerotin-producing Streptomyces strain is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: : At least about one amino acid sequence selected from the group consisting of: SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42 34. The fermentation broth of claim 33, comprising a nucleic acid sequence encoding an amino acid sequence having 80% sequence identity.
</span>
    </claim-text>
  </claim>
  <claim num="35" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記グーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株が、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約９０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む、請求項３４に記載の発酵ブロス。
</span>
&nbsp;&nbsp;The gougerotin-producing Streptomyces strain is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: : At least about one amino acid sequence selected from the group consisting of: SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42 35. The fermentation broth of claim 34, comprising a nucleic acid sequence encoding an amino acid sequence having 90% sequence identity.
</span>
    </claim-text>
  </claim>
  <claim num="36" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵ブロスが、少なくとも約１ｇ／Ｌ、少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、少なくとも約７ｇ／Ｌ又は少なくとも約８ｇ／Ｌのグーゲロチンを含有する、請求項３３に記載の発酵ブロス。
</span>
&nbsp;&nbsp;The fermentation broth is at least about 1 g / L, at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, at least about 6 g / L, at least about 7 g / L, or at least about 8 g. 34. Fermentation broth according to claim 33, containing / L gougerotin.
</span>
    </claim-text>
  </claim>
  <claim num="37" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記発酵ブロスが、約１ｇ／Ｌ〜約１５ｇ／Ｌの濃度でグーゲロチンを含有する、請求項３３に記載の発酵ブロス。
</span>
&nbsp;&nbsp;34. The fermentation broth of claim 33, wherein the fermentation broth contains gougerotin at a concentration of about 1 g / L to about 15 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="38" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株が、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）菌株又はストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）菌株である、請求項３４に記載の発酵ブロス。
</span>
&nbsp;&nbsp;35. The fermentation broth according to claim 34, wherein the Streptomyces strain is a Streptomyces microflavus strain or a Streptomyces puniceus strain.
</span>
    </claim-text>
  </claim>
  <claim num="39" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）菌株が、ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株からなる群から選択される、請求項３８に記載の発酵ブロス。
</span>
&nbsp;&nbsp;The Streptomyces microflavus strain is selected from the group consisting of a Streptomyces microflavus NRRL B-50550 strain or a phytophagic-acaricidal mutant strain derived therefrom, 39. A fermentation broth according to claim 38.
</span>
    </claim-text>
  </claim>
  <claim num="40" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）菌株が、ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性の突然変異株からなる群から選択される、請求項３９に記載の発酵ブロス。
</span>
&nbsp;&nbsp;40. The Streptomyces puniceus strain is selected from the group consisting of a Streptomyces puniceus A strain or a phytophagous-acaricidal mutant derived therefrom. Fermentation broth as described in.
</span>
    </claim-text>
  </claim>
  <claim num="41" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスを製造する方法であって、発酵ブロスは少なくとも約１ｇ／Ｌのグーゲロチンを含有し、前記方法は前記消化可能な炭素源及び消化可能な窒素源を含有する培地において好気性条件下でストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養することを含み、前記培地が少なくとも１ｇ／Ｌのグーゲロチン濃度を達成するのに有効な濃度でアミノ酸を含有する、前記方法。
</span>
&nbsp;&nbsp;A method for producing a fermentation broth of a gougerotin-producing Streptomyces strain, the fermentation broth containing at least about 1 g / L of gougerotin, said method comprising said digestible carbon source and digestible nitrogen source Culturing a Streptomyces strain in an aerobic condition in a medium containing, wherein the medium contains amino acids at a concentration effective to achieve a gougerotin concentration of at least 1 g / L .
</span>
    </claim-text>
  </claim>
  <claim num="42" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が少なくとも約２ｇ／Ｌ、少なくとも約３ｇ／Ｌ、少なくとも約４ｇ／Ｌ、少なくとも約５ｇ／Ｌ、少なくとも約６ｇ／Ｌ、少なくとも約７ｇ／Ｌ又は少なくとも約８ｇ／Ｌのグーゲロチンの濃度でグーゲロチンを含有するまで、前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培地中で培養する、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;The medium has a concentration of at least about 2 g / L, at least about 3 g / L, at least about 4 g / L, at least about 5 g / L, at least about 6 g / L, at least about 7 g / L, or at least about 8 g / L of gougerotin. 42. The method of claim 41, wherein the Streptomyces strain is cultivated in a medium until it contains.
</span>
    </claim-text>
  </claim>
  <claim num="43" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が約１ｇ／Ｌ〜約１５ｇ／Ｌのグーゲロチンの範囲の濃度でグーゲロチンを含有するまで、前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培地中で培養する、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The method of claim 41, wherein the Streptomyces strain is cultured in the medium until the medium contains gougerotin at a concentration ranging from about 1 g / L to about 15 g / L of gougerotin.
</span>
    </claim-text>
  </claim>
  <claim num="44" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記アミノ酸が、グリシン、グルタミン酸、グルタミン、セリン及びこれらの混合物からなる群から選択される、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The method of claim 41, wherein the amino acid is selected from the group consisting of glycine, glutamic acid, glutamine, serine, and mixtures thereof.
</span>
    </claim-text>
  </claim>
  <claim num="45" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が、少なくとも約２ｇ／Ｌの初期濃度でアミノ酸を含有する、請求項４４に記載の方法。
</span>
&nbsp;&nbsp;45. The method of claim 44, wherein the medium contains amino acids at an initial concentration of at least about 2 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="46" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が、約５ｇ／Ｌ〜約１５ｇ／Ｌの初期濃度でグリシンを含有する、請求項４５に記載の方法。
</span>
&nbsp;&nbsp;46. The method of claim 45, wherein the medium contains glycine at an initial concentration of about 5 g / L to about 15 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="47" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が、約５ｇ／Ｌ〜約１５ｇ／Ｌの初期濃度でグルタミン酸を含有する、請求項４５に記載の方法。
</span>
&nbsp;&nbsp;46. The method of claim 45, wherein the medium contains glutamic acid at an initial concentration of about 5 g / L to about 15 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="48" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が、炭素源としてグルコースとオリゴ糖の混合物を含有する、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The method of claim 41, wherein the medium contains a mixture of glucose and oligosaccharides as a carbon source.
</span>
    </claim-text>
  </claim>
  <claim num="49" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記オリゴ糖がマルトデキストリン又はデキストリンである、請求項４８に記載の方法。
</span>
&nbsp;&nbsp;49. The method of claim 48, wherein the oligosaccharide is maltodextrin or dextrin.
</span>
    </claim-text>
  </claim>
  <claim num="50" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地中の初期マルトデキストリン濃度が約５０ｇ／Ｌ〜約１００ｇ／Ｌである、請求項４９に記載の方法。
</span>
&nbsp;&nbsp;50. The method of claim 49, wherein the initial maltodextrin concentration in the medium is from about 50 g / L to about 100 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="51" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地中の初期マルトデキストリン濃度が約６０ｇ／Ｌ〜約８０ｇ／Ｌである、請求項５０に記載の方法。
</span>
&nbsp;&nbsp;51. The method of claim 50, wherein the initial maltodextrin concentration in the medium is about 60 g / L to about 80 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="52" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地中の初期グルコース濃度が約２０ｇ／Ｌ〜６０ｇ／Ｌである、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The method of claim 41, wherein the initial glucose concentration in the medium is about 20 g / L to 60 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="53" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地中の初期グルコース濃度が約３０ｇ／Ｌ〜約５０ｇ／Ｌである、請求項５２に記載の方法。
</span>
&nbsp;&nbsp;53. The method of claim 52, wherein the initial glucose concentration in the medium is about 30 g / L to about 50 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="54" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が約１ｇ／Ｌ〜３ｇ／Ｌの初期濃度で炭酸カルシウムを含有する、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The method of claim 41, wherein the medium contains calcium carbonate at an initial concentration of about 1 g / L to 3 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="55" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記窒素源が、少なくとも部分的に、大豆ペプトン、大豆酸加水分解物、大豆粉加水分解物、カゼイン加水分解物、酵母エキス及びこれらの混合物からなる群から選択される、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The nitrogen source of claim 41, wherein the nitrogen source is at least partially selected from the group consisting of soy peptone, soy acid hydrolyzate, soy flour hydrolysate, casein hydrolysate, yeast extract and mixtures thereof. Method.
</span>
    </claim-text>
  </claim>
  <claim num="56" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株が、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約８０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含んでいる、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;The Streptomyces strain is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, At least about 80% relative to at least one amino acid sequence selected from the group consisting of SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42. 42. The method of claim 41, comprising a nucleic acid sequence encoding an amino acid sequence having sequence identity.
</span>
    </claim-text>
  </claim>
  <claim num="57" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株がストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）菌株である、請求項４１に記載の方法。
</span>
&nbsp;&nbsp;42. The method of claim 41, wherein the Streptomyces strain is a Streptomyces microflavus strain.
</span>
    </claim-text>
  </claim>
  <claim num="58" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）菌株がストレプトマイセス・ミクロフラブス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｍｉｃｒｏｆｌａｖｕｓ）ＮＲＲＬ  Ｂ−５０５５０株又はそれから誘導される植物食性−殺ダニ性の突然変異株からなる群から選択される、請求項５６に記載の方法。
</span>
&nbsp;&nbsp;The Streptomyces microflavus strain is selected from the group consisting of a Streptomyces microflavus NRRL B-50550 strain or a phytophagic-acaricidal mutant strain derived therefrom. Item 56. The method according to Item 56.
</span>
    </claim-text>
  </claim>
  <claim num="59" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株がストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）菌株である、請求項５６に記載の方法。
</span>
&nbsp;&nbsp;57. The method of claim 56, wherein the Streptomyces strain is a Streptomyces puniceus strain.
</span>
    </claim-text>
  </claim>
  <claim num="60" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）菌株がストレプトマイセス・プニセウス（Ｓｔｒｅｐｔｏｍｙｃｅｓ  ｐｕｎｉｃｅｕｓ）Ａ株又はそれから誘導される植物食性−殺ダニ性の突然変異株である、請求項５９に記載の方法。
</span>
&nbsp;&nbsp;60. The method of claim 59, wherein the Streptomyces puniceus strain is a Streptomyces puniceus A strain or a phytophagous-acaricidal mutant derived therefrom.
</span>
    </claim-text>
  </claim>
  <claim num="61" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン産生性ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株の発酵ブロスのグーゲロチンレベルを高める方法であって、消化可能な炭素源及び消化可能な窒素源を含有している培地中において好気性条件下でストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株を培養する段階を含み、前記培地が、約１ｇ／Ｌ未満の１種以上のアミノ酸を含有している培地で達成されるグーゲロチン濃度より少なくとも２倍大きいグーゲロチン濃度を達成するのに有効な濃度のアミノ酸を含有している、前記方法。
</span>
&nbsp;&nbsp;A method for increasing the level of gougerotin in a fermentation broth of a gougerotin-producing Streptomyces strain, wherein the step is performed under aerobic conditions in a medium containing a digestible carbon source and a digestible nitrogen source. Culturing a Streptomyces strain, wherein the medium achieves a gougerotin concentration that is at least two times greater than the gougerotin concentration achieved in a medium containing less than about 1 g / L of one or more amino acids. The method of claim 1, wherein said method comprises an effective concentration of amino acids.
</span>
    </claim-text>
  </claim>
  <claim num="62" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記培地が約２ｇ／Ｌの１種以上のアミノ酸の濃度でアミノ酸を含有する、請求項５５に記載の方法。
</span>
&nbsp;&nbsp;56. The method of claim 55, wherein the medium contains amino acids at a concentration of one or more amino acids of about 2 g / L.
</span>
    </claim-text>
  </claim>
  <claim num="63" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記アミノ酸がグルタミン酸、セリン又はグリシンである、請求項６２に記載の方法。
</span>
&nbsp;&nbsp;64. The method of claim 62, wherein the amino acid is glutamic acid, serine or glycine.
</span>
    </claim-text>
  </claim>
  <claim num="64" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）菌株が、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも約８０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む、請求項６１に記載の方法。
</span>
&nbsp;&nbsp;The Streptomyces strain is SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, At least about 80% relative to at least one amino acid sequence selected from the group consisting of SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 42. 62. The method of claim 61, comprising a nucleic acid sequence encoding an amino acid sequence having sequence identity.
</span>
    </claim-text>
  </claim>
  <claim num="65" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：４３のヌクレオチド配列に対して少なくとも７０％の配列同一性を有し、該配列の発現を指令するために少なくとも１の外因性及び／又は異種の調節要素に機能的に連結された核酸配列。
</span>
&nbsp;&nbsp;A nucleic acid having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 43 and operably linked to at least one exogenous and / or heterologous regulatory element to direct expression of the sequence An array.
</span>
    </claim-text>
  </claim>
  <claim num="66" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、配列番号：４３の位置１０８２０〜位置１２０１３のヌクレオチド配列を含む、請求項６５に記載の核酸配列。
</span>
&nbsp;&nbsp;66. The nucleic acid sequence of claim 65, further comprising the nucleotide sequence of position 10820 to position 12013 of SEQ ID NO: 43.
</span>
    </claim-text>
  </claim>
  <claim num="67" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  さらに、配列番号：４３の位置１３２１９〜位置１４３３４のヌクレオチド配列を含む、請求項６５または６６に記載の核酸配列。
</span>
&nbsp;&nbsp;67. The nucleic acid sequence of claim 65 or 66, further comprising the nucleotide sequence of position 13219 to position 14334 of SEQ ID NO: 43.
</span>
    </claim-text>
  </claim>
  <claim num="68" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記核酸配列が、Ｓ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）、Ｓ．グリセウス（Ｓ．ｇｒｉｓｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）、又はＳ．グラミネアルス（Ｓ．ｇｒａｍｉｎｅａｒｕｓ）から単離される、請求項６５〜６７のいずれか１項に記載の核酸配列。
</span>
&nbsp;&nbsp;The nucleic acid sequence is S. cerevisiae. S. microflavus, S. S. griseus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. S. alboviridis, S. alboviridis S. puniceus, or S. 68. The nucleic acid sequence of any one of claims 65 to 67, isolated from S. graminearus.
</span>
    </claim-text>
  </claim>
  <claim num="69" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  請求項６５〜６８のいずれか１項に記載の核酸配列を含む、宿主細胞。
</span>
&nbsp;&nbsp;69. A host cell comprising the nucleic acid sequence of any one of claims 65-68.
</span>
    </claim-text>
  </claim>
  <claim num="70" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン又はグーゲロチンアナログを製造する方法であって、前記方法は、前記グーゲロチン又はグーゲロチンアナログを生産させ培地中に排泄させるために、ストレプトマイセス（Ｓｔｒｅｐｔｏｍｙｃｅｓ）科のグーゲロチン又はグーゲロチン産生性細菌を培地中で培養する段階と、前記グーゲロチン又はグーゲロチンアナログを培地から収集する段階を含み、前記細菌が請求項６５〜６８のいずれか１項に記載の核酸配列の遺伝子の発現を高めるように改変されている、前記方法。
</span>
&nbsp;&nbsp;A method for producing gougerotin or a gougerotin analog, the method comprising producing the gougerotin or gougerotin analogue and excreting it in a medium, wherein the gougerotin or gougerotin-producing bacterium of the family Streptomyces 69. The method comprises: culturing a bacterium in a medium; and collecting the gougerotin or guerotine analog from the medium, so that the bacterium increases the gene expression of the nucleic acid sequence according to any one of claims 65 to 68. Wherein said method has been modified.
</span>
    </claim-text>
  </claim>
  <claim num="71" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記細菌が、Ｓ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）、Ｓ．グリセウス（Ｓ．ｇｒｉｓｅｕｓ）、Ｓ．アヌラツス（Ｓ．ａｎｕｌａｔｕｓ）、Ｓ．フィミカリウス（Ｓ．ｆｉｍｉｃａｒｉｕｓ）、Ｓ．パルブス（Ｓ．ｐａｒｖｕｓ）、Ｓ．ラベンデュラエ（Ｓ．ｌａｖｅｎｄｕｌａｅ）、Ｓ．アルボビリディス（Ｓ．ａｌｂｏｖｉｒｉｄｉｓ）、Ｓ．プニセウス（Ｓ．ｐｕｎｉｃｅｕｓ）及びＳ．グラミネアルス（Ｓ．ｇｒａｍｉｎｅａｒｕｓ）からなる群から選択される、請求項７０に記載の方法。
</span>
&nbsp;&nbsp;The bacterium is S. cerevisiae. S. microflavus, S. S. griseus, S. Anuratus, S. et al. S. fimicarius, S .; S. parvus, S. S. lavendulae, S. S. alboviridis, S. alboviridis S. puniceus and S. 72. The method of claim 70, wherein the method is selected from the group consisting of S. graminearus.
</span>
    </claim-text>
  </claim>
  <claim num="72" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  前記細菌がＳ．ミクロフラブス（Ｓ．ｍｉｃｒｏｆｌａｖｕｓ）である、請求項７０に記載の方法。
</span>
&nbsp;&nbsp;The bacterium is S. cerevisiae. 71. The method of claim 70, wherein the method is S. microflavus.
</span>
    </claim-text>
  </claim>
  <claim num="73" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  請求項６５〜６８のいずれか１項に記載の核酸配列から選択されるポリペプチドサブユニットをコードする遺伝子を含む発現ベクター。
</span>
&nbsp;&nbsp;69. An expression vector comprising a gene encoding a polypeptide subunit selected from the nucleic acid sequence of any one of claims 65-68.
</span>
    </claim-text>
  </claim>
  <claim num="74" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  請求項７３に記載のベクターを含む、宿主細胞。
</span>
&nbsp;&nbsp;74. A host cell comprising the vector of claim 73.
</span>
    </claim-text>
  </claim>
  <claim num="75" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  グーゲロチン又はグーゲロチンアナログを製造する方法であって、<br class="style-scope patent-text">
    （ａ）  請求項６５〜６８のいずれか１項に記載の核酸配列を含有する組換え発現ベクターを構築するステップ；<br class="style-scope patent-text">
    （ｂ）  ステップ（ａ）の核酸配列を含有する発現ベクターで宿主細胞を形質転換して形質転換体を生成させるステップ；<br class="style-scope patent-text">
    （ｃ）  ステップ（ｂ）の形質転換体を培養するステップ；及び、<br class="style-scope patent-text">
    （ｄ）  ステップ（ｃ）の形質転換体の培養産物から前記グーゲロチン又はグーゲロチン  アナログを単離し精製するステップ；<br class="style-scope patent-text">
を含む、前記方法。
</span>A method for producing gougerotin or a gougerotin analogue, comprising: <br class="style-scope patent-text"> (A) constructing a recombinant expression vector containing the nucleic acid sequence of any one of claims 65-68; <br class="style-scope patent-text"> (B) transforming a host cell with an expression vector containing the nucleic acid sequence of step (a) to produce a transformant; <br class="style-scope patent-text"> (C) culturing the transformant of step (b); and <br class="style-scope patent-text"> (D) isolating and purifying the gougerotin or gougerotin analog from the culture product of the transformant of step (c); <br class="style-scope patent-text"> Said method.</span>
    </claim-text>
  </claim>
  <claim num="76" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  トランスジェニック原核生物細胞であって、配列番号：２、配列番号：４、配列番号：６、配列番号：１０、配列番号：１２、配列番号：１４、配列番号：１６、配列番号：１８、配列番号：２２、配列番号：２４、配列番号：２６、配列番号：２８、配列番号：３０、及び配列番号：４２からなる群から選択される少なくとも１つのアミノ酸配列に対して少なくとも７０％の配列同一性を有するアミノ酸配列をコードする核酸配列を含む、前記トランスジェニック原核生物細胞。
</span>
&nbsp;&nbsp;Transgenic prokaryotic cells, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, sequence SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, and at least 70% sequence identity to at least one amino acid sequence selected from the group consisting of SEQ ID NO: 42 The transgenic prokaryotic cell comprising a nucleic acid sequence encoding an amino acid sequence having sex.
</span>
    </claim-text>
  </claim>
  <claim num="77" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：１３のヌクレオチド配列に対して少なくとも７０％の配列同一性を有し、該配列の発現を指令するために少なくとも１の外因性及び／又は異種の調節要素に機能的に連結される核酸配列。
</span>
&nbsp;&nbsp;A nucleic acid having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 13 and operably linked to at least one exogenous and / or heterologous regulatory element to direct expression of the sequence An array.
</span>
    </claim-text>
  </claim>
  <claim num="78" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：１７のヌクレオチド配列に対して少なくとも７０％の配列同一性を有する核酸配列をさらに含む、請求項７７に記載の核酸配列。
</span>
&nbsp;&nbsp;78. The nucleic acid sequence of claim 77, further comprising a nucleic acid sequence having at least 70% sequence identity to the nucleotide sequence of SEQ ID NO: 17.
</span>
    </claim-text>
  </claim>
  <claim num="79" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：１、配列番号：３、配列番号：５、配列番号：９、配列番号：１１、配列番号：１５、配列番号：２１、配列番号：２３、配列番号：２５、配列番号：２７、配列番号：２９、及び配列番号：４１からなる群から選択されるヌクレオチド配列に対して少なくとも７０％の配列同一性を有する少なくとも１の核酸配列をさらに含む、請求項７７又は７８に記載の核酸配列。
</span>
&nbsp;&nbsp;SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25, SEQ ID NO: 27, 79. The nucleic acid sequence of claim 77 or 78, further comprising at least one nucleic acid sequence having at least 70% sequence identity to a nucleotide sequence selected from the group consisting of SEQ ID NO: 29 and SEQ ID NO: 41. .
</span>
    </claim-text>
  </claim>
  <claim num="80" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">
  配列番号：１、配列番号：３、配列番号：５、配列番号：９、配列番号：１１、配列番号：１３、配列番号：１５、配列番号：１７、配列番号：２１、配列番号：２３、配列番号：２５、配列番号：２７、配列番号：２９及び配列番号：４１からなる群から選択される核酸配列に対して少なくとも７０％の配列同一性を有している核酸配列であって、さらに、外因性の制限酵素開裂部位を含む核酸配列を含んでいる、前記核酸配列。
</span>
&nbsp;&nbsp;SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 23, A nucleic acid sequence having at least 70% sequence identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO: 25, SEQ ID NO: 27, SEQ ID NO: 29 and SEQ ID NO: 41, The nucleic acid sequence comprising a nucleic acid sequence comprising an exogenous restriction enzyme cleavage site.
</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (7)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS4625026B1/en"><a id="link" href="#" class="style-scope state-modifier">JPS4625026B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1968-09-11</span>
                    <span class="td style-scope patent-result">1971-07-19</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PL82003B1/en"><a id="link" href="#" class="style-scope state-modifier">PL82003B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1971-08-03</span>
                    <span class="td style-scope patent-result">1975-10-31</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE2513249C2/en"><a id="link" href="#" class="style-scope state-modifier">DE2513249C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1974-03-28</span>
                    <span class="td style-scope patent-result">1983-11-03</span>
                    <span class="td style-scope patent-result">Takeda Chemical Industries, Ltd., Osaka</span>
                    <span class="td style-scope patent-result">
  Antibiotic B-98891 Process for its production and plant protection products containing it
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS53109998A/en"><a id="link" href="#" class="style-scope state-modifier">JPS53109998A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1977-03-08</span>
                    <span class="td style-scope patent-result">1978-09-26</span>
                    <span class="td style-scope patent-result">Nippon Soda Co Ltd</span>
                    <span class="td style-scope patent-result">Preparation of miticide, gougerotin 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101822273B/en"><a id="link" href="#" class="style-scope state-modifier">CN101822273B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-21</span>
                    <span class="td style-scope patent-result">2012-05-09</span>
                    <span class="td style-scope patent-result">中国农业科学院草原研究所</span>
                    <span class="td style-scope patent-result">Application of streptomyces microflavus in alfalfa disease control 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103183729B/en"><a id="link" href="#" class="style-scope state-modifier">CN103183729B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-12-29</span>
                    <span class="td style-scope patent-result">2014-09-17</span>
                    <span class="td style-scope patent-result">中国科学院微生物研究所</span>
                    <span class="td style-scope patent-result">Protein system associated with biosynthesis of gougerotin, and encoding gene cluster and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20140107061A1/en"><a id="link" href="#" class="style-scope state-modifier">US20140107061A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-11</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Bayer Cropscience Lp</span>
                    <span class="td style-scope patent-result">Novel strains of streptomyces microflavus and methods of their use to control plant diseases and pests 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (8)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112015018693A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112015018693A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-02-11</span>
                    <span class="td style-scope patent-result">2017-07-18</span>
                    <span class="td style-scope patent-result">Bayer Cropscience Lp</span>
                    <span class="td style-scope patent-result">
  compositions comprising a streptomyces-based biological control agent and an insecticide
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015048627A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015048627A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-09-30</span>
                    <span class="td style-scope patent-result">2015-04-02</span>
                    <span class="td style-scope patent-result">Bayer Cropscience Lp, A Delaware Limited Partnership</span>
                    <span class="td style-scope patent-result">Streptomyces microflavus strains and methods of their use for the treatment and prevention of citrus greening disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3209130B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3209130B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-17</span>
                    <span class="td style-scope patent-result">2023-03-01</span>
                    <span class="td style-scope patent-result">BASF Corporation</span>
                    <span class="td style-scope patent-result">Compositions comprising recombinant bacillus cells and another biological control agent 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102394938B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102394938B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-05-21</span>
                    <span class="td style-scope patent-result">2022-05-09</span>
                    <span class="td style-scope patent-result">삼성전자주식회사</span>
                    <span class="td style-scope patent-result">Semiconductor devices and methods of manufacturing semiconductor devices 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107488655B/en"><a id="link" href="#" class="style-scope state-modifier">CN107488655B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-06-12</span>
                    <span class="td style-scope patent-result">2021-07-09</span>
                    <span class="td style-scope patent-result">中国科学院分子细胞科学卓越创新中心</span>
                    <span class="td style-scope patent-result">Method for removing 5 'and 3' adaptor connection by-products in sequencing library construction 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110551739A/en"><a id="link" href="#" class="style-scope state-modifier">CN110551739A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-01</span>
                    <span class="td style-scope patent-result">2019-12-10</span>
                    <span class="td style-scope patent-result">武汉大学</span>
                    <span class="td style-scope patent-result">Pyrazolomycin biosynthesis gene cluster, recombinant bacterium and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN112980627A/en"><a id="link" href="#" class="style-scope state-modifier">CN112980627A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-03-22</span>
                    <span class="td style-scope patent-result">2021-06-18</span>
                    <span class="td style-scope patent-result">山西五台山天域农业开发有限公司</span>
                    <span class="td style-scope patent-result">Quinoa whisky and preparation method thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN117264851B/en"><a id="link" href="#" class="style-scope state-modifier">CN117264851B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-11-10</span>
                    <span class="td style-scope patent-result">2024-02-09</span>
                    <span class="td style-scope patent-result">中国热带农业科学院三亚研究院</span>
                    <span class="td style-scope patent-result">Streptomyces strain and application thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2015534950A/en"><a id="link" href="#" class="style-scope state-modifier">JP2015534950A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-12-07</span>
                    <span class="td style-scope patent-result">
  Streptomyces microflavus strain and methods for its use for controlling plant diseases and pests
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6359696B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6359696B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-07-18</span>
                    <span class="td style-scope patent-result">
  Sixteen-membered macrolide compounds and their use
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101163986B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101163986B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">Bacillus velezensis g341 strain and method for controlling plant diseases using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN111356761A/en"><a id="link" href="#" class="style-scope state-modifier">CN111356761A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-06-30</span>
                    <span class="td style-scope patent-result">Methods and compositions for biological control of plant pathogens 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/13707909307750290498"><a id="link" href="#" class="style-scope state-modifier">Hu et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014</span>
                    <span class="td style-scope patent-result">Formulations of Bacillus subtilis BY-2 suppress Sclerotinia sclerotiorum on oilseed rape in the field</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8101732B2/en"><a id="link" href="#" class="style-scope state-modifier">US8101732B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-01-24</span>
                    <span class="td style-scope patent-result">Methods of producing validamycin A analogs and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005090553A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005090553A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-09-29</span>
                    <span class="td style-scope patent-result">Bacillus subtilis strain having antagonistic activity for controling plant diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20200029571A1/en"><a id="link" href="#" class="style-scope state-modifier">US20200029571A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-01-30</span>
                    <span class="td style-scope patent-result">Bacterial strain bacillus amyloliquefaciens subsp plantarum bs89 as agent for increasing productivity of plants and protecting same from diseases 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102375336B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102375336B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-03-17</span>
                    <span class="td style-scope patent-result">Composition for controlling plant diseases using Brevibacillus brevis HK544 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101456171B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101456171B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-10-31</span>
                    <span class="td style-scope patent-result">Plant growth promotion by using bacterial strains isolated from roots of Miscanthus sacchariflorus 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW201605348A/en"><a id="link" href="#" class="style-scope state-modifier">TW201605348A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-16</span>
                    <span class="td style-scope patent-result">Streptomyces microflavus strains and methods of their use to control plant diseases and pests 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1041887A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1041887A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-11</span>
                    <span class="td style-scope patent-result">Biocontrol agents for control of root diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/15472847419095929381"><a id="link" href="#" class="style-scope state-modifier">Cheng et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016</span>
                    <span class="td style-scope patent-result">Endophytic Bacillus subtilis MJMP2 from Kimchi inhibits Xanthomonas oryzae pv. oryzae, the pathogen of Rice bacterial blight disease</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110699288B/en"><a id="link" href="#" class="style-scope state-modifier">CN110699288B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-03-18</span>
                    <span class="td style-scope patent-result">Bacillus amyloliquefaciens strain for preventing and treating potato black nevus, microbial inoculum and application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015048627A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015048627A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-04-02</span>
                    <span class="td style-scope patent-result">Streptomyces microflavus strains and methods of their use for the treatment and prevention of citrus greening disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20140107061A1/en"><a id="link" href="#" class="style-scope state-modifier">US20140107061A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Novel strains of streptomyces microflavus and methods of their use to control plant diseases and pests 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2021255181A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2021255181A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-12-23</span>
                    <span class="td style-scope patent-result">Bacteria 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20140106406A1/en"><a id="link" href="#" class="style-scope state-modifier">US20140106406A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Gene cluster for the production of gougerotin, gougerotin analogues, and precursors thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/14771608727582307886"><a id="link" href="#" class="style-scope state-modifier">Hyun et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999</span>
                    <span class="td style-scope patent-result">Isolation and evaluation of protective effect against Fusarium wilt of sesame plants of antibiotic substance from Bacillus polymyxa KB-8</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN113980945B/en"><a id="link" href="#" class="style-scope state-modifier">CN113980945B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-10-20</span>
                    <span class="td style-scope patent-result">Trichoderma viride histone deacetylase and encoding gene and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN112898389A/en"><a id="link" href="#" class="style-scope state-modifier">CN112898389A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-06-04</span>
                    <span class="td style-scope patent-result">Coding protein sequence and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN117165453A/en"><a id="link" href="#" class="style-scope state-modifier">CN117165453A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-12-05</span>
                    <span class="td style-scope patent-result">Method for improving biocontrol fungi insecticidal toxicity by cross-species interference of insect genes by non-coding small RNA 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN112314631A/en"><a id="link" href="#" class="style-scope state-modifier">CN112314631A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-02-05</span>
                    <span class="td style-scope patent-result">Biological source pesticide and preparation method thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008075907A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2008075907A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-06-26</span>
                    <span class="td style-scope patent-result">Oxyporus latemarginatus strain having antagonistic activity against plant diseases 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (17)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201261712626P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-10-11</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/712,626<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-10-11</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201261714267P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-10-16</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/714,267<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-10-16</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201261718674P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-10-25</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/718,674<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-10-25</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201261734541P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/734,541<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201361759955P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-02-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201361759977P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-02-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/759,955<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-02-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/759,977<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-02-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2765200A1/en"><a id="link" href="#" class="style-scope state-modifier">EP13154355.5A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-02-07</span>
                    <span class="td style-scope patent-result">Process for producing gougerotin employing Streptomyces microflavus strains 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        EP13154355.5<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-02-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201361879601P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-09-18</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/879,601<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-09-18</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014059275A2/en"><a id="link" href="#" class="style-scope state-modifier">PCT/US2013/064537</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">Streptomyces microflavus strains and methods of their use to control plant diseases and pests 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.483368541" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.483368541" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=586219841" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>